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ABSTRACT 
 
Digestive problems are common in calves between birth and weaning, and about 25% of 
pre-weaned heifer population in the US commonly presents diarrhea. Moreover, about 57% of 
the mortality in pre-weaned heifers is due to diarrheal disease. Costs associated with high 
mortality and reduced productivity exceed $200 million annually. 
Part of the problem is that methods to assess gut health in pre-weaning dairy calves at the 
farm level are not well defined. Aside from sound facility hygiene protocols, there is a lack of 
effective preventive gut health schemes and mostly ex-post therapeutic schemes are available. 
Development of complementary ex-ante quantitative models based on gut health measures at the 
calf and tissue level could help prevent disease.  
Here, results from analysis of calf level data are reported, where quantitative changes in 
calf gut health throughout the first month of life as measured by fecal scores, and their 
relationship with thermal variability, blood protein and bodyweight at birth, are described. We 
also assessed the changes in calf gut health as measured by intestinal paracellular permeability in 
response to age, failure of passive transfer, and intestinal location.  
Analysis of fecal score data indicated that risk for intestinal disease changed 
hyperbolically from 5 to 35 days with a risk peak around 13 days of age (~0.7), which agrees 
with previous reports in the literature. The variations in time, however, depended on the calf-
specific features noted above, suggesting that variables related to thermal homeostasis, passive 
immunity obtained by the calf, and variables related to fetal maturity in early life might influence 
the risk of diarrheal episodes. However, the direction and size of such effects were not consistent 
and seem to be dependent upon other unknown variables that evolve over time.   
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On the other hand, gut health as measured by paracellular permeability in Ussing 
chambers appeared not to be intrinsically related with time but colon appeared to be the tissue 
having the largest changes in permeability compared to other GIT regions. Also, failure of 
passive transfer appeared to have no influence on gut health at the tissue level even though it 
reduced the odds (0.84/day) of scour episodes at the calf level. More data on intestinal 
permeability should be collected in response to key predictor variables. Furthermore, indicators 
of gut health other than just permeability need to be evaluated for development and 
implementation of quantitative models to be feasible. Specific areas of search for risk factors, 
including calf immune, intestinal pathogen load and metabolomic/metabonomic profiling appear 
to be promissing for development of calf and tissue level empirical prediction models that 
support individual calf preventive care protocols.  
Another portion of this research related to the assessment of the effect of age and 
gastrointestinal location (rumen vs colon) on microbiota diversity and composition, and short-
chain fatty acid profiles of Holstein pre-ruminant calves. Compared to rumen, higher lactic acid 
bacteria abundance (e.g. Lactobacillus: 51 vs 2 %, p < 0.001) and high concentrations of lactate 
(0.1 vs 1.5 mmol/mL, p<0.05) and butyrate (0.4 vs 2.3 mmol/mL, p<0.05) were observed in the 
colon at 2 and 4 weeks of age. Comparatively, ruminal microbiota was not stable and varied 
more between animals by 4 weeks of age. Such microbiota and fermentation profiles in the hind 
gut could help prevent diarrheal infections. 
In addition, the prebiotic potential of enzymatically treated whey permeate rich in 
galactooligosacharides was evaluated. Galactooligosacharide (GOS) supplementation at 3.4% of 
dietary dry matter caused a dramatic increase in the lactobacillus (Control: 39, GOS: 63%) and 
bifidobacterium (Control: 2.3, GOS: 5.6%) populations along with more developed intestinal 
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epithelial structures. Nevertheless, greater odds (2.36, p<0.001) of higher fecal scores, indicative 
of diarrhea, were observed as a result of prebiotic supplementation. Because epithelium barrier 
function was unaffected, we hypothesize that a laxative effect from prebiotic overdosing caused 
the diarrhea like condition observed in these animals. Definition of the galactooligosacharide 
dose response curves and its dependence on milk feeding rates is crucial to optimize use of this 
prebiotic in terms of calf health. 
Lastly, another experiment was conducted to test the hypothesis that glucose, non-
metabolizable glucose, stevioside and a glutamate source could enhance GLP-2 secretion and 
thereby increase gut growth or health of newborn Holstein calves. No effect of any treatment on 
intestinal growth and development, as measured by epithelium histomorphological dimensions, 
cellular proliferation, gastrointestinal organ size or the mRNA expression of the GLP2 signaling 
pathway, was observed. Such lack of response was perhaps due to consideration of one single 
fixed food intake rate and failure to identify supplementation levels that could stimulate incretin 
release, even though previously published and non-published work with models such as lambs 
and pigs, respectively, had detected responses at these concentrations. Species-specific 
sensitivity to sweet flavor or glutamate may render direct dose extrapolation between species 
inappropriate. Species-specific dose response surfaces, likely in interaction with food intake 
levels, may provide a better approach to optimize the incretin release response. 
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CHAPTER I 
 
LITERATURE REVIEW 
 
Introduction 
Digestive health in pre-weaning calves. Digestive problems are common in calves 
between birth and weaning. According to the last national survey conducted by The National 
Animal Health Monitoring System (NAHMS, 2010), about 25% of pre-weaned heifers in the US 
had diarrheal diseases during 2007. Moreover, 7.8 % of the pre-weaned heifers died during this 
period and scours or other digestive problems accounted for 57% of this mortality (NAHMS, 
2007). Costs associated with high mortality and reduced productivity exceed $200 million 
annually, excluding expenses of antibiotic treatment, lost feed, labor and overhead costs 
(Quigley et al., 2005).   
Scours (i.e., feces with dry matter below 10%) in the newborn calf involve an interaction 
between one or more pathogenic bacterial, viral or protozoal microorganisms; the immune status 
of the calf; and the environment. It is estimated that enterotoxigenic Escherichia coli (ETEC), 
rota- and corona-viruses, and Cryptosporidium spp. together account for 75 to 95 % of all cases 
of neonatal calf diarrhea (Butler and Clarke, 1994).    
Neonatal calf diarrhea can take place in calves from 3 to 21 days of age and leads to loss 
of extracellular fluids and electrolytes (Butler and Clarke, 1994). The onset and duration of a 
diarrheal episode will depend on the number of pathogens involved and the immune condition of 
the animal (Butler and Clarke, 1994). In chronic cases, bodyweight loss results from dehydration 
and muscle wasting due to protein catabolism induced by inadequate caloric intake and poor 
digestion (Butler and Clarke, 1994).   
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The resultant growth delay may have major financial consequences in the long run for the 
farm. A recent report on the impact of pre-weaning growth performance on first lactation yield of 
dairy cows in a research herd found that, for every 1 kg of pre-weaning average daily weight 
gain (ADG), heifers, on average, produced 850 kg more milk during their first lactation and 235 
kg more milk for every megacalorie of metabolizable energy intake above maintenance; 
whereas, in a commercial herd, for every 1 kg of preweaning ADG, milk yield increased by 
1,113 kg in the first lactation and, further, every 1 kg of prepubertal ADG was associated with a 
3,281 kg increase in first-lactation milk yield (Soberon et al., 2012). Moreover, prepubertal 
growth also determines the age at first breeding and first lactation; while calving below optimal 
bodyweight (BW) results in lower milk yield (NAHMS, 2010).   
Calf diarrhea and intestinal function and integrity 
Etiology of diarrhea in calves. Development of microbial populations in the 
gastrointestinal tract (GIT) of the newborn calf commences soon after birth (Izzo et al., 2011) 
and while pathogens autochthonous to the gut ecosystem can live in harmony with the host 
during this process, they can become pathogenic under certain circumstances (Izzo et al., 2011). 
Some commensal organisms such as Bifidobacteria and Lactobacilli species have been linked to 
increased resistance to pathogen infection and diarrheal disease (Izzo et al., 2011) by, for 
instance, competing for nutrients and attachment sites in the gut epithelium, producing 
bacteriocins, increasing production of short-chain fatty acids (SCFA) that lower intestinal pH, 
and stimulating the immune system (Izzo et al., 2011). But under specific calf and environmental 
circumstances, as of yet not fully understood, pathogens can override the colonization resistance 
of such commensal organisms, spread and cause infection.   
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Thus, the most commonly incriminated agents in neonatal calf scours include viral 
(rotavirus and coronavirus), protozoal (Cryptosporidium parvum) and bacterial pathogens 
(enterotoxigenic Escherichia coli and Salmonella spp.) (Izzo et al., 2011). 
These pathogens colonize and spread through distal small and proximal large intestine 
(Butler and Clarke, 1994), and can cause secretory or exudative diarrhea. For example, ETEC 
and Salmonella spp. produce toxic peptides that induce secretory diarrhea where electrolyte and 
water secretion is triggered by the direct effect of the toxin on the cell’s secretory system as 
mediated by adenylyl cyclase and cyclic adenosine monophosphate (cAMP)synthesis. However, 
like rotavirus and coronavirus, they can also impact the intestinal tissue and cause cell loss and 
tissue disruption, thereby compromising the epithelial barrier function. This leads to exudative 
diarrhea with water, electrolytes, mucus, and protein accumulating luminally as a result of 
permeability loss (Sears, 2000; Field, 2003; Ulluwishewa et al., 2011).   
Pathogen-induced secretory diarrhea. Chloride secretion is the principal determinant 
of luminal water outflow. With Cl
-
 secretion, paracellular movement of Na
+
 follows. The 
resulting accumulation of luminal NaCl provides an osmotic gradient for the diffusion of water 
(Field, 2003). 
 In the case of secretory diarrhea induced by ETEC, a heat labile enterotoxin can bind to a 
glycolipid in the enterocyte membrane where it is endocytosed into the cell to elicit activation of 
adenylyl cyclase and synthesis of cAMP, which causes an increase in its cellular concentration 
[cAMP] (Field, 2003). High [cAMP] induces electrolyte net secretion by: (a) stimulation of Cl
–
 
secretion into the lumen against the electrochemical gradient, and (b) inhibition of NaCl 
absorption (Field, 2003; Croxen and Finlay, 2010). 
 4 
 
High [cAMP] causes Cl
-
 secretion into the lumen by opening the Cl
-
 secretory channel 
(CFTR) on the apical membrane, thereby triggering its dumping into the intestine (Croxen and 
Finlay, 2010).  
At the same time, the high [cAMP] opens a basolateral membrane K
+
 channel that 
enables K
+
 efflux, hence re-polarizing the cell and counteracting the depolarizing effect of the 
opening of the Cl
–
 channel, which maintains the electrical driving force for the continued Cl
–
 
secretion into the lumen. High [cAMP] also enhances the basolateral influx of Cl
-
 into the cell 
through the NaK2Cl channel to sustain prolonged Cl
-
 secretion into the intestine. The net result is 
Cl
-
 secretive loss (Berkes et al., 2003). As a result, during secretion, the cell’s electric potential is 
~ -40 to -50 mV and the serosal potential is 5 to 30 mV, both relative to the lumen (Berkes et al., 
2003). This transcellular potential difference drives Na
+
 movement into the lumen through the 
lateral paracellular spaces in order to reach electroneutrality. Water follows Na+ and Cl- 
intestinal secretion osmotically (Berkes et al., 2003; Field, 2003; Croxen and Finlay, 2010). 
Pathogen-induced exudative diarrhea. In the case of exudative diarrhea, enteric 
pathogens disrupt the intestinal barrier either by directly binding to cell-surface molecules and 
inducing changes in tight junction (TJ) proteins or indirectly by releasing toxins, which cause 
cell damage, alter epithelial ion transport, and disrupt TJ and the cytoskeleton (Sears, 2000; 
Groschwitz and Hogan, 2009; Croxen and Finlay, 2010; Ulluwishewa et al., 2011).  
Tight junctions are adhesive junctional protein complexes between epithelial cells that 
form a continuous belt-like ring around the cells. These multiprotein complexes function as a 
semipermeable paracellular barrier, which facilitates the passage of ions and solutes through the 
intercellular space while preventing the translocation of luminal antigens, microorganisms, and 
their toxins. The TJ consist mainly of 3 families of interacting transmembrane proteins: occludin, 
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claudins, and junctional adhesion molecules (JAM). These proteins interact extracellularly with 
each other to hold adjacent cells together and intracellularly with adaptor proteins such as zonula 
occludens 1, 2, and 3 (ZO-1, ZO-2, ZO-3) that link them to the actin cytoskeleton of the cell, 
thereby tightening the whole structure and maintaining the selective permeability capacity of the 
tissue (Liu et al., 2005; Turner, 2006). Pathogen disturbance of the TJ with the concomitant loss 
of selective permeability is illustrated below.     
For instance, enteropathogenic Escherichia coli (EPEC) attachment and infection 
stimulates phosphorylation of the myosin light chains (MLC) by MLC kinase, inducing 
contraction of the perijunctional actomyosin ring. This exerts tension on the cell membrane in 
the region of the zonula adherens where the perijunctional actomyosin ring inserts. This tension 
is transmitted to the TJ thereby increasing paracellular permeability. Additionally, EPEC also 
causes occludin dephosphorylation and relocation from the TJ into the cytosol of the cell, further 
disrupting the TJ and increasing permeability (Sears, 2000; Groschwitz and Hogan, 2009; 
Ulluwishewa et al., 2011). Gutmann et al. (2006) showed that in vivo infection with a pathogen 
capable of attaching to and effacing the microvillus border of the enterocyte, similar to EPEC, 
caused alteration of theTJ by relocation of the transmembrane TJ proteins claudin 1, 3, and 5. 
This resulted in increased permeability and colon luminal water content (Guttman et al., 2006).  
Another example is the toxin produced by Clostridium perfringens. Exposure of intestinal 
cells to the toxin results in tissue damage followed by fluid and electrolyte secretion and 
increased tissue permeability. Structurally, this toxin has been shown to induce disruption of TJ 
fibrils and remove claudin 4 from the TJ in vitro (Berkes et al., 2003).       
Also, exposure to the toxins A and B produced by Clostridium difficile causes 
degradation of the cytoskeleton filamentous actin leading to increased permeability and 
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paracellular flux, possibly due to TJ disruption. Parallel to this is the direct effect on the 
relocation of TJ proteins such as ZO-1 and occludin away from the TJ and into the cytoplasm of 
the cell (Berkes et al., 2003).  
Furthermore, in vitro, exposure of Caco-2 cells to rotavirus has resulted in increased 
paracellular permeability and disorganization of occludin as well (Sears, 2000).  
Immune status of the calf and its impact on animal health 
 As mentioned above, the immune status plays a major part in neonatal calf diarrhea 
(Butler and Clarke, 1994). Immunoglobulins transferred from the cow to the calf through the 
colostrum are all the immune endowment of the offspring at birth. Poor immunoglobulin transfer 
is called failure of passive transfer (FPT) and is linked to increased neonatal morbidity and 
mortality in dairy calves (Robison et al., 1988; Quigley et al., 2005). According to NAHMS 
(NAHMS, 2010), the estimated prevalence of FPT in US dairy heifer calves is about 20%.  
On the other hand, although all essential immune components are present in neonates at 
birth, many of the components are not functional until calves are at least 2 to 4 weeks of age and 
may continue to develop until puberty. In part, this is related to immune suppression from 
placental production of progesterone, prostaglandin E2, and cytokines (e.g., IL-4 and Il-10) that 
affect the near-term fetus and the dam and suppress cell-mediated and memory (TH1) responses 
(Chase et al., 2008). Cows also produce estrogen and cortisol before parturition that have 
immunosuppressive effects. Finally, as part of the parturition process calves produce high levels 
of cortisol; which remain elevated for the first weeks of life. Thus, the cumulative effect of these 
hormones is to suppress immune responses and direct the immune response away from the TH1 
response (Chase et al., 2008).    
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Furthermore, stress related suppression of the active immune system has also been related 
with intestinal infection and pathogen shedding (Vilte et al., 2011). The term “super shedders” 
has been used to describe animals which shed E. coli O157 at higher levels and for a longer 
duration compared to other animals in the same herd. One possible factor that may influence the 
presence of “super shedders” is immunosuppression potentially related to stress. Indeed, 
dexamethasone-treated calves (i.e. corticosteroid immunodepressed) have been shown to 
increase E. coli shedding by ~33% (p=0.04) during the days when they are immunosuppressed 
but not in the long-term. This is accompanied by a reduction of ~70% in the number of 
lymphocytes and an increase in the number of neutrophil granulocytes of ~47% in blood 
(Sreerama et al., 2008). However, when calves have been vaccinated against intimin and EspB, 
the virulence factors of E. coli O157, significantly higher levels of IgG (~ 4-7 fold, p<0.05) in 
blood have been induced for about 8 weeks. The greater immune status achieved by vaccination 
was followed by a ~38% lower pathogen shedding (p<0.05) over the course of 2 weeks 
compared to non-immunized animals (Vilte et al., 2011).  
At the farm level, management practices like allowing for the newborn to spend longer 
than 1 hour with the dam have been associated with 59% greater odds of diarrhea (Trotz-
Williams et al., 2007).  
Altogether, GIT microbial colonization  disturbance, intake and absorption of colostrum 
immunoglobulins by neonates, degree of perinatal immune suppression induced by hormonal 
changes in the dam and calf, calf stress and pathogen exposure levels defined by management 
practices, for instance, could potentially determine a large portion of the risk factors for intestinal 
infection issues in the pre-weaning calf.     
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Finally, thorough understanding of those risks factors will provide the opportunity for 
preventive action aimed at diminishing the effects of diarrhea in newborn calves. Clear definition 
of risk factors will also allow better evaluation of nutritional interventions to improve intestinal 
wellness, overall health and even maybe growth performance. 
Within this framework, 4 research manuscripts are presented in this document that focus 
on the following topics:  
1. Definition of gut health and how it can be measured for prognostic purposes.  
2. Changes in composition and activity of the intestinal microbiome during the calf’s first 
month of life and their potential role in gut health. 
3. Evaluation of the prebiotic potential of a galactooligosacharide rich milk replacer on 
intestinal microbiome composition, short-chain fatty acids, intestinal function and 
development, and calf growth performance. 
4. Evaluation of supplements with secretagogue potential to promote gut development 
through enhanced release of glucagon like peptide 2. 
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CHAPTER II 
 
 
 
 
CALF INTESTINAL HEALTH ASSESSMENT DURING THE BIRTH TO 
WEANING PERIOD 
 
ABSTRACT 
Methods to assess gut health in pre-weaning dairy calves in farms are not well defined. 
Simultaneous use of subjective methods like scoring systems and objective methods like 
biomarkers or intestinal function measurements can provide a more integral assessment that 
leads to targeted therapeutic strategies for intestinal infection. Also, eventual replacement of ex-
post diagnostic therapy protocols for quantitative ex-ante forecasting prevention schemes may be 
desirable to reduce the financial impact of diarrheal disease on farms and improve calf welfare.  
Here we have quantified the changes in calf gut health throughout the first month of life 
as measured by fecal scores and their relationship with thermal variability, blood protein, and 
bodyweight at birth. We also assessed the changes in calf gut health as measured by intestinal 
paracellular permeability in Ussing chambers, in response to age, failure of passive transfer, and 
intestinal location. Analysis of fecal score data indicated risk for diarrhea changed hyperbolically 
from 5 to 35 days with a risk peak around 13 days of age, which agrees with previous reports in 
the literature. The variations in time, however, depended on the calf-specific features noted 
above, suggesting that variables related to thermal homeostasis, passive immunity obtained by 
the calf, and perhaps variables related to fetal maturity in early life, might influence the risk of 
diarrheal episodes occurrence. However, the direction and size of such effects was not consistent 
and seem to be dependent upon other unknown variables that evolve over time.   
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On the other hand, gut health as measured by paracellular permeability appeared not to be 
intrinsically related with time but colon appeared to be the tissue to undergo the largest changes 
in permeability compared to other GIT regions. Also, blood protein (i.e., failure of passive 
transfer) appeared to have no influence on gut health at the tissue level even though it affected 
the risk of scour episodes at the calf level.  
Finally, while further evaluation of epithelial permeability in response to meaningful 
predictor variables should be conducted, indicators of gut health other than just permeability 
need to be evaluated for development and implementation of quantitative models to be feasible. 
Specific areas of search for gut health risk factors, including calf immune, intestinal pathogen 
load and metabolomic/metabonomic profiling appear to be promissing to eventually develop 
complementary calf and tissue level empirical prediction models that support individual calf 
preventive care protocols. 
INTRODUCTION 
Digestive problems are common in calves between birth and weaning. According to the 
last national survey conducted by The National Animal Health Monitoring System (NAHMS, 
2010), about 25% of pre-weaned heifers in the US had diarrheal diseases during 2007. Moreover, 
7.8 % of the pre-weaned heifers died during this period and scours or other digestive problems 
accounted for 57% of this mortality (NAHMS, 2010). Costs associated with high mortality and 
reduced productivity exceed $200 million annually, excluding expenses of antibiotic treatment, 
lost feed, labor and overhead costs (Quigley et al., 2005).  
Neonatal calf diarrhea can take place in calves from 3 to 21 days of age and the onset and 
duration of a diarrheal episode will depend on the number of pathogens involved and the 
immune condition of the animal (Butler and Clarke, 1994).  
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Scours (i.e., feces with dry matter below 10%) in the newborn calf involve an interaction 
between one or more pathogenic bacterial, viral or protozoal microorganisms, the immune status 
of the calf, and the environment. It is estimated that enterotoxigenic Escherichia coli (ETEC), 
rota and corona viruses, and Cryptosporidium spp. together account for 75 to 95 % of all cases of 
neonatal calf diarrhea (Butler and Clarke, 1994).    
Pathogens colonize and spread through distal small and proximal large intestine (Butler 
and Clarke, 1994), and can cause secretory or exudative diarrhea. For example, ETEC and 
Salmonella spp. produce toxic peptides that induce secretory diarrhea where electrolyte and 
water secretion is triggered by the direct effect of their enterotoxins on the cell’s secretory 
system as mediated by adenylyl cyclase and cAMP synthesis. However, like rotavirus and 
coronavirus, they can also impact the intestinal epithelium at the molecular level disrupting the 
tight junctions and cytoskeleton architecture causing cell loss and tissue damage,  thereby 
compromising the epithelial barrier function (Sears, 2000; Groschwitz and Hogan, 2009; Croxen 
and Finlay, 2010; Ulluwishewa et al., 2011). This leads to exudative diarrhea with water, 
electrolytes, mucus, and protein accumulating luminally as a result of permeability loss (Sears, 
2000; Field, 2003; Ulluwishewa et al., 2011).   
But even though these mechanisms underlying both types of diarrhea are well 
documented, assessing overall gut health of calves at the farm level is not possible currently. 
Like in humans, the expression “gut health” has become commonly used in the literature and by 
the feed additive and pharmaceutical industry, but it is infrequently measured in the field since it 
is still unclear exactly what gut health is and how it can be measured (Bischoff, 2011).   
For instance, in newborn dairy calves fecal scoring scales (e.g., 1 to 4) where higher 
scores indicate poorer health are used routinely in the research setting to assess intestinal health. 
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At the farm level though, these scoring systems are replaced by pure visual appraisal of the calf 
behavior and fecal consistency. In any case, however, scoring systems provide no information on 
other aspects related to gut health such the types and abundance of pathogens causing infection, 
their impact on epithelial integrity, or the intestine mucosal immune response. A practical 
consequence is that standard antibiotic therapeutic intervention decisions are often limited and 
blindly taken (e.g., 75% of diarrhea-ill calves in 2007 were treated with antibiotics (NAHMS, 
2010). In humans, integral assessment of intestinal health has been recommended to include both 
subjective measures like scoring systems, but also biological indicators like permeability, 
histomorphology, mucus secretion, inflammatory and regulatory cytokines, immunoglobulins, 
bacterial cultures and toxin measurements (Bischoff, 2011).  
On-farm decision support tools that provide ex-ante technical guidance based on calf 
specific characteristics to reduce diarrheal incidence in pre-weaning calves are clearly non-
existent at this time. Identification of meaningful and effective risk factors to predict diarrheal 
episode occurrence based not only on scores at the calf level, but also definition of intestinal 
barrier function changes at the tissue level will be needed to build complementary quantitative 
prevention schemes that help forecast and prevent or buffer the effect of diarrhea in newborn 
calves.  
Some potentially useful farm and calf level risk factors such as failure of passive transfer 
(FPT) (Robison et al., 1988), plasma cortisol level (Sreerama et al., 2008), immunization against 
virulence factors (Vilte et al., 2011), milk feeding rate (Quigley et al., 2006), calf diarrhea 
prophylaxis of the cow, maternity facilities type and  management or time spent by the newborn 
with the cow (Trotz-Williams et al., 2007), have been related to diarrheal occurrence or pathogen 
shedding. For example, at the tissue level, immune profiling of newborn calves may uncover 
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useful predictors of gut health during the first few weeks of life, as evidence indicates that 
combining passively acquired antibodies with induced early recruitment of CD4+ and CD8+ T 
lymphocytes into the intestinal mucosa may stimulate thorough mucosal protection against 
pathogen infection and shedding (Wyatt, 2000). Newborn age and its apparent interaction with 
the environment appear also to affect gut permeability in human newborns (Weaver et al., 1984; 
van Elburg et al., 2003) and infants as well (Lunn et al., 1991).  
In clinical practice with humans it is considered that both approaches, subjective (e.g., 
scores) and objective (e.g., biomarkers and functions) gut health indicators, are complementary, 
equivalent and cannot replace each other (Bischoff, 2011). The objectives of this work were to: 
1) quantify the effect of age, serum protein level (BP), body temperature at the first 24 (BT_24), 
48 (BT_48) and 72 hours of life (BT_72), variation in body temperature during the first 72 hours 
of life (TV), and birth BW on the occurrence of diarrhea, 2) assess the effect age, FPT and 
gastrointestinal (GIT) site on epithelial paracellular permeability during the first month of life of 
Holstein calves, and 3) qualitatively contrast observations on diarrheal events at the calf level 
(i.e., subjective gut health measure) with changes in permeability at the tissue level to identify 
patterns (i.e., objective gut health measure) and discuss their potential degree of 
complementarity.    
MATERIALS AND METHODS 
Effect of Age and Other Newborn Calf Characteristics on the Occurrence of Diarrheal 
Episodes 
Two data sets from studies conducted in our laboratory where fecal scores were measured 
daily were used to define the relationship of age, BP, BT_24, BT_48, BT_72, TV and birth BW 
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of the new born calf with the probability of occurrence of a diarrheal episode during the first 
weeks of life.  
To this purpose, a mixed effects logistic regression model containing such effects was fit 
to this repeated measures dataset. Adding a random intercept to model the calf-to-calf variability 
is reasonable because two levels of variability must be differentiated, namely, variation between 
and variation within calves (Schabenberger and Pierce, 2002). This approach also aids in 
accounting for autocorrelation between observations from the same calf over time 
(Schabenberger and Pierce, 2002).   
In the first experiment (GAM), 93 calves were employed. The objective of that trial was 
to evaluate a plasma protein based formula for newborn calves on performance, morbidity, and 
mortality in the pre-weaning period. Feeding rate was 1.5% of BW as DM and grain was fed ad 
libitum during the first month of life. In the second experiment (GOS), 48 calves were employed. 
The objective of that experiment was to evaluate the effect of inclusion of prebiotics on intestinal 
health and development, and performance during the pre-weaning period. Feeding rate was 2% 
of BW as DM and, unlike GAM, no grain was fed during the first month of life.  
Calves from both experiments originated from a sale barn, were ~72 ours old, and were 
evaluated by the veterinary staff upon arrival to UIUC research facilities. The evaluation 
included hydration status, alertness, mobility, navel status, and body temperature. A blood 
sample was obtained by jugular venipuncture and plasma protein was determined by 
refractometry. Calves were then weighed and body temperatures recorded for the first 5 days.   
Fecal scores were recorded daily with a scale from 1 to 4 where: 1= dry, hard; 2 = soft 
and formed to pudding-like; 3 = mix of liquids with some solids; and 4 = liquid. 
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Fecal scores were then binary coded as 1 if the fecal score was 3 or 4 and as 0 if the fecal 
score was 1 or 2. Therefore, the event of a diarrheal episode Yij, conditional upon the predictor 
variables Xij and the random effects bi, was considered a Bernoulli distributed random variable:   
                             
Where, Yij represents the occurrence of a diarrheal episode on the j
th
 day for the i
th
 calf 
with mean probability πij to be estimated. The probability of no occurrence is thus 1- π. A logit 
link function was used to linearly relate the predictor variables in Xij with πij as: 
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Thus, Xij contained the fixed effects of study (GAM, GOS), age, BP, BT_24, BT_48, 
BT_72, TV and birth BW. Birth BW and TV were coded as dummy variables and calves were 
considered to present “normal” BW if above the 50th percentile (40.7 kg) or “underweight” 
otherwise, while TV values above and below the 50
th
 percentile (0.69) were deemed as ‘High’ 
and ‘Low’ thermal variability, respectively. B is a vector of regression parameters for the fixed 
effects; Zi is the random effects design matrix which only contained an intercept for the i
th
 calf 
and b is the random effects parameter vector. Descriptive statistics and the rationale to include 
each independent variable are shown in Table 2.1.   
 18 
 
From exploratory plots (Figure 2.1) of the observed log odds for diarrheal episodes (i.e 
scores 3 and 4), the following specific hypotheses were defined based on non-parametric Loess 
smoothing with 95% confidence bands: the log odds 1) change quadratically with time (Figure 
2.1a), 2) increase with lower BP (i.e. FPT) but this effect may vary with age and depend on the 
study (GAM vs GOS; Figure 2.1b), 3) are higher for the 50% of the population with lower birth 
BW but this effect may vary with age and differ among studies (Figure 2.1c), 4) are higher for 
the 50% of the population whose TV in the first 72 hours of life is larger but this effect may vary 
with age and differ among experiments (figure 2.1d). Body temperature at 24, 48 and 72 hours 
showed no relationship with diarrhea and thus no specific hypotheses were formulated. 
Preliminary model development and selection was based on Wald t-tests, Wald t confidence 
intervals, deviance tests and corrected Akaike Information Criteria (Bolker et al., 2009; 
Fitzmaurice et al., 2011).  
Three final models are reported (Table 2.2). Model 1 displayed the greatest deviance and 
AICc reduction compared to an empty model (i.e., only intercept model) and considers, aside 
from the study effect, the linear and quadratic effect of age along with TV and its interaction 
with time and experiment. It was, in turn, considered the reduced model against which models 2 
and 3 were compared. Model 2 considers the linear and quadratic effect of age as well as the 
impact of BP and its interaction with age and experiment. Model 3, in turn, considers the linear 
and quadratic effect of age, the effect of BW and its interaction with age and experiment. Blood 
protein and BW were considered separately because, when in the same model, autocorrelation of 
their 3-way interactions with age and experiment would render them non-significant despite their 
large individual contributions to lower deviance compared to model 1. The BT_24, BT_48, 
BT_72 did not affect the probability of diarrheal events and thus were discarded. 
 19 
 
Inclusion of a random intercept was justified by a reduction in the -2 x log likelihood 
from 4398 to 4155 with 1 degree of freedom. Variance components for the linear or quadratic 
effects of age or serum protein were not justified by the deviance test.  
Parameters were estimated by approximating the likelihood function using Laplace 
approximation. To estimate the day j
th
 at which the probability of a diarrheal episode (i.e., π) was 
maximal for the i
th
 animal, the first derivative of the function containing the coefficients for the 
linear and quadratic components of age from model 1 was set equal to zero (Figure 2.2): 
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Effect of age, GIT region and FPT on epithelium permeability in the calf  
Data from two different studies conducted in our lab where electrical conductance as a 
surrogate for permeability was measured were used here to define the relationship of age and 
FPT with intestinal paracellular permeability in different regions of the GIT.  
In the first experiment (“Experiment 1”), 32 newborn calves were used and 16 calves 
were slaughtered at 14 and 28 days of age. In the second experiment (“Experiment 2”), 34 calves 
were used, and 6 calves were slaughtered on each of days 0, 7, 14 and 21; whereas, 9 calves were 
slaughtered on day 28.  
In both experiments, within 20 minutes of euthanasia, pieces about 3 inch
2
 of rumen and 
7 cm long of jejunum, ileum and colon were collected for permeability measurements in 
modified Ussing chambers (Physiologic Instruments; San Diego, CA) as per Cannon (2009). 
Samples were placed in oxygenated (95% O2:5% CO2) Krebs’ solution (120 mM MgCl2, 120 
mM CaCl2, 40 mM KH2PO4, 240mM K2HPO4 , 1.15 M NaCl2, and 260 mM NaHCO3) on ice and 
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transported to the laboratory for immediate electrophysiological and ion transport analysis. Basal 
resistance was assessed upon stabilization of tissue incubation for ~20 min (Cannon, 2009). 
In experiment 1, the following hypotheses were tested: 1) Overall intestinal permeability 
differs between 14 and 28 days, and 2) Overall intestinal permeability differs between FPT 
groups. Permeability data were subjected to multivariate analysis of variance (MANOVA). 
Before conducting MANOVA variables were log transformed in order to meet multivariate 
normality assumptions. MANOVA was then performed on the 4 variables to test the effect of age 
and FPT on overall gut parcellular permeability through Wilks' Lambda, Pillai's Trace, 
Hotelling-Lawley Trace, and the Roy's Greatest Root hypothesis tests.  Subsequently, canonical 
analysis (Johnson, 1998) was performed to determine which tissue has the most weight to 
differentiate age or FPT groups in terms of epithelial permeability.  
In experiment 2, the following hypotheses were tested: 1) permeability differs among 
fore stomach, small intestine and hind gut, 2) Statistically significant changes in intestinal 
permeability occur throughout time during the first month of life in calves, 3) Changes in 
epithelial permeability throughout time will depend on the GIT location, and 4) Animals positive 
for FPT will have greater epithelium permeability compared to the negative ones.  
The following linear model was assumed to analyze the epithelium permeability data, 
               
Where yi is the set of permeability measures from the different regions of the GIT 
performed on the i
th
 calf. Permeability measures were log transformed to conform to normality. 
Observations were therefore assumed to be normally distributed with mean Xijβ and variance Vi.  
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The design matrix Xij contained the independent variable levels for age in days, GIT site, 
failure of passive transfer status (FPT=yes or no). The vector   contained the respective 
regression parameters, including an intercept.   
The error covariance matrix Vi was first fully parameterized (i.e., unstructured) to gauge 
the degree of correlation among observations along the GIT belonging to the same calf, but all 
covariance parameters were non-significant according to a Wald Z and a deviance test. However, 
variances of permeability measures were heterogeneous among GIT locations and, therefore, a 
simple heterogeneous compound symmetric structure of the form  
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was adopted simply to account for heterogeneity and to avoid pseudo-replication.   was 
estimated to be 0.09 and not different from 0 by a Wald test (p =0.36) and a deviance test 
comparing against a 0 banded heterogeneous Toeplitz (p > 0.56). Otherwise, errors met 
normality assumptions as assessed from the Pearson residuals. Permeability means from the 
different GIT locations were compared using a Bonferroni adjustment to maintain the experiment 
wise error rate at 5%. 
RESULTS 
Effect of age and other newborn calf characteristics on the occurrence of diarrheal episodes 
Table 2.2 shows the results of the logistic mixed model fitting. Model 1 indicates that 
there was a significant effect of experiment on the odds of a diarrheal episode, which is obvious 
and expected. Calves in the GAM experiment had only ~ 0.11 times the odds           
       of presenting diarrhea compared to GOS. Also, as suggested by Figure 2.1a and initially 
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hypothesized, a quadratic function seems adequate to describe the changes in the log odds of 
diarrheal events over time. Moreover, the maximal probability for a diarrheal episode to take 
place was identified at ~13 days of age (Figure 2.2). 
On the other hand, TV in the newborn calf affected the quadratic coefficient of age, 
slowing or accelerating the rate of decay in the probability of a scour event happening. This 
effect, however, was different between the GOS and GAM experiments and was larger by 1 
order of magnitude roughly in the former compared to the latter experiment. In the GAM trial 
such effect appears to be null (Figure 2.3a). The deviations from the quadratic coefficient of age 
for the reference group (i.e., -4.62 x 10
-3
 for GOS /LOW TV) were 6.98 x 10
-4
 for GOS/HIGH-
TV, -2.10x10
-3
 for GAM/LOW, and -1.83x10
-3
 for GAM/LOW; the first of which, although 
seemingly minuscule, could have a large impact in the longer term. For instance, when the 
probability functions of HIGH and LOW TV groups in the GOS experiment are compared in 
Figure 2.3a, after 2 weeks, right after the function maxima at 13 days, the two groups begin to 
separate and by day 35 the difference in the estimated probability of presenting diarrhea between 
HIGH and LOW is about 20%.  
In regards to BP in model 2, the Wald t-test and confidence intervals indicated non 
significance at a type 1 error rate of 5% but only a tendency towards an effect; however, the 
deviance test, the AICc index and a partial F test (not shown) suggested otherwise and hence it 
was deemed worth including in the model for the sake of discussion. The BP main effect was not 
significant and depended on the age of the animal instead. Like TV status, this interaction also 
was different among GOS and GAM experiments. In GAM, the log odds of a diarrheal event 
increased by 0.012 per unit increase in age per unit increase in BP; whereas, in GOS they 
decreased by -8.71x10
-3
. Figure 2.4 illustrates this interaction in terms of probability of a scour 
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event and depicts a decreasing likelihood of a scour outbreak as the calf ages in both GOS and 
GAM experiments; nonetheless, per each unit increase in BP, while holding every other variable 
constant and ignoring the intercepts, there is a further reduction in the probability of diarrhea in 
the GOS study. In contrast, BP seemed to drive such probability upwards in the GAM study. For 
instance, from 6 to 13 days of age, when diarrheal episodes appear to exacerbate, and at average 
BP of 5.6 mg/dL, the estimated probability of a scour outbreak increased from 0.57 to 0.58 in the 
GOS study; whereas, it went from 0.67 up to 0.72 in the GAM study. 
Lastly, model 3 shows that calves with normal BW had lower odds (             ) of 
presenting diarrhea compared to underweight calves (i.e. BW < 40.7 kg). Moreover, BW 
interacted with the linear component of age affecting the rate of increase of the odds of 
presenting scours, but this interaction differed between studies as well. Compared to the GOS 
study, the increase in the odds of a diarrheal episode was faster for calves in the GAM trial 
(                      ). Figure 2.3b illustrates this in terms of probability. 
Finally, none of the variables employed in the 3 models could lower the calf specific 
variance below 0.7 (Table 2.2) even though they improved the fit of the model, indicating that 
other unknown calf specific variables are responsible for the differences among calves. Yet, the 
average intra calf correlation (Fitzmaurice et al., 2011) of the score measures for the 3 models 
was ~ 0.14, indicating rather low variability among calves (14%); this is the proportion of total 
unexplained variance attributed to variation among calves (i.e., clusters). The remaining 86% is 
due to unidentified sources of variation at the repeated measure level; these are variables whose 
values change from one day to the next for a given calf and that remain to be identified.   
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Effect of age, GIT region and FPT on epithelium permeability in the calf  
Regarding the effect of age in experiment 1, all multivariate hypothesis tests were highly 
significant (P < 0.01), indicating a significant effect of age on paracellular permeability. 
Subsequently, canonical analysis was performed to determine which tissue’s epithelial 
permeability has the most importance in differentiating calves 14 and 28 days old.  
The standardized canonical coefficients indicated colon permeability to have the largest 
influence (6.5) compared to rumen (1.1), jejunum (0.88) and ileum (0.86). The product of these 
coefficients with the raw permeability data was computed to obtain a linear function so called 
canonical variable. Naturally, the degree of correlation between permeability and the canonical 
variable reflects the weight given by the standardized canonical coefficients and thus colon is the 
most highly correlated followed by ileum. In short, these correlation coefficients (Table 2.3) 
indicate that changes in colon permeability weigh most in making animals at 14 and 28 days of 
age different with respect to other tissues.  
A subsequent analysis of variance to test the effect of calf age on the estimated canonical 
variable, which could be seen as a permeability measure weighted by the relative contribution of 
each tissue, indicates that age explains about 48% of its variation and there is a significant 
difference between 14 and 28 d of age (Table 2.4). Error assumptions of normality and constancy 
were checked and met.  
The box and scatter plots below (Figure 2.5) illustrate the distribution and distance 
between the two age groups based on intestinal permeability, and also the relation between 
colonic permeability and the estimated canonical function, and how calves cluster by age in 
accordance with gut permeability.   
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On the other hand, and contrary to our initial hypothesis, FPT had no effect on 
paracellular permeability. All multivariate hypothesis tests were not significant (P > 0.6). 
In conclusion, paracellular permeabitity was statistically higher at 2 than at 4 weeks of 
age and the colon seemed to be the most affected tissue compared to other regions of the GIT. 
However, the extent to which the decrease in permeability from week 2 to 4 is an animal intrinsic 
ontogenic change or is rather due to recovery from disturbance is unknown.  
With the intent to obtain a better idea of temporal changes in epithelial permeability, we 
analyzed the experiment 2 data set, which contained measures collected at several time points 
during the first month of life. Unexpectedly, in contrast with experiment 1, we observed no 
relationship of age with permeability throughout the first month of life in the calves. Also, no 
interaction with GIT location was present. Failure of passive transfer showed no effect on 
permeability either. The GIT location main effect, however, did affect average paracellular 
permeability and jejunum and colon showed to be the most permeable epithelia while rumen and 
ileum were least (Table 2.5).  
In summary, jejunum and colon presented the highest permeability throughout the first 
month of life in experiment 2. 
DISCUSSION  
Effect of age and other newborn calf characteristics on the occurrence of diarrheal episodes 
Although rather expected, this analysis confirms through the significant study effect how 
fecal scores can differ from trial to trial or from farm to farm, due to subjective scorer perception 
and actual biological unidentified causes (e.g. diets, management, year season, etc.); therefore, 
the need for complementary underlying information is emphasized. Also, the fact that not only 
the mean probability of a scour episode differs between studies, but the fact the age regression 
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coefficients vary from one to the other, highlights the temporal dynamic and interactive nature of 
TV, BP and BW and other unknown variables that likely assume particular importance at a given 
trial or farm.    
Yet, although GAM and GOS studies differed widely in the frequency of diarrheal 
episodes, analysis of the joint data set indicates that episodes were maximal around day 13 of 
age. This observation coincides with previous reports from Canada (Trotz-Williams et al., 2007). 
Although discrete time frames have been identified for diarrhea incidence from different 
pathogens like ETEC (4 days of age), Cryptosporidium parvum (14 days of age), rotavirus (6 
days of age) and coronavirus (4 to7 days of age) (Foster and Smith, 2009) to peak in the early 
life of the calf, a diarrheal episode is the result of the joint action of several pathogen types 
(Butler and Clarke, 1994). Thus, the estimated critical point at 13 days of age is likely a sort of 
weighted average of the abundance and activity of each of various such pathogens. Assuming 
that the onset and duration of a diarrheal episode depend on the number and type of pathogens 
involved and the immune condition of the animal (Butler and Clarke, 1994), the prognostic value 
of a statistical predictive model would then lie on the knowledge of the calf specific pathogen 
intestinal load and its immune profile very early in life.  
In that sense, in the current study, BP and TV were initially reasoned as potentially sound 
indicators of the immune and inflammatory status of newborn calves, respectively, and perhaps 
good predictors of diarrheal outbreaks given their wide variability among animals and apparent 
straightforward biological meaning. However, even though FPT is linked with increased calf 
morbidity and mortality (Robison et al., 1988), BP level impacted the probability of a scour 
episode in different direction for the GOS and the GAM trials. Similarly, differential TV effects 
were seen in the GOS compared to the GAM trial. The significant but inconsistent direction of 
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these effects and their size throughout time and between studies suggests that other calf specific 
unknown variables could confound or modulate the effect of BP and TV. For instance, 
dehydration (i.e., plasma volume) can bias BP concentrations but BP effects could perhaps also 
be modulated by the pathogen population size and calf stress. Furthermore, BW, although 
lacking an obvious biological interpretation related to intestinal health, did have a direct effect 
and smaller animals were more likely to undergo illness, but this effect also varied across 
studies. At any rate, associations observed here must be cautiously interpreted because these 
predictor variables are not causal factors and, rather, are only proxy variables for underlying 
physiological process networks that ultimately define the animal response. For example, low BW 
animals many not be more prone to scours simply because they are smaller, but perhaps because 
of an immature gut that is more intolerant to food and susceptible to pathogenic infection due to 
poor mucosal barrier function as is documented with human infants with extremely low birth 
weights (Neu, 2007).   
Our observations, nonetheless, contribute information on risk factors that with further 
knowledge could indeed be practical and ‘easy to use’ predictors to forecast which newborn 
animals will likely present disease and undertake preventive intervention instead of therapeutic 
treatment after the fact. Good calf, farm and environmental level predictors such as maternity 
pen management, time spent by calf with the dam, calf-scours prophylactic dam treatment, calf 
enteropathogen shedding, birth season or facility cleanliness among others, have already shown 
promise  (Trotz-Williams et al., 2007) and warrant further evaluation in longitudinal studies.  
Moreover, measuring other colostrum components, either in the colostrum itself or calf 
blood such as IgG, cytokines (e.g., IL-4 ,  IL-6, interferon gamma and IL-10) and leukocyte (e.g., 
macrophages, lymphocytes and neurophils) concentrations could yield a more effective index of 
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passive immunity status (Chase et al., 2008). Moreover, calf cortisol and peripartum cow levels 
of hormones like progesterone, prostaglandin E2, estrogen, and cortisol could provide an index 
of the immunosuppressive status of the newborn calf (Chase et al., 2008). Although cost 
prohibitive currently, performing many such tests may become less expensive in the future as a 
preventive medicine industry develops.  
Remarkably, the fact that 86% of unknown variance is due to differences from one day to 
the next (i.e., among repeated measures), and 14% to differences among calves, suggests that 
major unidentified risk factors in this trials are evolving over time and frequent monitoring might 
be required. Empirical model robustness will eventually be achieved upon their iterative 
refinement and evaluation. 
Effect of age, GIT region and FPT on epithelium permeability in the calf  
While calf level empirical models can provide specific information about the risk of a 
calf to become ill, when and how long a scour episode can last, they provide no information on 
relevant matters like the type of predominant pathogens and intestinal infection under course 
(i.e., secretory vs. exudative diarrhea) and the concomitant changes of the intestinal barrier.  
Although gut barrier is more than simply measuring permeability (Bischoff, 2011), the 
latter can at least tell us about the integrity of the tight junctions between epithelial cells 
(Boudry, 2005), and thus hint whether diarrhea is secretory or malabsorptive.  For instance, our 
paracellular permeability measures in experiment 1 show a reduction from 2 to 4 weeks of age, 
suggesting closure of the tight junctions, but whether this is an ontogenic establishment of a low 
permeability status or a recovery from a temporal increase caused by pathogenic action in the 
first 2 weeks of life, is unknown. This dataset also highlights colon as the organ that experiences 
the largest fluctuations in this time window. On the other hand, experiment 2 identified jejunum 
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and colon as the organs with highest paracellular permeability. However, since no change 
throughout the first month of life was evidenced, those values could simply be characteristic of 
‘healthy’ epithelia in those GIT regions. Otherwise, if those calves ever presented intestinal 
infection, it did not compromise the tight junction structure.  
In addition, FPT, as a measure of immune status after birth, did not bear any influence 
upon the integrity of the intercellular space according to both experiments even though it was 
associated with the probability of diarrheal occurrence at the calf level. Variations in paracellular 
permeability (i.e., tight junction integrity) need to be further evaluated in relation to a variety of 
risk factors.    
Although the mechanisms through which pathogens like EPEC, Cryptosporidium 
parvum, rotavirus, and coronavirus damage the brush border and disrupt the tight junctions 
supporting the epithelial barrier are understood (Sears, 2000; Klein et al., 2008; Foster and 
Smith, 2009; Ulluwishewa et al., 2011), there is currently no means to predict and prevent 
infection and the concomitant barrier function loss in farms. At this time, dairy operations can 
only provide ex-post standard antibiotic and hydration therapy (NAHMS, 2007), regardless of 
whether infection is bacterial, protozoal, or viral; due partly to lack of knowledge. Thus, sound 
indicators of gut health and risk factors for intestinal barrier loss must be identified in early life 
to advance quantitative knowledge to the point where recommendations can be made based on 
calf specific characteristics during the first few days of life. 
A specific example is the realization that the intensity of Cryptosporidium parvum 
infection in the distal bowel depends on the antigen specific antibodies present in colostrum and 
the timing of calf exposure to the parasite oocytes, which determines the power of the mucosal 
immune response in terms of CD4
+
 and CD8
+
 T lymphocyte recruitment into the intestinal 
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mucosa (Wyatt, 2000). Thus, for instance, a robust equation that defines the optimal specific 
antibody concentration and exposure age at which clinical signs and shedding are minimized 
would prove useful in order to make a technical recommendation to prevent or at least control 
infection.  
Furthermore, technologies such as genomic sequencing and metabolomic/metabonomic 
profiling are suggested to be the basis for a new kind of personalized medicine in humans 
(Nicholson, 2006; Bischoff, 2011), in which the interaction between the genetic makeup of the 
individual, the current metabolic status and exogenous factors, such as exposure to pathogens, is 
quantified to determine the possible outcomes to pharmaceutical or dietary (i.e., prebiotics) 
intervention (Nicholson, 2006).   
Hopefully, in the future, complementary implementation of models at the calf and tissue 
level should aid in forecasting when and what type of intestinal infection (i.e., secretory, 
exudative or both) could occur unless preventive action tailored to the individual calf is taken. 
CONCLUSIONS  
Methods to assess gut health in pre-weaning dairy calves in farms are not well defined. 
Joint use of subjective methods like scoring systems and objective methods like biomarkers or 
intestinal function measures, can provide better assessments in order to properly choose the best 
therapeutic strategy for intestinal infection and recovery. In addition, because of the financial and 
animal welfare toll a diarrheal episode takes, it may be desirable to eventually replace ex-post 
therapeutic protocols for ex-ante preventive schemes. Nevertheless, this approach requires the 
ability to predict the risk and potential extent of infection at the calf and tissue level in order to 
provide specific recommendations. Here we have quantified the changes in calf gut health 
throughout the first month of life as measured by fecal scores and whether this can be modulated 
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by TV, BP, and birth BW. We also assessed the changes in calf gut health throughout the first 
month of life as measured by intestinal paracellular permeability and whether this can be 
modulated by BP and how it changes across GIT regions. Analysis of fecal score data indicated 
risk for gut health changed hyperbolically from 5 to 35 days with a risk peak around 13 days of 
age, which agrees with previous reports in the literature. Also, a modulatory effect of TV, BP 
and birth BW was observed, suggesting that variables related to thermal homeostasis, passive 
immunity obtained by the calf, and perhaps variables related to fetal maturity in early life 
influence the risk of diarrheal episodes occurrence. However, the direction and size of such 
modulatory effects seem to be dependent, in turn, upon other unknown variables.  Importantly, 
86% of the unknown variance comes from differences between daily measures, suggesting that 
risk factors that vary over time are involved.   
On the other hand, temporal changes in gut health based on paracellular permeability are 
difficult to reconcile across the two datasets employed here. While one dataset suggested no 
change from 0 to 4 weeks of age, the other suggested a significant reduction from 2 to 4 weeks of 
age and colon appeared to undergo the largest changes. More data needs to be collected 
evaluating permeability in response to other predictor variables to develop permeability response 
surfaces. 
Also, FPT (i.e., serum protein level) appeared to have no influence on gut health at the 
tissue level even though BP affected the risk of scour episodes at the calf level. 
Of course, because fecal score and permeability data reported here arise from different 
experiments and animals, direct objective comparison is not possible and only qualitative 
discussion is proposed for consideration. 
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Finally, more indicators of gut health than just permeability need to be evaluated and 
implemented and specific areas of search for risk factors, including calf immune, intestinal 
pathogen load and metabolomic/metabonomic profiling appear to be promissory to eventually 
develop individual calf preventive care protocols.      
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 TABLES AND FIGURES 
 
Table 2.1. Descriptive statistics for predictor variables 
 
Variable n Mean Std.Dev. Minimum Maximum CV Rationale 
BP 141 5.6 0.82  3.9 9.8 14.8 FPT indicator 
BT_24 141 101.7 1.04 99.5 106.0 1.03 Fever-infection indicator 
BT_48 141 101.7 0.84  99.7 104.1 0.83 Fever-infection indicator 
BT_72 129 101.8 0.89 98.6 103.6 0.87 Fever-infection indicator 
TV 141 0.73 0.46  0.06 3.1 63.6 Overall thermal homoestasis  
BW 141 41.3 2.83 36.0 48.6 6.8 Non-specific 
1 n: Number of calves 
2 CV: Coefficicent of variation 
3 Std.Dev: Standard deviation 
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Table 2.2. Estimated fixed effects, standard errors and 95% confidence intervals (CIs) for models predicting occurrence of diarrheal episodes  
  Model 1  
1
 Model 2 Model 3 
Effect Group
1
 β  SE 95% CI6  β  SE 95% CI β  SE 95% CI 
Intercept  1.08  0.30  
0 .49,  
1 .68  2.74  0.90  
0 .96,   
4 .52  2.47  0.44  
1 .6 ,  
3 .4***  
Exp  
2
 GAM  -2 .21  0.21  
-2 .64,   
-1 .78  ***  -3 .18  0.35  
-3 .88,  
 -2 .47  ***  -3 .80  0.48  
-4 .7 ,  
-2 .85***  
Age  0.13  0.02  
0 .08,   
0 .17  ***  0.11  0.04  
0 .03,  
0 .18  ***  0.016  0.04  
-0 .05,   
0 .09  
Age
2
   -4 .62x10 - 3  5.24x10 - 4  
-5 .65x10 - 3 ,  
 -3 .59x10 - 3  *** -3 .21x10 - 3  6.55x10 - 4  
-4 .49x10 - 3 ,  
-1 .92x10 - 3   ***  -2 .4x10 - 3  7.8x10 - 4  
-3 .9x10 - 3 ,  
 -9 .0x10 - 4 ** 
TV  
3
 HIGH  0.02  0.19  
-0 .36,  
 0 .40  -0 .02  0.1960  
-0 .40,  
 0 .36  0.026  0.19  
-0 .36,  
0 .41  
TV x Age
2
x Exp GAM/HIGH -1 .83x10 - 3  3.67x10 - 4  
-2 .55x10 - 3 ,  
 -1 .11 x 10 - 3 ***  -4 .56x10 - 3  8.55x10 - 4  
-6 .24 x10 - 3 ,   
-2 .89x10 - 3 ***  -6 .3x10 - 3  1.2x10 - 3  
-8 .6x10 - 3 ,   
 -3 .9x10 - 3 *** 
TV x Age
2
x Exp GAM/LOW  -2 .10x10 - 3  3.54x10 - 4  
-2 .79x10 - 3 ,        
 -1 .40x1 0 - 3   *** -4 .93x10 - 3  8.71x10 - 4  
-6 .64x10 - 3 ,   
 -3 .22x10 - 3   ***  -6 .6x10 - 3  1.2x10 - 3  
-8 .9x10 - 3 ,  
-4 .2x10 - 3 ***  
TV x Age
2
x Exp GOS/HIGH  6.98x10 - 4  2.61x10 - 4  
1 .85x10 - 4 ,  
1 .21x10 - 3   ***  6.58x10 - 4  2.64x10 - 4  
1 .40 x10 - 4 ,  
1 .176x10 - 3   **  6.8x10 - 4  2.7x10 - 4  
1 .7x10 - 4 ,   
1 .2x10 - 3 **  
BP  
4
     -0 .18  0.14  
-0 .47,    
0 .1     
BP x Age x Exp GAM     0.012  6.39x10 - 3  
-3 .5x10 - 4 ,  
0 .02  *     
BP x Age x Exp GOS    -8 .71x10 - 3  6.33x10 - 3  
-0 .02,  
3 .7x10 - 3     
BW  
5
 NW       -0 .73  0.25  
-1 .2 ,   
0 .2**  
BW x Age x 
Exp GAM/NW        0.21  0.05  
0 .12,  
0 .31 *** 
BW x Age x 
Exp GAM/UW        0.16  0.05  
0 .07,  
0 .25 *** 
BW x Age x 
Exp GOS/NW        0.02  0.01  
-4 .4x10 - 3 ,  
0 .04  
Variance components  
σca l f   0 .73  0 .12   0 .70  0 .12   0 .73  0 .12   
Fit indices  
6 
 
-2 LLH  4060    4045    4029    
AICC  4078    4069    4055    
1Hypothesis tested concerning specific groups, and as defined by the regression model are explicitly explained in table 2.6 in the appendix. 
2 Exp: Experiment (GAM, GOS) 
3 TV: thermal variation (high or low) 
4 BP: blood protein 
5 BW: body weight (normal weight (NW) or underweight (UW)) 
6 -2LLH: deviance, AICC: Corrected Akaike Information Criteria, Wald t test significance: * P < 0.1, **P < 0.01 and *** P< 0.0001  
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Table 2.3. Correlation coefficient between the log of the permeability measures 
for different tissues and the canonical function 
Variable Correlation with Canonical 
function 
Log (rumen) 0.48 
Log (Jejunum) 0.45 
Log (Ileum) 0.54 
Log (Colon) 0.71 
 
 
 
 
 
 
 
 
 
 
 
Table 2.4 Means difference for canonical variable at 14 and 28 days of age in Holstein calves 
Age Mean Standard error  R
2
 P ≥ |t |  
14 vs. 28 days 9.3 2.12 0.48 0.0002 
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Table 2.5. Effect of GIT locations, age and FPT on epithelial permeability 
GIT location    P-value 
Rumen Jejunum Ileum Colon   Location  
3.40 ± 0.17
b
 5.10 ±  0.44
 a
 2.71 ± 0.09
c
 3.98 ± 0.11 
a
   < 0.001  
Age     
0d 7d 14d 21d 28d  Age L x A
1
 
3.90 ± 0.27 3.65 ± 0.27 3.78 ± 0.27 3.83 ± 0.27 3.80 ± 0.27  0.98 0.3 
Failure of passive transfer      
 No Yes    FPT  
 3.93 ± 0.15 3.65 ± 0.15    0.11  
1L x A: GIT location by age interaction 
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Table 2.6. Hypothesis or contrasts under test in each model 
Effect
1
 Contrast or hypothesis  
  MODEL 1  
Exp GAM Experiment effect, GAM  ≠ GOS  
Age  Age effect ≠ 0  
Age
2
   Age
2
effect 
 ≠ 0  
TV HIGH HIGH vs LOW 
TV x Age
2
x Exp GAM/HIGH GAM/HIGH vs GOS /LOW  
TV x Age
2
x Exp GAM/LOW GAM/LOW vs GOS/LOW 
TV x Age
2
x Exp GOS/HIGH GOS/HIGH vs GOS/LOW 
   
  MODEL 2 
BP  BP effect ≠ 0  
BP x Age x Exp GAM BP x Age in GAM ≠ 0  
BP x Age x Exp GOS BP x Age in GOS ≠ 0  
   
  MODEL 3 
BW  BW effect,  NORMAL  ≠ UNDERWEIGHT  
BW x Age x Exp GAM/NW 
BW x Age effect , GAM/NORMAL vs 
GOS/UNDERWEIGHT 
BW x Age x Exp GAM/UW 
BW x Age effect, GAM/ UNDERWEIGHT vs 
GOS/UNDERWEIGHT 
BW x Age x Exp GOS/NW 
BW x Age effect, GOS/ NORMAL vs 
GOS/UNDERWEIGHT 
1Effect: Exp= Experiment effect (GAM, GOS), TV=Thermal variability (High, low), BP=Blood protein, and 
BW=Bodyweight.  
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Figure 2.1. Exploratory plots of log odds for GOS and GAM experiments with respect to: a) age; b) Blood protein as 
categorized into failure of passive transfer groups (FPT: Yes (dashed line), No (solid line)); c) Bodyweight (BW; light 
(dashed line), heavy (solid line)) and d) Thermal variability (TV; Low (dashed line), high (solid line)). 
a b 
c d 
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Figure 2.2. Diarrhea episode probability function and age at maximal value.  
Figure 2.3.Estimated probability of a diarrheal episode for a) Thermal variability (TV: High/Low) and b) Bodyweight 
(BW: Heavy/Light) groups. 
a b 
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Figure 2.4.Estimated probability of diarrhea occurrence across studies (GAM/GOS) in function of age and 
blood protein (BP).  
  
  
 Figure 2.5. Permeability canonical variable distribution by age groups. Permeability Function is unit less (See 
Canonical discriminant analysis in materials and methods). Dashed ellipse: 14 days, Solid ellipse: 28 days. 
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CHAPTER III 
 
MICROBIOTA COMPOSITION AND ACTIVITY IN THE 
GASTROINTESTINAL TRACT OF PRE-RUMINANT HOLSTEIN 
CALVES AND THEIR POTENTIAL ROLE IN GUT HEALTH 
 
ABSTRACT 
The objective of this work was to assess the effect of age and gastrointestinal location (rumen vs 
colon) on microbial community diversity and composition, SCFA profiles and predicted 
metabolic functionality, of Holstein pre-ruminant calves set on an intensive milk feeding 
program. Thirty-two calves were fed at 2% of their bodyweight on DM basis from day 10 until 
slaughter. Sixteen calves were euthanized at 2 and 4 weeks of age post-arrival to collect digesta 
samples from the rumen and colon. The rumen and colon of pre-ruminant calves showed a 
similar degree of diversity (i.e. Shannon index) (p = 0.44) whereas composition differed 
(p=0.001) appreciably. Colonic microbiota was characterized by the dominance of lactic acid 
bacteria such as Lactobacillus, Streptococcus, Enterococcus and Bifidobacterium. In addition, 
colonic SCFA and lactic acid concentrations were between 50 and 850% higher compared to 
rumen indicating greater fermentative activity. On the other hand, in the rumen, no genus 
showed to over-dominate and more variation among animals was present according to a 
multivariate Levene test (p<0.05). Therefore, microbial and fermentative development of fore 
and hind gut in calves fed only milk seems to present different timings. The authors believe that, 
because of an active esophageal groove and low grain intake during first 1 to 3 weeks of life, 
ruminal fermentation may not take preponderance until after 4 to 6 weeks of life, when 
significant metabolizable energy contributions will start to take place. Until then, high lactic acid 
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bacteria, lactate, and butyrate concentrations could bring about beneficial effects for the 
intestinal health of the calf during the first of life.  
INTRODUCTION 
Development of microbial populations in the gastrointestinal tract (GIT) of higher 
animals commences soon after birth (Mackie et al., 1999). Some observations indicate that the 
rumen anaerobic microbiota quickly attains concentrations as high as 10
9
 cells ml
-1
, thus 
becoming predominant by the second day after birth (Stewart et al., 1988); whereas, bacteria that 
are essential for mature rumen function can be detected as early as 1 day after birth, long before 
the rumen is active or even before ingestion of plant material occurs (Jami et al., 2013). 
Moreover, in only milk fed calves all major types of rumen microorganisms and a stable wide 
array of microbial metabolic functions have been identified before introducing solid feed, 
suggesting that the rumen of the young bovine is all but rudimentary (Li et al., 2012).  
Once fermentable substrate, especially starch, is supplied to the calf, microbial 
fermentation develops progressively and the resulting SCFA like acetate, propionate, and 
butyrate directly stimulate growth and function of the rumen epithelium (Flatt et al., 1958; Sutton 
et al., 1963b) and will eventually provide over 90% of the energetic requirement of the animal 
(Beever and Mould, 2000); thereby rendering the calf energetically independent from an external 
milk source, be it the dam’s milk or milk replacer. However, fermentation sufficiency, adequate 
rumen size, and full absorptive capability are not achieved until after about 4 to 6 weeks of age 
(Davis and Drackley, 1998) and the calf thus relies mostly on milk as a nutrient source for the 
first 1 to 4 weeks of life.   
Given that during this period the diet is largely milk based, that the esophageal groove is 
fully functional and that all digestion is performed by the host enzymes, the newborn calf can be 
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considered a monogastric (Orskov, 1992). Since 10 to 15% of milk dry matter (DM) consumed 
passes undigested (Petit et al., 1989; Hill et al., 2010) through ileum into the cecum and colon, an 
amount in the range of 40 to 120 g DM/day, depending on the feeding rate, is likely readily 
available for colonic fermentation in a calf of 40 kg BW. Comparatively, for the same calf, less 
than 10 g of milk DM would be expected to enter the rumen for fermentation (Toullec and 
Guiloteau, 1989). Despite this apparently higher supply of fermentable nutrients into the hindgut 
of the pre-ruminant calf,  little information is available on how microbial activity can impact its 
development and health (Oikonomou et al., 2013) as compared to the developing rumen (Warner 
et al., 1956; Sutton et al., 1963a; Sutton et al., 1963b; Warner and Flatt, 1965; Huber, 1969);  
Early observations using colon digesta samples indicated that Escherichia coli, 
Clostridium welchii and Streptococci were the first organisms to be found in milk fed calves 
shortly after birth while bacteroides was found after 2 days of age in the large intestine and by 
day 12 it was competing with the lactobacilli for predominance (Smith, 1965). Human infants 
have also been observed to be initially colonized by large numbers of E. coli and Streptococci 
(Mackie et al., 1999) and it has been proposed that these bacteria are responsible for the creation 
of a reduced environment favorable for the establishment of facultative anaerobes like 
lactobacilli or the anaerobic genera Bacteroides, Bifidobacterium, and Clostridium by day 4 to 7 
after birth (Mackie et al., 1999). But while pathogens are autochthonous to the gut ecosystem and 
can live in harmony with the host, they can become pathogenic under certain circumstances 
(Mackie et al., 1999), and organisms like enterotoxigenic E. coli and Salmonella spp. are indeed 
responsible for a large proportion of cases of neonatal calf diarrhea (Butler and Clarke, 1994; 
Izzo et al., 2011), which affects about 25% of pre-weaned heifers and accounts for nearly 50% of 
their annual mortality in the US (NAHMS, 2010).     
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On the other hand, Bifidobacterium and Lactobacillus species have been directly linked 
to increased resistance to infection and diarrhoeal disease, and stimulation of the mucosal 
immune system (Macfarlane et al., 2008). For instance, Bifidobacterium longum has inhibited 
bacterial translocation by E. coli through a lymphocyte activation mechanism (Yamazaki et al., 
1985). Lactobacillus plantarum and L. rhamnosus have been able to sensitize epithelial cells to 
respond against enteric Salmonella typhymurium, apparently through up regulation of toll like 
receptors which recognize flagelin (Vizoso Pinto et al., 2009). In addition, L. rhamnosus GG and 
Lactobacillus casei DN-114-001 can also protect epithelial barrier function against Escherichia 
coli-induced redistribution of the tight junction proteins (Parassol et al., 2005; Johnson-Henry et 
al., 2008; Cani et al., 2009).  
Also indirectly, through butyrate production, colonic microbiota can exert positive effects 
such as suppression of over-inflammation in epithelial cell lines (Macfarlane et al., 2008), 
improvement of gut barrier function and increased tight junction protein expression and lower 
endotoxemia (Cani et al., 2009). 
Therefore, during the pre-ruminant stage, microbial colonization and fermentation 
establishment in the hindgut appear to be comparatively equally or more relevant than in the 
foregut for the health and survival of the newborn. The objective of this work was to assess the 
effect of age and gastrointestinal location (rumen vs. colon) on microbial diversity, community 
composition, SCFA profiles and predicted metabolic functionality, in intensively milk fed 
Holstein calves. A grasp of the relative degree of ruminal and colonic microbial development in 
the pre-ruminant calf shall be attained.   
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MATERIALS AND METHODS 
Animals, Feeding and Treatment Allotment 
Thirty-two newborn calves were purchased from Stone Ridge Dairy farm (Manheim, IL). 
Upon arrival to the University of Illinois research facilities, animals received an electrolyte 
solution (Land O Lakes, Electrolyte System - Add Pack), vaccines and prophylactic antibiotic 
treatment (2 mL, Muse, MERCK; 2 mL BoSe, Shering-Plough; 1mL vitamin A and D; 1.1mL  
Draxxin, ; Bovisera (50mL antibody serum, 20 mL C and D antitoxin, Behringer Ingelheim; 2 
mL  INFORCE-3, Pfizer). Milk replacers were fed at a rate of 1.25% of BW on a dry matter 
(DM) basis for the first 2 days, 1.5% of BW until day 10, and then 2% of BW through day 30.  
Calves were fed the milk replacer from arrival to day 30 with no grain offered.   
Animal Slaughter and Sampling 
Sixteen calves were euthanized at 2 and 4 weeks after arrival to collect digesta samples 
from the rumen and colon. Euthanasia was performed by administering an overdose (85-150 
mg/kg BW) of sodium pentobarbital intravenously according to IACUC procedures. 
Digesta samples from rumen and proximal colon were collected into 5 ml sterile 
cryovials and snap frozen in liquid nitrogen to quickly stop microbial activity.  Samples were 
submitted to an external laboratory for bacterial tag encoded FLX amplicon pyrosequencing 
(Research and Testing Laboratory, Lubock, TX).  
Microbial DNA Amplicon Sequencing and Taxonomic assignment   
Total microbial DNA was extracted using a QIAamp stool DNA mini (Qiagen Inc., 
Valencia, CA) as previously reported (Dowd et al., 2008a; Dowd et al., 2008b). Sample DNA 
was quantified using a Nanodrop spectrophotometer (Nyxor Biotech, Paris, France). Upon 
extraction, the V1-V3 hyper variable regions of the 16-S ribosomal DNA gene were amplified by 
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PCR using barcoded primers and the product sequence determined by bacterial tag-encoded FLX 
(non-titanium chemistry) amplicon pyrosequencing (Roche, Nutley, New Jersey) as reported 
previously (Dowd et al., 2008a; Dowd et al., 2008b). Afterwards, sequences were depleted of 
barcodes and primers. Sequences that were too short (< 200bp), that had ambiguous base calls or 
homopolymer runs exceeding 6bp were removed.  Chimera removal and sequence de-noising 
were then performed. The remaining sequence reads were clustered at 97% similarity to 
determine operational taxonomic units (OTU’s) as illustrated elsewhere (Dowd et al., 2008a; 
Dowd et al., 2008b; Edgar, 2010; Capone et al., 2011; Swanson et al., 2011). The OTUs were 
subsequently classified using BLASTn against a curated database (DeSantis et al., 2006) and 
compiled into the different taxonomic levels such as phyla and genera. The final average number 
of sequence reads per sample was 6,203 with a minimum of 1834 and a maximum of 16400. The 
25
th
 and 75
th
 percentile for the 32 samples were 4328 and 7511 quality reads per sample after 
filtering.  
Predicted Metagenome 
A new robust algorithm named “PICRUSt” was used, which predicts metagenomes from 
16S data and reference genome databases (Langille et al., 2013). The accuracy of such technique 
strongly depends on the availability of reference genome sequences for organisms present in a 
sample. When reference genome sequences for taxa present in a sample are well established, the 
correlations between predicted and metagenomically measured gene content can reach 0.8 to 0.9 
(Langille et al., 2013).   
To quantify the availability of a reference genome representative of the overall 
microbiome in a sample, the nearest sequenced taxon index (NSTI) is estimated (Langille et al., 
2013). The NSTI is the sum of phylogenetic distances for each organism in the OTU table to 
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their nearest relative with a sequenced reference genome. The closer to zero such distance is, the 
more amenable the sampled OTU matrix is for metagenome prediction. Although very variable, 
the estimated NSTI was in general very close to zero for our OTU matrix, thus rendering the 
algorithm suitable to apply (Table 4.1). 
Inferred gene contents produced by PICRUSt were annotated against the KEGG 
Orthology (KOs) classification scheme to obtain a functional gene abundance matrix.  
Digesta SCFA Concentration 
Ruminal and colonic digesta samples were collected and acidified with a 10-N 
hydrochloric acid solution. Afterward, samples were centrifuged at 15,000 × g for 15 min, the 
supernatant extracted, frozen and send to North Carolina State University to the laboratory of Dr. 
Vivek Fellner for SCFA analysis by gas liquid chromatography. Briefly, digesta samples 
supernatant was injected (1 μL) into a column (Varian CP 3380/3800 with a Nukol Fused Silica 
Capillary Column, 30 m × 0.25 mm × 0.25 mm; Sigma-Aldrich, St. Louis, MO). A flame 
ionization detector was used to quantify VFA elution (Herfel et al., 2013).  
Data Analysis  
Microbial Community Diversity. The total number of species present (i.e., species 
richness) and the Shannon index were calculated as proxy measures of diversity. The Shannon 
index takes into account not only richness but also the abundance evenness among species 
(Tuomisto, 2010). Richness and Shannon index values estimated for each sample were used as 
dependent variables in function of GIT site and calf age. To account for the lack of independence 
between samples from rumen and colon from the same calf (i.e., possibly auto-correlated errors), 
a generalized linear model with a random intercept was fitted to the data to induce a compound 
symmetry correlation structure among observations from the same calf (Zuur et al., 2009). 
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Penalized quasi-likelihood was used to estimate parameters and standard errors. Statistical 
inference followed guidelines by others (Bolker et al., 2009). Richness data were analyzed under 
a negative binomial (NB) distribution to account for over-dispersion in species counts; whereas, 
diversity data were analyzed under a gamma distribution because a normal distribution did not 
meet its error distribution assumptions.   
A log link linear predictor for modelling richness was specified as: 
        
   
           
       (      )    (     )                       , 
  
where, μij = expected number of species in a given week and GIT site, total # reads= total 
number of sequence reads per sample included as an offset variable, B0 = intercept, B1= 
regression coefficient for GIT site, B2= regression coefficient for calf age in weeks and b0= calf 
random effects. Because the total number of sequence reads varies from sample to sample due to 
technical matters, it was used as an offset variable to express abundance in relative terms (Zuur 
et al., 2009). Calf random effects are assumed to be normally distributed and independent from 
each other. 
For the sake of interpretability of the coefficients for richness, the above model is 
equivalent to: 
   
           
                                                          
 
to estimate the expected number of reads of a specific taxon  adjusted for the average total 
number of sequence reads present in a particular age by GIT site group.  The exponentiated 
intercept represents richness at 2 weeks of age in colon, the exponentiated coefficient for site is 
the fold change in rumen with respect to colon and the coefficient for week is the fold change in 
week 4 relative to week 2. 
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Microbial Community Composition. The sequence read counts of each of the most 
predominant bacterial taxa were analyzed in the same fashion as richness. Since large 
overdispersion was present, a Poisson distribution was not suitable and a negative binomial 
distribution was used (Fitzmaurice et al., 2011).   
For multivariate analysis, a Bray-Curtis distance matrix that provides a measure of the 
similarity among each pair of samples across ages and GIT sites was built. To visually explore 
the degree of microbial composition similarity between samples collected at 2 and 4 weeks of 
age from rumen and colon, non-metric multidimensional scaling (NMDS) was conducted on the 
above Bray-Curtis distance matrix (Borcard et al., 2011). Square root transformed and non-
transformed distances provided similar output, thus the latter was used throughout.  
To statistically test any visually apparent microbiome group differences from the NMDS 
plots, Analysis of Similarities (ANOSIM) (Clarke, 1993) and Permutational Multivariate 
Analysis of Variance (PERMANOVA) (Anderson, 2001) were conducted with sites nested 
within week. The ANOSIM statistically tests whether there is a significant difference between 
two or more groups of sampling units based on the difference of mean distance ranks computed 
from the matrix. The ANOSIM statistic R ranges from -1 to 1 with 0 indicating no grouping of 
samples. The statistical significance (i.e., P-value) of the observed R statistic is assessed by 
permutation. The PERMANOVA partitions the total sums of squares estimated from the distance 
matrix among sources of variation and uses a permutation test with pseudo-F ratios to compute a 
P-value.  
Multivariate homogeneity of variances (Anderson, 2006) was tested by calculating the 
distance of each sample to the group median (i.e., centroid) in multivariate space and then testing 
if the average distance among groups is different through parametric ANOVA. Six pairwise 
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comparisons of group mean dispersions were carried out by calculating Tukey's Honest 
Significant Differences between groups with a specified family-wise error probability of 5% to 
control the type 1 error rate.  
Subsequently, in order to identify which genera contributed most to the microbiome 
observed differences among groups, Similarity Percentage Analysis (SIMPER) (Clarke, 1993) 
was run separately across weeks of age and GIT sites. Due to SIMPER methodological 
limitations (Warton et al., 2012), some of these results are complemented by univariate tests as 
appropriate using the generalized linear mixed model framework (Fitzmaurice et al., 2011) to 
test statistical differences among groups as explained above for richness data.  
Besides the intergroup abundance criteria, it was also of interest to detect the assemblage 
of organisms that best characterizes calves of a certain age or a GIT site based on their affinity 
for that niche. Thus, Species Indicator Analysis (INDVAL) (Dufrene and Legendre, 1997) was 
performed. This analysis provides a species indicator index that ranges between 0 and 1. If a 
genus is uniquely present in one group of calves and it is present in each individual calf 
belonging to that group, then the indicator index takes a maximum value of 1 (Legendre, 2013). 
A permutational p-value is used to assess statistical significance of the indicator value. 
The NMDS and ANOSIM were carried out in Primer-E software V.6.0, SIMPER (Clarke 
and Gorley, 2006), PERMANOVA and multivariate heterogeneity of variances tests were 
conducted with the package Vegan (Oksanen et al., 2012), INDVAL was carried out with the 
package Labdsv (Roberts, 2012), and generalized linear models were performed with the 
package MASS (Venables and Ripley, 2002) in the open access R language version 2.14.0.  
Predicted Metagenome. This abundance data matrix was subjected to multivariate 
analysis methods similar to the microbial composition data.  
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Intestinal SCFA Concentrations. Colon and rumen SCFA data were analyzed as 
repeated measures on the same calf. A compound symmetric error structure with heterogenous 
variances was implemented in PROC MIXED of SAS (SAS) (SAS Institute Inc. Cary, NC., ). 
Residuals were normally distributed.   
RESULTS 
Microbial Community Diversity  
Figure 3.1 visually illustrates the distributions for richness and diversity. While the rumen 
may visually appear to host a greater total number of species, groups appear more similar in 
terms of the Shannon index.  
Table 3.2 displays the regression coefficients describing the effect of age and GIT site on 
richness and Shannon diversity indices. 
Richness. The effects of age and site were significant. Calves at 4 weeks of age are 
expected to have 1.4 times as many species in the GIT as those at 2 weeks (exp
0.34 
= 1.4); 
whereas, compared to colon, there were 1.56 times as many species in the rumen (exp
0.45
 = 1.56). 
There was no interaction effect between week and site and thus it was removed from the model.  
Shannon diversity index. The coefficients for age and site were not different from zero 
and therefore the mean Shannon diversity index value is about 3.74 (exp
1.32
 = 3.74) across ages 
and sites.  
Taking richness and the diversity indices together, it appears that although calves harbor 
a 1.56 the number of species in the rumen at 4 weeks, the number of equally abundant species 
[i.e. effective number of species (Tuomisto, 2010)] does not really differ across ages or GIT 
sites.   
Microbial Community Composition 
 55 
 
Phyla level. Out of 18 phyla identified, only 5 of them were found to make up ~98.5% of 
the total (fig.4.2). Firmicutes was the most abundant with 70%, followed by Bacteroidetes 
(12%), Actinobateria (8%), Tenericutes (5%) and Proteobacteria (3.5%). Phyla distribution is 
illustrated in Figure 3.3. 
Regression coefficients for the statistical assessment of the effects of age and GIT site on 
relative abundance of each phylum are displayed below (Table 3.3). Firmicutes abundance was 
affected by the calf age and GIT site. At 4 weeks calves presented 1.36 times the abundance of 
this phylum compared to calves 2 weeks old. In addition, rumen contained only ~68% the 
Firmicutes abundance observed in colon. For Bacteroidetes, there was no effect of age on its 
abundance, but this phylum was 510% statistically more abundant in rumen than in colon. 
Actinobacteria abundance was not different between ages or GIT sites. For Tenericutes, both age 
and GIT site affected its abundance. It was found to be more abundant at 2 than at 4 weeks of 
age and largely more abundant (i.e., ~4 times) in rumen than in colon.  Proteobacteria was also 
significantly more abundant in rumen than in colon. Unfortunately, because of multicollinearity 
problems between the coefficients for the main effects and the interaction term, the latter must be 
removed from the model and only main effects could be considered. Overall, it thus appears that 
Firmicutes is stronger in colon; whereas, Bacteroidetes, Proteobacteria and Tenericutes exist in 
larger quantities in rumen. 
Genus Level. The NMDS plot below displays the samples belonging to colon and rumen 
at 2 and 4 weeks of age (Figure 3.4a). Whereas rumen samples from 2 and 4 weeks of age appear 
to group apart, colon samples from 2 and 4 weeks of age display overlap suggesting that the 
composition of microbiota is more similar at weeks 2 and 4 in the colon than in the rumen. At the 
same time, rumen and colon form different clusters (Figure 3.4a) and when considered across 
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ages, there is a visually evident dissimilarity between ruminal and colonic microbial 
communities (Figure 3.4b). When comparing weeks 2 and 4, only moderate separation of 
clusters can be appreciated suggesting that calves 2 and 4 weeks of age share more of their 
microbial community composition than GIT sites do (Figure 3.4c).   
To statistically test these compositional differences, ANOSIM and PERMANOVA were 
conducted (Tables 3.4 and 3.5). The ANOSIM indicates that there is a large and significant 
dissimilarity between rumen and colon but none between 2 and 4 weeks of age. Like ANOSIM, 
PERMANOVA allows evaluation of the main effects of age and GIT site, but in addition, it also 
allows testing their interaction. Results of PERMANOVA analysis are shown in Table 3.2. 
Contrary to ANOSIM, PERMANOVA indicates a significant effect of week. In addition, 
it indicates a significant interaction between age and GIT site on the microbiota composition of 
calves meaning that the effect of age depends on the gastrointestinal site. Indeed, it is evident 
from figure 1a that whereas samples collected at 2 and 4 weeks from colon do not appear to 
differ greatly, samples from rumen do seem to be different. Still, the sum of squares for GIT site 
is by far the largest, explaining ~20% of the total variation in microbiota composition compared 
to age or their interaction. 
A variance homogeneity test was conducted and indicated that the microbial community 
composition in the colon of calves at 4 weeks of age is much less variable than that in the rumen 
at 2 and 4 weeks or colon at 2 weeks. This is illustrated in Figure 3.5 and agrees with the visual 
appraisal from Figure 3.4a. Tukey's Honest Significant Differences test between groups shows 
the variances of the other groups do not differ (Table 3.6). While this observation warns that the 
variances homogeneity condition is not strictly met, it also raises an interesting question as to 
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why and how the microbial population in the colon becomes so much more consistent after 4 
weeks as compared to the rumen. 
We next tried to identify the genera that contributed most to the observed differences 
between calves at 2 and 4 weeks of age and between colon and rumen. To that end, SIMPER was 
carried out. Table 3.7 lists the most influential genera in differentiating the 2 age groups in terms 
of abundance. Also indicated is the anatomical location, the average abundance in each age 
group and the proportion they contribute to the dissimilarity between 2 and 4 week old calves. 
Only 14 genera, which represent ~3.6% of the total 393 genera identified, accounted for 60% of 
the microbial compositional difference between 2 and 4 weeks of age. For instance, 
Lactobacillus, Streptococcus and Faecalibacterium in the colon contributed about 17, 4 and 4 %, 
respectively, while Bacteroides and Oscillospira in rumen contributed about 5 and 4% each to 
the overall dissimilarity between 2 and 4 week old calves. There was a seemingly remarkable 
increase of the colonic Lactobacillus population from ~34 to 69% and a reduction of 
Streptococcus genus from ~12 to 4% in the time course between 2 and 4 weeks. During the same 
time span, in the rumen, Bacteroides and Porphyromonas populations dropped from ~14 to 3 and 
from ~9.5 to 0.7%, respectively.  
Regarding GIT sites (Table 3.8) and similarly surprising, only 7 out 393 genera identified 
(~1.7%) accounted for 60% of the compositional difference between rumen and colon. Table 3.8 
indicates that Lactobacillus is by far the main contributor to the abundance differences between 
colon and rumen, being ~50% more abundant in the hindgut and adding 28% of the total 
dissimilarity. Furthermore, Streptococcus, Faecalibacterium, Clostridium, Ruminococcus, 
Oscillospira, and Bacteroides were able to determine the remaining 32% dissimilarity in 
microbial community composition across GIT sites. Thus, not only did these 7 genera account 
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for most of the abundance difference between rumen and colon, but their population size also 
changed so drastically over time that they could explain up to ~46% of the dissimilarity between 
2 and 4 week old milk fed calves (Tables 3.7 and 3.8).  
Table 3.9 below shows results for univariate tests complementary to SIMPER for those 
genera whose additive contributions to age and GIT site dissimilarities add to 49 and 60%, 
respectively. Lactobacillus and Streptococcus were statistically greater in colon than in rumen, 
while Oscillospira, Bacteroides and Porphyromonas were statistically in greater numbers in 
rumen than in colon. Unlike Lactobacillus, which increased by 270% from week 2 to 4, all other 
genera statistically remained at the same level or diminished. No statistical effect of age or GIT 
site was observed for Faecalibacterium, Oscillospira, Clostridium or Ruminococcus. 
Table 3.10 shows the species indicator index values at a cut-off of 0.8 for the genera 
showing greatest affinity for an age group and their GIT location. These results show that 
Escherichia and Enterococcus from the colon, and Actinomyces and Porphyromonas from the 
rumen are present almost exclusively and highly frequently in 2 week old calves while rarely or 
in lesser amount in 4 week old calves. On the other hand, at 4 weeks of age, Prevotella and 
Lactobacillus from the rumen are almost an exclusive feature of this organ with respect to the 
younger calves.  
The index values for best indicator genera of colon and rumen are shown next (Table 
3.11). While only 3 genera are highly specific to the colon, about 9 genera are so to the rumen. 
Lactobacillus, Streptococcus and Bifidobacterium for instance, have an extremely high affinity 
for the colon; whereas, Actynomices, Prevotella and Eubacterium do so for the rumen. 
Contrary to SIMPER, INDVAL can eventually, but does not necessarily, identify the 
most abundant genera overall, and instead identifies those that are most specific to each group. 
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While abundant taxa like Lactobacillus could be expected to impact nutrient fluxes and 
fementation product pools, it is intriguing whether highly specific low abundance taxa could play 
an important functional role. In this sense, the exclusive but transitory presence of Escherichia 
and Enterococcus in the colon at ~1.5 and 6 %, respectively, and of Actinomyces and 
Porphyromonas in the rumen at ~6.3 and 9.5%, respectively, during the first 2 weeks of life, 
raises the question of what their role could be.    
Predicted metagenome 
Another objective of this work was to gain insight into the potential metabolic function 
pool of the microbiota by using a recently published algorithm that allows predicting the 
metagenome structure based on 454 Pyrosequencing data (Langille et al., 2013). After annotation 
against the KEGG database and removing all possible host functions, 104 pathways were 
identified.    
The NMDS was applied to all 104 pathways identified to visualize the similarities in the 
predicted metagenome of samples from colon and rumen at 2 and 4 weeks of age. Figure 3.6 (a 
and b) suggests that unlike the microbial community composition, metabolic functions do not 
differ as clearly between 2 and 4 week old calves. Nevertheless, there is a seemingly stronger 
separate clustering of rumen and colon (Figure 3.6.c), suggesting that microbiome functionality 
differs to a larger extent from forestomach to hindgut than throughout time during the first month 
of life of pre-ruminant calves.  
The ANOSIM confirmed the NMDS ordination indicating only a moderate difference 
between rumen and colon and the absence of difference in the metagenome between 2 and 4 
weeks of age. Table 3.12 below illustrates these results.  
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The PERMANOVA results (Table 3.13) agreed with NMDS and ANOSIM, and the test 
for interaction between calf age and GIT site was not significant. These results indicate that GIT 
site was more important in defining the microbial metabolic potential in milk fed calves even 
though the variation it explained is very small according the sums of squares.   
Based on these findings we tested for significant differences between GIT sites for the 
most abundant pathways. The most predominant metabolic potential functions are displayed 
below (fig.3.7). These variables accounted for ~25% of all potential functions identified, and the 
remaining ~75% was comprised by functions representing less than 0.2% each and are not 
displayed. The observed average percentage of each function for colon and rumen seem very 
similar at eye sight. 
Indeed, except for galactose metabolism and bacterial motility proteins, at 5% type 1 
error rate, no difference was observed for any of these variables (data not shown) between colon 
and rumen. Galactose metabolism and bacterial motility protein pathways were present at ~1.5 
and 0.9, and 0.2 and 0.7 % in colon and rumen, respectively.   
Subsequently, INDVAL was performed to identify signature functions of each GIT 
location. Table 3.14 shows those KEGG pathways with indicator index values above 0.75. 
Remarkably, there were 5 pathways of high characteristic value for the colon; whereas, there was 
none for rumen. 
SCFA Concentrations 
In addition, SCFA concentrations were measured to gauge metabolic activity in each GIT 
site at 2 and 4 weeks of age. Figure 3.8 displays the distribution of SCFA in each week by GIT 
site group. Except for acetate and isovalerate, all other SCFA had higher concentrations in the 
colon than in the rumen. Propionate, isobutyrate, butyrate and lactate were on average about 1.5, 
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4.4, 5.2 and 8.5-fold, respectively, higher in colon than in rumen suggesting colon as a much 
more metabolically active organ in milk fed pre-ruminant calves. These differences did not 
depend on time; in fact, calf age had no effect at all on SCFA concentrations (table 3.15).     
DISCUSSION 
In spite of the fact that rumen at 4 weeks displayed the greatest total number of species, 
using a diversity index that accounts for the evenness among them indicated that both rumen and 
colon were just as diverse at 2 and 4 weeks of age. The physiological importance of the 
difference between the absolute and the effective number of species is unknown. 
A remarkable observation was the significantly higher homogeneity of the colonic 
microbiota composition among calves by week 4. This has been observed before by Jami et al 
(2012) to occur in the rumen of preweaning calves fed starter in an age dependent fashion in 
which similarity between calves increased to plateau by 6-months of age. Unlike colon, the 
ruminal bacterial community remained more heterogenous among calves at 4 weeks in our study, 
maybe due to the absence of fermentation substrate for the microbial community to develop and 
structure. 
In this work we also observed Firmicutes and Actinobacteria as the most abundant phyla 
in the calf hindgut making up >90% of the whole microbial community, while Firmicutes and 
Bacteroidetes dominated in the forestomach accounting for ~80%.  
In general, at 2 weeks the calf colon was characterized by large numbers of Lactobacillus 
(33%), Streptococcus (12%), Faecalibacterium (11%), Clostridium (6.5%), Enterococcus (6%) 
and Bifodobacteria (5%). Two weeks later, Lactobacillus increased its primacy to ~69%, and 
along with Streptococcus (~4%), Collinsella (~5%) and Bifidobacterium (~2.5%), remained 
dominant and highly specific to the colon comprising ~80% of the microbial population. 
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In contrast, the rumen underwent many more compositional changes from week 2 to 4 of 
age and no overwhelming dominance by a particular genus was observed.  At 2 weeks of age, 
Bacteroides, Oscillospira, Porphyromonas, Bulleidia, Faecalibacterium and  Actinomyces were 
characteristically abundant and specific to this niche at ~14, 12, 9, 7, 6 and 6% of the population, 
respectively. By 4 weeks, Oscillospira and Faecalibacterum became the most abundant taxa by 
hardly increasing to 16 and 10%, correspondingly, while the others declined sharply. At the same 
time, other genera like Ruminococcus, Prevotella, Clostridium, Blautia and Eubacteria increased 
to be in the range of 4 to 8%. However, unlike in the colon, these dominating genera altogether 
barely accounted for ~55% of the whole community and thus the remaining ~45% must have 
been composed by many multiple organisms.  
The minor compositional changes and the consolidation of the initially dominating 
microbiota in the colon suggests there was greater colonization resistance by lactic acid bacteria 
(Macfarlane et al., 2008) compared to rumen where no dominant taxa were observed and many 
more compositional changes occurred. It suggests that colonic populations stabilized earlier than 
those in rumen (Rolfe, 1996). 
On the other hand, our findings differ with some previous observations in pre-weaning 
calves fed milk  or milk plus grain where the phyla Bacteroidetes predominated over Firmicutes 
and the genera Bacteroides and Prevotella consistently made up the majority of the population in 
ruminal, colonic or fecal samples at ages between 1 and 6 weeks of life (Edrington et al., 2012; 
Li et al., 2012; Jami et al., 2013; Malmuthuge et al., 2014). A possible explanation could be that 
we fed no grain and used an intensified milk replacer feeding program with feeding rates of 2% 
of BW as DM. This translates to a dietary supply of ~1 kg of DM/d for a 45-kg BW calf. 
Assuming an average milk replacer total DM digestibility of ~80% (Petit et al., 1989; Hill et al., 
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2010), an actual dietary concentration of 28% protein and 43% lactose and assuming each 
nutrient fraction is at least 80% digestible; then, at least 56 g of protein and 86 g of lactose 
should have passed undigested into the cecum and colon on a daily basis. In contrast, because the 
esophageal groove is nearly fully functional in newborn milk fed calves (Orskov, 1992; Davis 
and Drackley, 1998), milk flow into the rumen, and hence provision of any fermentable substrate 
may not have exceeded 10 g/d (Toullec and Guiloteau, 1989).  
Because representative species in the Lactobacillus, Streptococcus, Enterococci and 
Bifidobacteria genera are known to grow well or be able to adapt and perform well with lactose 
or galactose as a substrate (Özen and Özilgen, 1992; Burgos-Rubio et al., 2000; Cabral et 
al.,2007), and are considered major lactic acid bacteria (Smith and Sherman, 1942; Macfarlane et 
al., 2008), we speculate that colonic supply of endogenous or lactose derived milk di- or mono-
saccharides led to their overabundance and the resulting ~ 850% higher lactate concentrations 
observed in the hindgut compared to the rumen. At the same time, high colonic acid molarities 
may have caused acidic conditions for bacteria such as Bacteroides spp to grow, establish and 
compete since they prefer a pH of  6.5 (Belenguer et al., 2007). Indeed, low pH is thought to be 
the major mechanism by which lactic acid bacteria, primarily Lactobacillus, Bifidobacteria and 
Streptococcus, inhibit growth of various facultative and anaerobic bacteria (Rolfe, 1996). 
Moreover, although propionate and butyrate production is not consistent with 
Bifidobacterial and Lactobacillus metabolism (Macfarlane et al., 2008); it has been shown that 
propionate producing species such as Veillonella spp and Megasphera elsdenii, and butyrate-
producing species such as Anaerostipes caccae and Eubacterium halli can cross-feed on lactate 
produced by Bifidobacterium adolescentis (De Vuyst and Leroy, 2011). Therefore, some of the 
increased propionate, isobutyrate and butyrate could possibly have been the end products of 
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lactate metabolism through extensive cross-feeding in the colon (Belenguer et al., 2006; De 
Vuyst and Leroy, 2011). 
Lactobacillus and Bifidobacteria have been linked to increased resistance to infection and 
diarrheal disease, and stimulation of immune system activity, possibly due to the chemical 
composition and structure of their cell wall components. Indeed, some Lactobacillus, 
Bifidobacteria and Enterococci species form substances that are antagonistic to other organisms, 
such as organic acids, hydrogen peroxide, diacetyl and bacteriocins (Macfarlane et al., 2008; 
Vizoso Pinto et al., 2009). For example, Bifidobacterium Infantis can produce substances that are 
inhibitory to E.Coli and Clostridium perfringens, whereas other bifido species can inhibit 
including Listeria, Shigella, Campylobacter, and Vibrio cholerae (Gibson and Wang, 1994). 
Given the high colonic abundance and specificity observed here, lactic acid bacteria and 
Bifidobacterieum may have had a role to play in the intestinal health of calves in this study. 
In addition to such direct microbial effects, SCFA, as the major fermentation end 
products, also have a role in colonic function and integrity. While acetate and propionate affect 
the epithelium’s energy and the host’s glucose homeostasis, respectively (Topping and Clifton, 
2001), butyrate production in the hindgut can improve epithelium permeability by up regulating 
tight junction protein expression (Cani et al., 2009), reduce epithelium inflammation (Macfarlane 
et al., 2008) and promote cell differentiation  (Topping and Clifton, 2001). 
From this standpoint, our observations would suggest a key role for the colonic 
microbiota of the newborn pre-ruminant calf, which was reflected, in this case, by propionate, 
isobutyrate, butyrate and lactate concentrations between 50 and 850% higher compared to the 
rumen. Consequently, colonic fermentation may appear to be more preponderant to potentially 
support intestinal health and integrity during the first few weeks of life, while ruminal 
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fermentation would develop and become increasingly important for the metabolic energy supply 
of the calf after ~4 to 5 weeks of life (Davis and Drackley, 1998).   
Functionally, the potentially higher supply of milk protein and lactose, galactose and 
glucose into the colon, and the resulting enhanced fermentation could provide a possible 
explanation for the specificity and unique presence of microbial functions such as alanine and 
galactose metabolism, and glycosyltransferase activity, with the latter two potentially related to 
mono and di-saccharide hydrolysis and sugar groups transfer and metabolism (Garrett and 
Grisham, 2010). Also, the augmented abundance of the glutathione metabolism pathway is 
perhaps related to the large abundance of the lactic acid bacteria, some of whose members are 
known to possess parts of the glutathione synthesis or utilization machinery (Pophaly et al., 
2012).  
Still, it is surprising that out 104 metabolic pathways identified only 4 of them could 
modestly differentiate the fore and hindgut; whereas, the most abundant ones related to transport, 
DNA maintenance, or translation were at the same level in both organs throughout time in spite 
of the fact that ruminal fermentation was rather inoperative. These observations coincide with 
those of Li et al. (2012) where milk fed calves presented a wide array of microbial metabolic 
potential functions including transport and metabolism of carbohydrates and amino acids, energy 
production, and DNA integrity maintenance. Like in our experiment, those authors noticed that 
calves at 2 and 6 weeks presented very similar metabolic ruminal potential in spite of major 
phylogenetic composition fluctuations over time. Hence, although the rumen appeared much less 
active metabolically in our experiment, probably because of minimal substrate availability, it did 
show to have all the bacterial and metabolic endowment to begin operation upon fermentative 
substrate delivery. 
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CONCLUSION 
The rumen and colon of intensively milk fed pre-ruminant calves had a similar number of 
effective bacterial species during the first month of life. The inter-calf variation in colonic 
microbiome composition diminished significantly by 4 weeks of age compared to the rumen. 
Lactic acid bacteria such as Lactobacillus, Streptococcus, Enterococcus and Bifidobacteria 
overly dominated the microbial community in the hindgut. In addition, SCFA concentrations 
were between 50 and 850% higher compared to rumen. These high concentrations may have 
inhibited the Bacteroides genus from expanding, which appears atypical in calves and other 
species. These microbial community and SCFA profiles could bring about beneficial effects for 
the intestinal health of the calf during the first 2 to 4 weeks of life. On the other hand, in the 
rumen, no genus showed to over-dominate and butyrate and lactate concentrations were much 
lower than in colon, presumably due to lack of fermentable substrate. It is reasonable to think 
that, because of an active esophageal groove and very low grain intake during first 2 to 3 weeks 
of life, ruminal fermentation may not take preponderance until after 4 to 6 weeks of life, when 
significant metabolizable energy contributions start to take place. Research studying potential 
nutritional management means to optimize hindgut fermentation during early life to support 
intestinal health should prove worthy.     
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TABLES AND FIGURES 
Table 3.1. NSTI values for sampled 16S sequences 
GIT
1
 site Week Mean S.E 
Colon 2 0.06 0.04 
Rumen 2 0.08 0.04 
Colon 4 0.06 0.06 
Rumen 4 0.12 0.06 
1 GIT: Gastrointestinal tract 
 
 
 
 
 
 
 
 
Table 3.2. Regression coefficients for effect of calf age and GIT site on diversity measures   
 Coefficients (β) S.E P-value exp(β)   1 
    
 Species number   
Intercept -3.28 0.12 <0.00001 0.038 
Week 4 0.34 0.13 0.017 1.40 
Rumen  0.45 0.13 0.0019 1.56 
    
 Shannon index   
Intercept 1.32 0.03 <0.00001 3.74 
Week 4 0.036 0.04 0.34  
Rumen  0.029 0.04 0.44  
1
 exp 
(Intercept)
: represents expected value for colon at 2 weeks of age; exp 
(Week4)
: represents fold change at 4 
weeks with respect to 2 weeks; exp 
(Rumen)
: represents fold change in rumen with respect to colon 
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Table 3.3. Regression coefficients for effects of calf age and GIT site on abundance of predominant phyla 
 Coefficient (β) S.E  P-value exp(β)   1 
    
 Firmicutes   
Intercept -0.36 0.08 0.0001 0.69 
Week 4 0.313 0.09 0.0022 1.36 
Rumen -0.38 0.08 0.0001 0.68 
     
 Bacteroidetes   
Intercept -3.17 0.51 < 0.0001 0.042 
Week 4 -0.21 0.59 0.7  
Rumen  1.63 0.59 0.01 5.1 
     
 Actinobacteria   
Intercept -2.19 0.23 <0.0001 0.11 
Week 4 -0.51 0.28 0.08  
Rumen  -0.40 0.28 0.15  
    
 Tenericutes   
Intercept -3.32 0.4 <0.001 0.0362 
Week 4 -1.31 1.39 0.01 0.27 
Rumen  1.39 0.5 0.01 4.01 
    
 Proteobacteria   
Intercept -4.60 0.35 <0.0001 0.01 
Week 4 0.06 0.44 0.9  
Rumen  1.0 0.30 0.002 2.71 
1
 exp 
(Intercept)
: represents expected value for colon at 2 weeks of age; exp 
(Week4)
: represents fold 
change at 4 weeks with respect to 2 weeks; exp 
(Rumen)
: represents fold change in rumen with 
respect to colon 
 
 
 
 
Table 3.4. ANOSIM among samples from rumen and colon and from weeks 2 and 4 of age for microbiota 
composition 
Contrast R Statistic
1
 P-value 
Rumen vs. Colon 0.75 0.001 
15 vs. 30 days of age 0 0.67 
1
 Strength of groups difference   
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Table 3.5. PERMANOVA for effect of calf age and GIT site on microbial community 
composition 
Source of variation df
1
 SS
2
 MS
3
 Pseudo-F P-value 
Site 1 4.8363 4.8363 21.4576 0.001 
Week 1 0.8797 0.8797 3.9029 0.001 
Site x Week 1 0.8034 0.8034 3.5647 0.004 
Residual 59 13.2978 0.2254   
Total 62 19.8172    
1
 Degrees of freedom 
2
 Sum of squared multivariate distances 
3
 Mean squared multivariate distances  
 
   
Table 3.6. Pairwise comparison of age by GIT site group variances 
Variance pairwise comparison P-value 
2 weeks-rumen vs 2 weeks-colon 0.95 
4 week-colon vs 2 week-colon <0.0001 
4 week-rumen vs 2 week-colon 0.61 
4 week-colon vs 2 week-rumen <0.0001 
4 week-rumen vs 2 week-rumen 0.9 
4 week-rumen vs 4 week-colon <0.0001 
 
 
 
 
 
Table 3.7. Contribution by specific genera to overall dissimilarity between the microbial community of 2 and 4 week 
old calves 
  Average abundance %  
Genus GIT location 2 weeks 4 weeks Dissimilarity % 
Lactobacillus  colon 33.60 68.90 17 
Bacteroides  rumen 14.40 3.01 5 
Oscillospira  rumen 12.00 15.90 4 
Streptococcus colon 12.30 3.95 4 
Faecalibacterium  colon 8.91 1.15 4 
Porphyromonas  rumen 9.49 0.74 3 
Faecalibacterium  rumen 5.71 9.57 3 
Bulleidia  rumen 7.23 1.87 3 
Ruminococcus  rumen 2.63 8.27 3 
Clostridium  rumen 4.12 8.16 3 
Oscillospira  colon 6.89 2.49 3 
Eubacterium rumen 3.67 4.24 3 
Enterococcus colon 6.43 1.07 3 
Collinsella  colon 4.53 4.81 2 
Total    60 
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Table 3.8. Contribution by specific genera to overall dissimilarity between the microbial community  
of rumen and colon 
 Average abundance %  
 Colon Rumen Dissimilarity % 
Lactobacillus 51.30 2.16 28 
Oscillospira 4.70 14.0 8 
Faecalibacterium 5.87 7.71 6 
Bacteroides 1.40 8.52 5 
Clostridium 3.86 6.21 5 
Streptococcus 7.73 1.26 4 
Ruminococcus 2.56 5.54 4 
Total   60 
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Table 3.9. Regression coefficients for effect of calf age and GIT site on abundance of differentiator 
genera 
 Coefficient (β) S.E  P-value exp(β)  1 
     
 Lactobacillus   
Intercept -1.34 0.31 < 0.0001 0.26 
Week 4 1.31 0.36 0.0012 3.7 
Rumen -3.52 0.36 < 0.0001 0.029 
     
 Oscillospira   
Intercept -3.1 0.33 < 0.0001 0.05 
Week 4 -0.32 0.39 0.42  
Rumen 1.3 0.38 0.002 3.66 
     
 Faecalibacterium   
Intercept -3.26 0.50 < 0.0001 0.038 
Week 4 -0.29 0.55 0.60  
Rumen  0.86 0.56 0.13  
     
 Bacteroides   
Intercept -4.37 0.33 < 0.0001 0.012 
Week 4 -1.69 0.41 < 0.0001 0.18 
Rumen 2.07 0.29 < 0.0001 7.92 
     
 Streptococcus   
Intercept -2.26 0.29 <0.0001 0.10 
Week 4 -0.85 0.34 0.01 0.42 
Rumen -1.71 0.34 <0.0001 0.18 
     
 Porphyromonas   
Intercept -6.51 0.44 <0.0001 0.001 
Week 4 -1.44 0.52 0.001 0.23 
Rumen 3.73 0.52 < 0.0001 41.6 
     
 Clostridium   
Intercept -3.76 0.59 <0.0001 0.02 
Week 4 -0.12 0.62 0.84  
Rumen 0.93 0.63 0.15  
     
 Ruminococcus   
Intercept -4.61 0.70 <0.0001 0.009 
Week 4 0.49 0.64 0.45  
Rumen 1.34 0.67 0.06 3.82 
1
 exp 
(Intercept)
: represents expected value for colon at 2 weeks of age; exp 
(Week4)
: represents 
fold change at 4 weeks with respect to 2 weeks; exp 
(Rumen)
: represents fold change in rumen 
with respect to colon 
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Table 3.10. Indicator index values for best identifier genera of calf age groups 
Genus GIT location Indicator value P-value 
  2 weeks 4 weeks  
Escherichia  colon 0.93 0.07 0.001 
Actinomyces  rumen 0.87 0.13 0.015 
Porphyromonas rumen 0.87 0.13 0.002 
Enterococcus  colon 0.86 0.14 0.01 
Prevotella  rumen 0.12 0.88 0.015 
Lactobacillus  rumen 0.13 0.87 0.043 
 
 
 
Table 3.11. Indicator index values for best identifier genera of rumen 
and colon 
Genus Indicator index P-value 
 Colon Rumen  
Lactobacillus 0.96 0.04 0.001 
Streptococcus 0.86 0.14 0.002 
Bifidobacterium 0.83 0.17 0.001 
Actinomyces 0.06 0.94 0.001 
Prevotella 0.09 0.91 0.002 
Eubacterium 0.1 0.9 0.001 
Anaerotruncus 0.12 0.88 0.001 
Porphyromonas 0.14 0.86 0.001 
Bacteroides 0.14 0.86 0.003 
Blautia 0.16 0.84 0.001 
Bulleidia 0.16 0.84 0.003 
Alistipes 0.19 0.81 0.001 
 
 
Table 3.12.ANOSIM among samples from rumen and colon and from weeks 2 and 4 of age for predicted 
metagenome 
Contrast R Statistic
1
 P-value 
Rumen vs. Colon 0.41 0.001 
15 vs. 30 days of age 0 1 
1 Strength of groups difference   
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Table 3.13. PERMANOVA for effect of calf age and GIT site on metagenome composition 
Source of variation df
1
 SS
2
 MS
3
 Pseudo-F P-value 
Site 1 0.54 0.54 3.45 0.035 
Week 1 0.02 0.02 0.002 0.49 
Site x Week 1 0.10 0.10 0.66 0.52 
Residual 59 9.28    
Total 62     
1 Degrees of freedom 
2 Sum of squared multivariate distances 
3 Mean squared multivariate distances  
 
 
 
 
 
Table 3.14. Indicator index values for best identifier microbial functions 
 Indicator index P-value 
 Colon Rumen  
D.Alanine metabolism 0.81 0.19 0.001 
Galactose metabolism 0.78 0.22 0.001 
Glutathione metabolism 0.78 0.22 0.001 
Glycosyltransferases 0.77 0.23 0.001 
Metabolism of cofactors and vitamins 0.75 0.25 0.001 
 
 
 
 
 
 
Table 3.15. Short chain fatty acid and lactate concentrations in rumen and colon at 2 and 4 weeks of age 
 Rumen Colon P-value 
 2 4 2 4 site age site x age 
 mmol/ml    
Acetate 23.5 31.3 26.9 29.6 0.74 0.14 0.33 
Propionate  3.9 4.1 5.65 6.22 0.004 0.43 0.78 
Isobutyrate 0.11 0.15 0.64 0.42 0.03 0.59 0.39 
Butyrate 0.43 0.45 2.44 2.15 0.001 0.71 0.66 
Isovalerate 0.25 0.27 0.16 0.44 0.53 0.15 0.08 
Lactate 0.09 0.25 1.65 1.41 0.0001 0.85 0.37 
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Figure 3.1. Richness and Shannon Index H1 diversity measures across GIT sites and calf ages (2.colon = colon at 2 
weeks; 2.rumen = rumen at 2 weeks; 4.colon = colon at 4 weeks; 4.rumen = rumen at 4 weeks). 
0 20 40 60 80 100
Actinomyces
Proteobacteria
Bacteroidetes
Firmicutes
Tenericutes
Others
2 rumen
2 colon
4 rumen
4 colon
Figure 3.2. Predominant phyla abundance across calf ages and GIT sites 
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Figure 3.3. Distribution of predominant phyla across calf ages and GIT sites (2.colon = colon at 2 weeks; 2.rumen = 
rumen at 2 weeks; 4.colon = colon at 4 weeks; 4.rumen = rumen at 4 weeks). 
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Figure 3.4.NMDS of observations among calf age and GIT site groups based on taxa relative abundance 
a) 
Stress: 0.18 
 
c) 
Stress: 0.18 
  
Stress: 0.18 
b) 
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Figure 3.6.NMDS of observations among calf ages and GIT site based on predicted metagenome. 
  
Stress: 0.11 
b) 
  
Stress: 0.11 
c) 
  
a) 
Stress: 0.11 
Figure 3.5.Variances distribution for calf age and GIT sites 
(2.colon = colon at 2 weeks; 2.rumen = rumen at 2 weeks; 
4.colon = colon at 4 weeks; 4.rumen = rumen at 4 weeks). 
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Figure 3.7. Most abundand predicted microbial functions in rumen and colon. 
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Figure 3.8.Distribution of SCFA at 2 and for weeks of age in colon and rumen. (2.colon = colon at 2 weeks; 2.rumen = 
rumen at 2 weeks; 4.colon =  colon at 4 weeks; 4.rumen = rumen at 4 weeks). 
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CHAPTER IV 
 
 
ASSESSMENT OF THE PREBIOTIC POTENTIAL OF A 
GALACTOOLIGOSACCHARIDE RICH WHEY PERMEATE IN MILK REPLACERS 
FOR HOLSTEIN CALVES ON THE INTESTINAL MICROBIOTA COMPOSITION, 
FERMENTATION PROFILE, GROWTH AND HEALTH  
 
 
 
 
ABSTRACT 
Digestive disorders are common during the first few weeks of life of the newborn calf. 
Prebiotics are non-digestible oligosaccharides with good fermentable potential that modulate 
growth and activity of beneficial microbial populations which can result in enhanced gut health 
and function. Galactooligosacharides (GOS) have demonstrated such prebiotic potential. In this 
study, the effect of GOS supplementation on intestinal microbiota composition and fermentation 
profiles; intestinal health, development and function; and on the performance of dairy calves was 
evaluated under accelerated feeding conditions. Eighty calves were assigned either to a control 
treatment consisting of commercial milk replacer or to a GOS rich milk replacer treatment (i.e. 
3.4% of dry matter). After 2 and 4 weeks in trial, 8 calves per treatment were slaughtered. 
Samples of intestinal digesta and tissue were collected for assessment of microbiota composition, 
short-chain fatty acid concentrations, in vitro measurement of nutrient transport and 
permeability, histomorphology, and gastrointestinal organs size. The remaining 48 calves 
continued in trial up to week 8 to measure body growth, nutrient intake and fecal and respiratory 
scores. Animals in the control treatment showed significantly better growth (p < 0.05), milk dry 
matter intake (p < 0.05) and fecal scores (p < 0.001) and spent less days with scours (p < 0.001) 
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than GOS supplemented animals. Size of intestinal organs, nutrient transport and epithelium 
permeability were not affected by treatment and, although digesta short chain fatty acid 
concentrations were higher for control (p < 0.05), villi height and width and crypt depth were 
larger in animals receiving GOS (p < 0.05). In conclusion, high GOS supplementation levels 
may have a laxative effect leading to slightly lower performance while promoting greater 
intestinal epithelium growth.     
INTRODUCTION 
Neonatal calves are faced with different types of stressors and promoting an early balance 
among the animal, its environment and etiological agents is necessary to minimize the 
probability of illness episodes (Davis and Drackley, 1998). At this stage, the gut has a central 
role, not only in nutrient assimilation, but also in preventing direct contact between pathogens 
and the internal body as mediated by commensal microbial colonization (Martin et al., 2010).  
Intestinal illness is not uncommon in newborn calves. Diarrhea is one of the most 
frequent health problems in young dairy calves (Svensson et al., 2003). The last National Animal 
Health Monitoring System survey (NAHMS, 2010), which represents ~ 80% of U.S. dairy 
operations, reported a death rate for pre-weaning heifers of 7.8 %. Scours, diarrhea, or other 
digestive problems accounted for 56.5 % of this mortality. This appears somewhat better 
compared to 60.5% in the previous survey (NAHMS, 1996) but still is too high.  
A potential alternative to promote gut health in newborns is to prevent infection by 
fostering growth of lactic acid bacteria (LAB) to inhabit the gastrointestinal tract (GIT). To 
achieve this, different types of prebiotics have been developed and their potential health benefits 
shown experimentally in different species. Prebiotics have been defined as “selectively 
fermented ingredients that allow specific changes, both in the composition and/or activity in the 
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GI microbiota that confers benefits upon host well-being and health” (Gibson et al., 2004). 
Usually, bidifobacteria and lactobacilli are the microbial populations targeted by prebiotics such 
as fructooligosacharides (FOS) and galactooligosaccharides (GOS) (Macfarlane et al., 2008). 
These microbes can potentially displace pathogenic bacteria by, for instance, competing for 
nutrients and attachment sites in the gut epithelium, producing bacteriocins, increasing 
production of SCFA that lower intestinal pH and stimulating the immune system (Van Loo and 
Vancraeynest, 2008). 
A potential source of GOS is whey permeate, which is a byproduct of whey protein 
concentrate manufacture and contains much of the whey lactose. By using enzymes, it is possible 
to synthesize galactosyl-oligosaccharides from the lactose, with some net hydrolysis of lactose 
resulting in an increase in monosaccharides as well (Torres et al., 2010).   
The objective of this experiment was to evaluate an enzyme treated whey permeate as a 
source of GOS in milk replacer for pre-weaning calves and assess its potential prebiotic effects 
on gut health, development and function, and the performance of such animals under accelerated 
feeding conditions.  
MATERIALS AND METHODS 
Animals, Feeding and Treatment Allotment 
Thirty-two newborn calves were purchased from Stone Ridge Dairy farm (Manheim, IL). 
Upon arrival to the University of Illinois research facilities, animals received an electrolyte 
solution (Land O Lakes, Electrolyte System - Add Pack), vaccines and prophylactic antibiotic 
treatment (2 mL, Muse, MERCK; 2 mL BoSe, Shering-Plough; 1mL vitamin A and D; 1.1mL  
Draxxin, ; Bovisera (50mL antibody serum, 20 mL C and D antitoxin, Behringer Ingelheim; 2 
mL  INFORCE-3, Pfizer). Calves were blocked by arrival bodyweight (BW) and plasma protein 
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score and, within block, treatments were assigned randomly. Treatments were:  1) commercial 
milk replacer (CON) and 2) commercial milk replacer containing whey permeate rich in 
galactooligosacharides (GOS). Final concentration of galactooligossaccharides was 3.4% of dry 
matter (DM). Also, CON contained ~44% as DM of lactose versus ~20% in GOS. This dosage 
was set based on previous observations with pigs where ~4.8% of the diet DM as 
galactooligossacharide supplementation resulted in a clear prebiotic effect (Smiricky-Tjardes et 
al., 2003).  
Milk replacers were formulated to be isoenergetic and isonitrogenous and to meet or 
exceed NRC daily nutrient allowance recommendations (NRC, 2001). Milk replacers were fed at 
a rate of 1.25% of BW on a DM basis for the first 2 days, 1.5% of BW until day 10, and then 2% 
of BW through d 42.  For days 43 to 49, milk replacer was fed at 1.5% of BW and from days 50 
to 56 at 1% of initial BW only once daily. Calf DMI was adjusted individually on BW basis 
every week. Calves were fed the milk replacer treatments from arrival to day 30 with no grain 
offered.  On day 31 grain was introduced and calves were weaned at day 56.  
Performance and Health 
Intakes of milk replacer and starter were measured and recorded daily.  Weekly growth 
measurements included body weight, heart girth, body length, withers height, hip height, and hip 
width. Fecal scores and respiratory scores were recorded daily. 
Animal Slaughter and Sampling 
Eight calves per treatment were euthanized at 2 and 4 weeks into the experiment to 
collect tissue and digesta samples. The animals remained unfed until euthanasia took place. 
Euthanasia was performed by administering an overdose of sodium pentobarbital intravenously 
(85-150 mg/kg BW). 
 89 
 
After euthanizing the animal, the thoracic cavity was cut open, the GIT was removed and 
ligated between omasum and abomasum, abomasum and duodenum and at the end of the ileum 
to prevent digesta flow due to manipulation. Then, the fore stomachs, small intestine and large 
intestine were separated for digesta and tissue sample collection. Once samples were collected all 
digesta was manually removed and GI organs weight and length were recorded. 
In vitro Nutrient Transport 
Within 20 minutes of euthanasia, pieces about 3 inch
2
 of rumen and 7 cm long of 
jejunum, ileum and colon were collected for nutrient transport and permeability measurements in 
modified Ussing chambers (Physiologic Instruments; San Diego, CA) following procedures by 
Cannon  (2009). Samples were placed in oxygenated (95% O2:5% CO2) Krebs’ solution (120 
mM MgCl2, 120 mM CaCl2, 40 mM KH2PO4, 240mM K2HPO4 , 1.15 M NaCl2, and 260 mM 
NaHCO3) on ice and transported to the laboratory for immediate electrophysiological and ion 
transport analysis. Basal short-circuit current (Isc; indicator of non-specific active ion transport), 
resistance (R; permeability), and potential difference (Pdo; total ion transport) were established 
during an initial stabilization period of ~20 min. Nutrient transport was assessed by changes in 
short-circuit current induced by addition of 10 mM D-glucose, L-glutamine and L-arginine to the 
mucosal medium (Cannon, 2009). Peak Isc values (point of maximal change) were measured 
after each nutrient was added, and the difference between basal (measured prior to each nutrient 
addition) and peak levels was calculated (Cannon, 2009). 
Histology 
Samples about 2 inch
2
 of rumen and 7 cm long of jejunum, ileum and colon were 
collected for histomorphology analysis. Tissues were fixated and maintained in 10% formalin 
solution. Afterwards, tissue was dehydrated with ethanol and embedded into paraffin blocks, 
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from which 5 µm thick sections were cut and set onto glass slides. The sections were then 
stained with hematoxylin and eosin. Measurements of papillae length and width were made from 
dorsal rumen, caudal ventral sac and cranial ventral sac of rumen. Villi length, width and crypt 
depth were measured for duodenum, jejunum and ileum. Crypt depth and width were measured 
in colon. Microscopy measurements were performed using a Nanozoomer scanner  and software 
(Hammatsu, Japan) at the Institute for Genomic Biology at the University of Illinois.  Ten 
measurements were recorded per animal per GI segment and their average used for statistical 
analysis.     
Digesta SCFA Concentration 
Ruminal and colonic digesta samples were collected and acidified with a 10 N 
hydrochloric acid solution. Afterward, samples were centrifuged at 15,000 × g for 15 min, the 
supernatant extracted, frozen and sent to North Carolina State University to the laboratory of Dr. 
Vivek Fellner for SCFA analysis by gas liquid chromatography. Briefly, digesta samples 
supernatant was injected (1 μL) into a column (Varian CP 3380/3800 with a Nukol Fused Silica 
Capillary Column, 30 m × 0.25 mm × 0.25 mm; Sigma-Aldrich, St. Louis, MO). A flame 
ionization detector was used to quantify SCFA elution (Herfel et al., 2013).  
Microbial Community Diversity and Structure 
Digesta samples from rumen and colon were collected into 5ml sterile cryovials and snap 
frozen in liquid nitrogen to quickly stop microbial activity. Later on, samples were stored at -20 
°C until DNA extraction. Samples were submitted for for bacterial tag encoded FLX amplicon 
pyrosequencing (Research and Testing Laboratory, Lubock, TX). 
Total microbial DNA was extracted using a QIAamp stool DNA mini (Qiagen Inc., 
Valencia, CA) as previously reported (Dowd et al., 2008a; Dowd et al., 2008b). Sample DNA 
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was quantified using a Nanodrop spectrophotometer (Nyxor Biotech, Paris, France). Upon 
extraction, the V1-V3 hyper variable regions of the 16S ribosomal DNA gene were amplified by 
PCR using barcoded primers and the product sequence determined by bacterial tag-encoded FLX 
(non-titanium chemistry) amplicon pyrosequencing (Roche, Nutley, New Jersey) as reported 
previously (Dowd et al., 2008a; Dowd et al., 2008b). Afterwards, sequences were depleted of 
barcodes and primers. Sequences that were too short (< 200bp), that had ambiguous base calls or 
homopolymer runs exceeding 6bp were removed.  Chimera removal and sequence de-noising 
were then performed. The remaining sequence reads were clustered at 97% similarity to 
determine operational taxonomic units (OTU’s) as illustrated elsewhere (Dowd et al., 2008a; 
Dowd et al., 2008b; Edgar, 2010; Capone et al., 2011; Swanson et al., 2011). The OTUs were 
subsequently classified using BLASTn against a curated database (DeSantis et al., 2006) and 
compiled into the different taxonomic levels such as phyla and genera. The final average number 
of sequence reads per sample was 6,203 with a minimum of 1834 and a maximum of 16400. The 
25
th
 and 75
th
 percentile for the 32 samples were 4328 and 7511 quality reads per sample after 
filtering. 
The Shannon index was calculated as a proxy measure of diversity. Shannon index takes 
into account the total number of species present in a niche but also the abundance evenness 
among them (Tuomisto, 2010). Shannon index values were estimated for each sample and used 
as a dependent variable in function of dietary treatment and calf age as illustrated below. 
Statistical analysis 
Microbial Community Composition. A Bray-Curtis distance matrix to estimate the 
similarity among each pair of digesta samples originating from different age by treatment by GIT 
site groups, was built from the OTU or genus level matrix. 
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Afterwards, to visually explore the degree of microbial composition similarity between 
samples, non-metric multidimensional scaling (NMDS) was conducted on the above Bray-Curtis 
distance matrix (Borcard et al., 2011). The stress index was always below 0.2 indicating NMDS 
provided a good multidimensional representation of the microbial community in a reduced 
number of dimensions (Borcard et al., 2011). Square root transformed and non-transformed data 
provided similar NMDS, thus the latter was used throughout.  
To contrast with NMDS and statistically test differences in microbiome composition 
between treatment, GI site and calf age groups, Analysis of Similarities (ANOSIM) (Clarke, 
1993) and Permutational Multivariate Analysis of Variance (PERMANOVA) (Anderson, 2001) 
were conducted. The ANOSIM statistically tests whether there is a significant difference 
between two or more groups of sampling units based on the difference of mean distance ranks 
computed from the matrix. The ANOSIM statistic R ranges from -1 to 1 with 0 indicating no 
grouping of samples. The statistical significance (i.e. p-value) of the observed R statistic is 
assessed by permutation. The PERMANOVA, on the other hand, partitions the total sums of 
squared Bray-Curtis distances among sources of variation and uses a permutation test with 
pseudo-F ratios to compute a p-value. The PERMANOVA is considered more robust to the 
homogenous variance assumption violation and to have greater statistical power to detect 
differences (Anderson, 2001; Anderson and Walsh, 2013). 
The multivariate homogeneity of variances (Anderson, 2006) assumption was tested and 
found to be partially unmet. Consistently, microbial communities in the colon presented 
statistically smaller variation (data not shown, Fig.4.2a for visual appraisal). Although, this can 
be undesirable for the validity of a multivariate analysis of variance test, it has been recently 
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observed that, with balanced designs (i.e., our study), heterogeneity is less of an issue for 
PERMANOVA (Anderson and Walsh, 2013)).  
Subsequently, in order to identify which genera contributed most to the microbiome 
observed differences among dietary treatment groups, Similarity Percentage Analysis (SIMPER) 
(Clarke, 1993) was performed. The SIMPER computes the contribution of individual genera to 
the overall Bray-Curtis dissimilarity. Only genera contributing up to 80% of the dissimilarity 
between CON and GOS are reported here. Due to SIMPER methodological limitations (Warton 
et al., 2012), results are complemented by univariate tests as appropriate using the generalized 
linear model framework (Fitzmaurice et al., 2011) to test statistical differences among groups. 
This approach also has the advantage that allows estimating the effect size of dietary treatment, 
age or their interaction.  
Relative abundance of specific taxa and diversity were thus analyzed through the linear 
predictor:  
     
         
where ɳi is a linear function of the β unknown parameters and the covariates X corresponding the 
i
th
 observation, which include, dietary treatment (CON, GOS), calf age (2 weeks, 4 weeks) and 
their interaction. Due to presence of large over dispersion in taxa counts with respect to a 
Poisson density, a negative binomial distribution was used to model these. Shannon index was 
analyzed under a gamma distribution because it is bound from below at zero and errors did not 
meet normality assumptions (Fitzmaurice et al., 2011). A log link function was used all 
throughout. Maximum likelihood was used to estimate parameters and standard errors. 
For the sake of interpretability of the coefficients in the log linear predictor, the above 
model for taxa counts at the genus level is expressed as: 
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                                           , 
to estimate the expected number of reads of a specific taxa  adjusted for the average total number 
of sequence reads present in a particular age by GIT site group.  The exponentiated intercept 
represents the relative abundance at 2 weeks of age in colon, the exponentiated coefficient for Xi 
is the fold change in GOS with respect to CON at 2 weeks, the exponentiated coefficient for Xj is 
the fold change in week 4 relative to week 2, and the exponentiated coefficient for Xij (i.e. the 
interaction term) is the adjustment to the GOS effect for its dependence on time.  
The NMDS and ANOSIM were carried out in Primer-E software V.6.0, SIMPER (Clarke 
and Gorley, 2006), PERMANOVA and multivariate heterogeneity of variances test were 
conducted with the package Vegan (Oksanen et al., 2012), and generalized linear models were 
performed with the base package in the open access R language version 2.14.0.  
Growth performance, nutrient intake and fecal scores. Average weekly measurements 
of nutrient intake and body size were analyzed as repeated measures. The error covariance 
matrix was modeled to choose the one with the least number of parameters and that would 
minimize the adjusted Akaike Information Criteria (AAIC) and -2 ratio log-likelihood. Residuals 
were checked for homogeneity of variance and normality. Heterogenous variances were common 
and an autoregressive function of first order allowing for heterogeneity (ARH1) handled well the 
problem. Significance was declared at P < 0.05 and trends were declared at P < 0.1. When 
interactions were significant, an experiment wise error rate of 5% was set to compare group 
means.    
Repeated fecal score measures, in a scale from 1 to 4, were analyzed by fitting a marginal 
ordinal logistics regression model (Fitzmaurice et al., 2011) in PROC GENMOD of SAS to 
estimate the odds of observing diarrheal episodes (i.e., fecal score 4) in GOS with respect to 
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CON. Each calf was considered a cluster. Also, the number of days with fecal scores over 2 were 
analyzed under a Poisson distribution with a variance inflation factor to account for over 
dispersion.   
SCFA concentrations, histology, nutrient transport and permeability. All these 
measurements were considered repeated measures on the same calf. As such, same guidelines as 
those for growth performance we followed. Residual errors were in general normally distributed. 
Error correlation and variance heterogeneity were dealt with as explained above. 
RESULTS 
Milk Replacer and Grain Mix Composition 
The composition of experimental milk replacers and the concentrate is shown in Table 
4.1. Milk replacers had similar concentrations of crude protein (CP), fat, net energy (NE), 
calcium (Ca) and phosphorus (P) (Table 4.1). They also contained different concentrations of 
lactose and GOS (table 4.2). The CON contained ~44% of lactose versus ~20% in GOS. At the 
same time, CON contained only 0.6 mg/g (0.06% of DM) of galactooligosacharides compared to 
33.5 mg/g (3.35% of DM) in GOS. Therefore, the remainder should have been present in the 
form of monosaccharides. The main galactosyl-oligosaccharides in milk replacer containing 
treated whey permeate were lacto-N-fucopentanose (~2.9%) and 2’-Fucosyl-lactose (~1 %).  
This implies that less than half of the carbohydrates in the enzymatically treated whey 
permeate were available for host enzymatic digestion and the remainder was substrate for 
fermentation in the hindgut.  
Microbiota Diversity and Community Composition  
Various things are highlighted by the PERMANOVA analysis (Table 4.3). First, at 5 % 
type 1 error rate, treatment can be considered to have a significant effect on the average 
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abundance of one or many of the several hundred organisms identified; however, its contribution 
to the total variation is small at 2.6%. This is clearly reflected in the wide variation within 
treatments as shown in the NMDS for dietary treatments presented in Figure 4.1a where hardly 
any difference between CON and GOS can be noticed.  
The 2-way interactions with week and GI site were not significant, suggesting the effect 
of prebiotic supplementation is independent from the effects of GI location and calf age. Figure 
4.1b and 4.1c show the lack of clearly cut associative patterns of the microbiota between dietary 
treatments at each age and GI site.   
Nevertheless, the significance of the 3-way interaction suggests that the dependence of 
the GOS effect on a particular GIT site, depends itself on the age of the calf. Yet, the variance 
explained by this interaction barely accounts for 3 % of the total variation. These significant, yet 
small effects of such dependency, will be dealt with in detail in a later section. 
Also, from the PERMANOVA analysis it is immediately apparent that GIT site, age and 
their interaction explain most of the variation in the GI microbiota composition of these pre-
weaning calves with a cumulative R
2 
of 32.8%.  Because these latter sources of variation 
account, by and large, for the majority of the variation and appear to act fairly independently 
from dietary treatment effects, as evidenced by the non-significance of the 2-way interactions, 
their influence on the microbiota composition was thoroughly explored elsewhere (i.e., previous 
chapter). 
In order to understand the previously observed 3 way interaction, exploratory ANOSIM 
was conducted to perform 1, 2 and 3 way multivariate pairwise comparisons for treatment, age 
and GI site.  
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In contrast to PERMANOVA, ANOSIM deems the difference between CON and GOS to 
be null with R statistic equal to zero and P-value of 1 (table 4.4) which agrees with the visual 
appraisal from NMDS in Figure 4.1a. However, when the overall treatment effect is broken 
down into the effect in colon and rumen, ANOSIM indicates that, while no microbiota 
compositional difference exists between GOS and CON in rumen, there is a very small (R=0.14) 
but highly significant difference in the colon (P = 0.007). This can be seen in Figure 4.2a where 
ruminal and colonic microbial communities are distinctly different, in agreement with 
PERMANOVA, but while GOS and CON groups are seemingly equal in the rumen, they would 
appear to differ in variability or location in the colon. 
When the 2-way comparisons are further broken into 2 and 4 weeks, the significance of 
the 3-way interaction identified by PERMANOVA becomes apparent. Whereas no changes 
occurred in the rumen in response to GOS treatment at both 2 and 4 weeks of age (R=0.04 and 
R=0.05, P=0.24 and P=0.21, respectively), the microbiota composition of the colon differed 
fairly strongly between GOS and CON groups (R=47, P=0.001) at 2 weeks of age, but these 
differences faded away by week 4 of age (R=0.06, P=0.13).  Because any treatment effects were 
completely absent in the rumen up to this point, we decided to consider only the colonic 
populations hereafter. Figure 4.2b clearly shows how colonic microbial populations exposed to 
GOS differ from CON, but only at 2 weeks of age, highlighting a very narrow and specific time 
window of the prebiotic effect.  
To identify which specific taxa were responsible for the observed differences between 
GOS and CON in colon, SIMPER analysis was performed at the genus level (Table 4.5). 
Interestingly, out of 393 genera identified, only 8 of them accounted for ~80% of the 
dissimilarities between CON and GOS. Galactooligosachharide supplemented calves were 
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characterized by more abundant Lactobacillus (~63 vs 39 %), Bifidobacterium (~5.6 vs 2.3 %) 
and Enterococcus (~4 vs 3 %). Meanwhile, Streptococcus (~5.7 vs 9.8 %), Faecalibacterium 
(~0.8 vs 11 %), Oscillospira (~1.2 vs 8.2 %), Collinsella (~2.8 vs 7 %) and Clostridium (1.2 vs 3 
%) were present in greater amounts in CON than in GOS. The cut off threshold of 80% was set 
arbitrarily since the additional contribution of each individual taxon to the dissimilarity was less 
than 2% and over 100 genera were to represent the remaining 20%. 
To assess whether the colonic abundance of these genera varied significantly due to age 
or prebiotic treatment, in an independent or interactive fashion, and to quantify such variation, 
negative binomial regression was performed to analyze the number of counts of DNA sequence 
reads corresponding to each taxon. Results are presented in Table 4.6. 
Estimated Lactobacillus relative abundance in the colon of calves at 2 weeks of age was 
~ 8% (Intercept = 0.0809 * 100= ~8%). In the presence of GOS it increased by about 7.37 fold 
(exp
(1.994)
 = 7.37). By week 4, this genus increased its abundance by 8.68 fold (exp
(week 4)
=8.68) 
compared to 2 weeks in CON animals. The significant interaction explains how the GOS effect 
depended on the week. Even though GOS treated calves had numerically and statistically greater 
amounts of Lactobacillus in their colon at 2 weeks of age, by 4 weeks such difference ceased to 
exist and GOS supplemented calves presented only ~ 0.96 times (exp
(1.994)
*exp
(-2.034)
 = 7.34 * 
0.13 = 0.96) the abundance of this lactic acid organism with respect to CON calves 4 weeks old 
(Table 4.6, Figure 4.3).        
In the case of Bifidobacterium, GOS treated calves at 2 weeks of age presented levels 
~8.9 times as high as those in CON calves. By 4 weeks, however, the GOS effect on 
Bifidobacterium levels went down to about 6% the GOS effect size at 2 weeks of age (exp
(week 4 x 
GOS)
 = 0.06).      
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Thus, it appears that the GOS effect on these 2 lactic acid bacteria was transient during 
the first 2 or 3 weeks of life and faded away by the 4
th
 week of life of these calves fed only milk 
replacer (Figure 4.3). 
  Streptococcus on the other hand was not statistically affected by GOS treatment even 
though it contributed 9% of the dissimilarity between CON and GOS groups according to the 
SIMPER analysis. Instead, it was only significantly affected by age, decreasing to 20% (exp
(week 
4)
 = 0.20) of the initial abundance levels by 4 weeks of age. Similarly, Collinsella and 
Enterococcus were not significantly affected by GOS treatment despite jointly contributing 10% 
of the dissimilarity between GOS and CON calves.  
Furthermore, the increase in LAB ( Lactobacillus + Bifidobacterium) in response to GOS 
supplementation occurred at the expense of Faecalibacterium, Oscillospira and Clostridium, 
which were reduced to 1.5, 4.1 and 9.8% (Table 4.6), respectively, of the abundance levels 
present in CON animals at 2 weeks of age.  Similar to LAB as well, these 3 genera were present 
at similar levels in both CON and GOS by 4 weeks of age. 
On a different note, we did not observe any changes in diversity as measured by the 
Shannon index, due to calf age or supplementation with GOS, or their interaction (Table 4.7).  
Overall, considering that the total number of bacterial species and their evenness was not 
affected at all, that out of 393 genera only 5 (i.e. Lactobacillus, Bifidobacteria, 
Faecalibacterium, Oscillospira and Clostridium) constituted the most significant response to 
prebiotic treatment, that LAB  were ~8-9 fold more abundant in GOS than CON, and that all 
effects were confined to the colon and to the first 2 weeks of life, it seems as though the prebiotic 
effect of treated whey permeate on the microbiota composition was very potent, specific and 
transient.    
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Visceral Organs Size 
Supplementation with GOS did not affect the weight or length of the GI tract. Neither 
was there an interaction between treatment and age or GI organ (Table 5.8).  
SCFA Concentration 
Main effect of prebiotic treatment  on SCFA concentration in the GIT was significant 
(Table 4.9). Counterintuitively, animals receiving CON showed a higher average total SCFA, 
propionate and butyrate concentrations than animals receiving GOS; however, this effect 
depended on the GI site. Total SCFA, acetate, propionate, butyrate and lactate concentrations 
were significantly larger for CON than GOS in the colon but not in the fore stomach or small 
intestine. This is not unexpected given the low influx of fermentable matter into the rumen of 
calves fed only milk where the esophageal groove is functional, and agrees with the absence of 
any significant shifts in the microbiota composition of the rumen at either 2 or 4 weeks under 
either diet.   
Overall, in colon, total SCFA, acetate, propionate, butyrate and lactate concentrations 
were between ~66 and 240 % greater for CON versus GOS.  
Analysis of SCFA concentrations expressed as molar proportion yielded similar results 
(data not shown).  
Nutrient Transport and Permeability 
There was no effect of treatment or its interaction with GIT location on epithelium 
permeability (Table 4.10). Similarly, no effect of treatment or its interaction with GI site on 
glucose, glutamine or arginine transport was observed (Table 4.10).  
Histology 
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Considering the length of the papillae and the villae in rumen and small intestine, we 
observed that the effect of treatment depended on the age of the calf. While the average 
villae/papillae length remained unchanged in the CON group, they increased significantly in the 
GOS group from 2 to 4 weeks of age. The effect of the interaction between dietary treatment and 
GIT site was not significant, meaning that the effect size of GOS supplementation was similar in 
both fore stomach and small intestine. In addition, there was a significant effect of treatment on 
the mean depth of the crypts in small and large intestine (Table 4.11) and this effect did not 
depend on GI site or calf age. On the other hand, treatment or its interaction with GI site or age 
did not affect the width of the papillae in the rumen, the villae in the small intestine or the crypts 
in the colon (Table 4.11).   
Dry Matter, Nutrient and Water intake 
Daily milk DMI was significantly affected by dietary treatment. The magnitude of such 
effect ranged between 20 and 40 g/d and was dependent on time as illustrated by the significant 
interaction between treatment and age. At 2, 4 and 8 weeks of age, average milk DMI was 
greater for CON than GOS and this difference slightly increased from week 2 through week 8. 
Grain DMI intake was not different between CON and GOS and was affected only by age, 
similar to total DMI meaning that GOS animals could not compensate the reduced milk DMI by 
increasing grain DM consumption (Table 4.12). 
The difference in DMI resulted in a marginally lower daily energy intake for GOS 
animals up to week 4 at which point the difference was not significant any further (Table 5.13).  
Daily crude protein intake differed between CON and GOS only between weeks 0 and 2 
as shown by a significant treatment by week interaction (means not shown). Afterwards, no 
difference was observed (Table 4.13).   
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Average daily water intake at 2, 4 or 8 weeks was not affected by dietary treatment 
overall (Table 4.14).   
Growth 
Body growth was slightly although significantly affected by dietary treatment and the 
CON diet consistently supported a better performance than GOS treatment. The CON animals 
presented between 0.64 and 2 kg higher bodyweights than GOS animals from week 2 to 8 (Table 
4.15). Heart girth and hip height also were greater in CON than in GOS animals at weeks 2, 4 
and 8 but the magnitude of the difference varied across weeks. Similarly for body length and 
wither height as shown by the significant interaction between week and treatment but only from 
week 4 through week 8. Hip width was significantly greater for CON versus GOS at 8 weeks of 
age. 
Health 
In Table 4.16 it can be seen that the odds of having fecal score 4 for GOS animals were 
2.36 times those of CON animals (Figure 4.4). Moreover, the number of days with fecal scores 
over 2 was statistically greater for the GOS treatment than CON at 2, 4 and 8 weeks of age when 
the latter was exceeded by about 10 days.  
DISCUSSION 
In the current experiment, feeding a GOS rich milk replacer potently boosted LAB such 
as Lactobacillus and Bifidobacteria in the colon at the expense of other genera like 
Faecalibacterium, Clostridium and Oscillospira. This prebiotic effect was characterized by LAB 
levels ~8-9 times higher in GOS than in CON, which lasted ~2 weeks and then disappeared 
afterwards. Therefore, enzymatically treated whey permeate has indeed shown to bear prebiotic 
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activity by allowing specific changes in the composition in the GI microbiota (Gibson and Wang, 
1994) in this study.  
Bifidobacteria and Lactobacillus species have been shown to provide resistance against 
diarrheal disease and to stimulate the immune system (Yamazaki et al., 1985; Gibson and Wang, 
1994; Parassol et al., 2005; Johnson-Henry et al., 2008; Vizoso Pinto et al., 2009). Hence, GOS 
rich milk replacer from whey permeate treated with B-galactosidases may certainly provide a 
means to support calf intestinal health during the first weeks of life.  
It is also remarkable that while Lactobacillus levels remained high in GOS by week 4 of 
life (~55%), the lack of difference with CON at that age was due to the sharp increase of this 
LAB in non-supplemented animals, reaching almost 60% of the colonic microbiota.  This 
contrasts strongly with observations in young calves where other genera like Bacteroides, 
Prevotella  or Faecalibacterium were fairly abundant at this age (Edrington et al., 2012; Li et al., 
2012; Jami et al., 2013; Malmuthuge et al., 2014).   
Unexpectedly, the increase in LAB was not reflected in the fermentation profile as CON 
animals presented much larger total SCFA, acetate, propionate, butyrate and lactate 
concentrations in the colon compared to GOS, which might suggest an enhanced fermentative 
state in the distal bowel of CON animals. Alongside, calves on GOS exhibited 82% higher odds 
of presenting diarrhea and spent a total of ~10 more days with fecal scores over 2 by week 8.  
The challenge is thus to reconcile the higher intake of non-digestible but fermentable 
oligosaccharides and the greater abundance of LAB in the hindgut with the lower colonic SCFA 
and overall diarrhea-like condition of prebiotic supplemented calves.   
There is evidence that carbohydrate malabsorption, even from fermentable sources, can 
eventually cause osmotic diarrhea to different extents as the colonic fermentative and VFA 
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absorptive capacities are progressively exceeded (Binder, 2010). Indeed, excess non-digestible 
fermentable carbohydrates arriving into the colon are fermented to SCFA plus CO2 and H
+
. 
SCFA are normally absorbed by the colonocytes, but when SCFA production rate exceeds the 
absorption rate, the luminal accumulation of SCFA and H cause colonic pH to decrease and 
water to be secreted into the lumen, leading to diarrhea (Binder, 2010). Let us gauge whether an 
osmotic gradient reversal due to an excessive colonic influx of GOS is a plausible explanation to 
our observations. At a hypothetical BW of 55 kg, with a given DM intake of 2% on a BW basis, 
and with a GOS concentration of ~ 3.4%, the average GOS consumption by supplemented 
animals must have been about 39 g/d as compared to ~1 g/d for CON animals. In humans, inulin 
oligosaccharides, FOS and GOS at lower dosages have shown to be mildly laxative and, if 
supplied in large amounts, can result in flatulence and osmotic diarrhea (Macfarlane et al., 2008). 
When 15 g/d were ingested by healthy adults, defecation frequency and flatulence increased 
(Teuri, 1998). Similarly, when healthy adults were dosed with 10 g/d of GOS, defecation 
frequency, feces softness and bowel movement and flatus symptoms were found to increase 
(Deguchi et al., 1997). In one other study in which 0, 2.5, 5.0 or 10.0 g of GOS per day were 
supplemented to human adults, the daily ingestion of 10 g increased the sensation of fullness, 
and there was a tendency for flatulence and abdominal pain to increase (Ito et al., 1990). 
Although BW was not reported in these studies, it is unlikely that average human adults weigh 
less than a newborn calf. On a per kilogram BW basis, GOS intake here was ~ 4 times higher 
compared to adult human subjects with a hypothetical calf BW of 55 kg and the aforementioned 
dosages for humans.  Based on this evidence, we deem a reversed osmotic gradient with the 
concomitant increased luminal water content in the colon a reasonable although speculative 
explanation for the lower SCFA concentrations and diarrhea-like condition.   
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Another measure that supports the idea of osmotic rather than infectious diarrhea is the 
similarity in the epithelium colonic resistance between CON and GOS. It has been shown that 
animals infected with pathogens such as enterohemorrhagic E. coli (EHEC) or enteropathogenic 
E. coli (EPEC) suffer from serious diarrhea-like conditions due to an increase in paracellular 
permeability from tight junction breakdown in the gut epithelium (Guttman et al., 2006). This 
leak-flux mechanism is exaggerated during Clostridium difficile and Vibrio cholera infection 
where toxins lyse the tight junctions (Guttman et al., 2006). However, when we measured 
intestinal epithelial resistance to assess gut barrier functionality in the different regions of the 
GIT, there were no statistically significant differences between GOS supplemented and CON 
animals, suggesting that the increase in luminal water for GOS animals did not result from leak 
flux due to pathogenic tight junction disruption.  
On the other hand, GOS was associated with a greater increase in the size of the villi in 
duodenum, jejunum and ileum from 2 to 4 weeks of age, and with deeper crypts in the colon and 
small intestine compared to CON animals. These effects of prebiotics have been shown before 
and appear to be mediated by a greater SCFA yield, especially butyrate (Kleessen et al., 2003; 
Bartholome et al., 2004), apparently through release of potent intestinal peptides like glucagon 
like peptide 2 (Cani et al., 2009), which can act in a para or endocrine way to elicit a powerful 
systemic trophic effect on the mucosa of both the proximal and distal gut. Although in this case 
GOS supplemented animals presented smaller luminal SCFA concentrations, it is important to 
take into account that only by measuring SCFA yields instead of molar concentrations could we 
be certain whether fermentation was in fact greater in CON or GOS fed animals. 
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Regarding functionality, the transport of glucose, glutamine (i.e., neutral amino acid) and 
arginine (i.e., basic amino acid) was unaffected by GOS supplementation even in the colon, 
indicating that these transport systems were indifferent to prebiotic mediated LAB enhancement.  
At the animal level, a slightly lower growth performance in GOS animals was observed. 
This could have been due to a ~20% lower dietary lactose availability. Since feeding rates were 
individually adjusted weekly according to BW, the slower growing GOS calves received less 
food than CON as reflected in an average reduction of ~90 kcal/d  of milk metabolizable energy 
intake by week 4 of life.  
Reported work with mannan and fructan-oligosacharides in calves has often (Heinrichs et 
al., 2003; Van Loo and Vancraeynest, 2008; Ghosh and Mehla, 2011) but not always (Heinrichs 
et al., 2009) resulted in consistent beneficial effects on fecal scores, commensal bacterial 
populations, feed intake and efficiency.  Besides the difference in oligosaccharide types studied, 
a much lower dosage used (~ 4g/d) and feeding rates ranging from 1.4 to 1.7 % of BW make it 
difficult to draw solid comparisons and conclusions against our observations.    
Feeding rate and prebiotic concentration determine the amount of not only non-digestible 
oligosaccharides, but also lactose and protein that that enter colonic fermentation and ultimately 
impact the microbiota composition and activity in the large bowel. Moreover, depending on 
oligosaccharide composition, GOS products will vary in their physiological effects (Torres et al., 
2010). For instance, the administration of a GOS mixture (3.6 g/d) containing mainly β1→3 
linkages with some β1→4 and β1→6 linkages proved to have a better bifidogenic effect than a 
GOS mixture (4.9 g/d) containing mainly β1→4 linkaages with some β1→6 linkages, after 1 
week of intake by healthy humans (Depeint et al., 2008).  
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To optimize and standardize the response to GOS supplementation in terms of microbial 
community composition, fermentation products and host health, the above 3 factors (i.e., feeding 
rate, GOS dosage and type) and their interactions will have to be taken into account to a build a 
reliable response surface.  
Therefore, even though potent enrichment of LAB during the first 2-3 weeks of life of 
dairy calves can have a positive impact on intestinal health (Macfarlane et al., 2008), inclusion of 
enzymatically treated whey permeate as a source of GOS must be optimized to avoid undesired 
collateral effects such as lower nutrient intake, performance or laxative effects. 
CONCLUSION  
One to one substitution of untreated for enzymatically treated whey permeate as a source 
of GOS resulted in very potent growth promotion of LAB in the colon for ~2 weeks of age. This 
was accompanied by greater development of intestinal epithelium structures in small and large 
intestine. However, GOS supplementation also resulted in lower intestinal SCFA concentrations 
and increased fecal scores.  A possible reason for this would be a GOS over-flux into the large 
bowel exceeding the fermentative capacity of the microbiota or the ability to absorb SCFA by 
this organ, resulting in water secretion. 
Also, slightly lower nutrient intake and growth were observed in GOS supplemented 
animals. Taking advantage of enzymatically treated whey permeate as a source of GOS to 
improve intestinal health in pre-weaning calves will require optimization of supplementation 
levels and milk replacer feeding rates to maximize LAB populations, fermentation and calf 
health responses while maintaining performance.   
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TABLES AND FIGURES 
 
Table 4.1. Nutrient composition of experimental milk replacers and grain mix 
1 GOS: Galacto-oligosacharide supplemented treatment. 
2CP: Crude protein. 
3NEm: Net energy of maintenance. 
4NEg: Net energy of gain. 
 
 
Table 4.2. Mono, di and oligosaccharides profile of CON and GOS 
milk replacer 
1 GOS: Galacto-oligosacharide supplemented treatment. 
 
Nutrient CON GOS
1
 Grain 
DM, % 95.9 95.0 88.2 
CP
2
, % DM 28.8 29.6 22.9 
Crude fat, % DM 15.7 15.1 N/A 
Ash, % DM 8.27 7.76 N/A 
NEm
3
, Mcal/kg 2.67 2.67 2.12 
NEg
4
, Mcal/kg 1.91 1.90 1.44 
Ca, % DM 1.05 1.12 1.00 
P, % DM 0.68 0.63 0.54 
 CON GOS
1
 
Total disaccharides, mg/g 437.3 197.3 
Sucrose 1.0 0 
Lactose 436.3 197.3 
   
Total oligosaccharides, mg/g 0.6 33.5 
2’-Fucosyl-lactose  0 3.7 
Lacto-N-fucopentanose 0 28.8 
Lacto-N-neotetraose  0.2 0 
Lacto-N-tetraose 0 0.8 
Sialic acid 0 0 
LS-tetrasacharide c 0 0.2 
6’-Sialyl-lactose 0 0 
3’-Sialyl- lactose 0.4 0 
   
Total hydrolyzed monosacharides, mg/g 487.2 473 
Fucose  0 0 
Galactose 260.8 188.6 
Glucose 223.3 281.4 
Mannose 3.1 3.0 
 109 
 
Table 4.3. PERMANOVA for effect of prebiotic treatment, calf age and GI site on microbial 
community composition 
1 Degrees of freedom 
2 Sum of squared multivariate distances 
3 Mean squared multivariate distances  
 
 
 
Table 4.4. ANOSIM between CON and GOS by GI site and calf age 
1 R statistic = 1 when groups difference is maximal, 0 when groups difference is null 
 
 
 
 
 
Source of variation df  
1
 SS  
2
 MS  
3
 R-square P-value 
Treatment 1 0.51 0.51 0.026 0.032 
Week 1 0.88 0.88 0.044 0.001 
Treatment x Week 1 0.41 0.41 0.021 0.074 
Site  1 4.84 4.84 0.244 0.001 
Treatment x Site   1 0.32 0.32 0.016 0.133 
Site x Week 1 0.79 0.79 0.040 0.006 
Treatment x Site x Week 1 0.62 0.62 0.031 0.016 
Residual 55 11.46 0.21 0.578  
Total 62 19.82    
 1 way: Treatment 
 R
1
 P-value 
CON vs GOS 0.0 1.0 
   
 2 way: Treatment by GI site 
 Colon Rumen 
 R P-value R P-value 
CON vs GOS 0.14 0.007 0.0 0.46 
     
 3 way: Treatment by GI site by age 
 Colon Rumen 
 R P-value R P-value 
CON vs GOS at 2 weeks  0.47 0.001 0.04 0.24 
CON vs GOS at 4 weeks  0.06 0.137 0.05 0.21 
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Table 4.5. SIMPER for genera driving dissimilarity between GOS and CON groups 
1 Contribution to overall dissimilarity between groups 
 
  Average abundance %  
Genus  GOS CON Dissimilarity %  
1
 
Lactobacillus 63.4 39.2 33 
Streptococcus 5.67 9.80 9 
Faecalibacterium 0.816 10.9 9 
Oscillospira 1.15 8.24 7 
Bifidobacterium 5.63 2.27 6 
Collinsella 2.80 7.03 6 
Clostridium 1.23 6.48 5 
Enterococcus 4.08 3.02 4 
Total   79 
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Table 4.6. Regression coefficients for effects of dietary treatment, calf age and GI site 
 on abundance of identified genera 
 Coefficient (β) S.E  P-value exp(β)   1 
 Lactobacillus   
Intercept -2.515       0.327    < 0.0001 0.0809 
GOS 1.994  0.462 < 0.0001 7.3417 
Week 4 2.162       0.462 < 0.0001 8.6878 
Week 4 x GOS -2.034       0.654 0.002 0.1308 
     
 Bifidobacterium   
Intercept -4.544       0.656 < 0.0001 0.01 
GOS 2.183       0.926 0.02 8.87 
Week 4   1.184       0.926 0.2  
Week 4 x GOS -2.822       1.309 0.03  0.06 
    
 Streptococcus   
Intercept -1.812       0.436 < 0.0001 0.163 
GOS -0.889       0.617  0.15   
Week 4 -1.605       0.618 0.01 0.201 
Week 4 x GOS 0.1583 0.873 0.16  
    
 Faecalibacterium   
Intercept -1.567       0.566 < 0.0001 0.2086 
GOS -4.181       0.804 < 0.0001 0.0153 
Week 4 -3.049       0.802 < 0.0001 0.0474 
Week 4 x GOS 4.464       1.136 < 0.0001 86.8183 
    
  Oscillospira   
Intercept -2.020       0.566 < 0.0001 0.1327 
GOS -3.186       0.802 < 0.0001 0.0413 
Week 4  -1.417       0.800  0.07 0.2424 
Week 4 x GOS 2.582       1.133 0.02 13.2241 
     
 Collinsella   
Intercept -2.590       0.668 < 0.0001 0.075 
GOS -1.085       0.945 0.25  
Week 4 -0.134       0.945 0.88  
Week 4 x GOS 0.323       1.336 0.80  
     
 Clostridium   
Intercept -2.136       0.517 < 0.0001 0.1181 
GOS -2.327       0.732 0.002 0.0976 
Week 4 -2.329       0.733 0.002 0.0974 
Week 4 x GOS 2.459       1.036 0.02 11.69 
     
 Enterococcus   
Intercept -3.116       0.517  < 0.0001  
GOS 0.544       0.731 0.42  
Week 4 -1.014       0.732 0.17  
Week 4 x GOS -1.649       1.036 0.11  
1 exp (Intercept): represents expected taxa relative abundance for CON at 2 weeks of age; exp 
(GOS): represents fold change in taxa relative abundance with GOS treatment at 2 weeks 
with respect to CON at 2 weeks; exp (week 4): represents fold change in taxa relative 
abundance with CON treatment at 4 weeks with respect to CON at 2 weeks ; exp(GOS) 
*exp( week 4)*exp( week 4 x GOS) : represents fold change in taxa relative abundance with GOS 
treatment at 4 weeks with respect to CON at 2 weeks.   
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Table 4.7. Regression coefficients for effect of calf age, dietary treatment  
and GI site on colonic microbiota diversity 
1 Intercept: represents the natural logarithm of the expected value 
for CON at 2 weeks of age;  Week4: represents natural log of fold 
change for CON at 4 weeks with respect to CON at 2 weeks; GOS: 
represents natural log of fold change for GOS at 2 weeks with 
respect to CON at 2 weeks; (Week 4 ) + (GOS) + (week 4 x GOS): 
represents natural log of fold change for GOS at 4 weeks with 
respect to CON at 2 weeks.   
 
 
 
 
 
 
Table 4.8. Least squares means ± standard error for organ size for CON and GOS treatments 
1 TRT: dietary treatment effect (CON vs GOS)  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Coefficients (β)  1 S.E P-value 
 Shannon index  
Intercept 1.30 0.05 <0.0001 
Week 4 0.06 0.07 0.34 
GOS  0.08 0.07 0.24 
Week 4 x 
GOS 
-0.05 0.08 0.49 
 Treatment  P-value 
 CON GOS  TRT
1
 TRT x GI site TRT x week 
Length, m 3.87 ± 0.12 3.84 ± 0.12  0.90 0.60 0.80 
Weight, kg 0.45 ± 0.013 0.44 ± 0.013  0.60 0.80 0.60 
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Table 4.9. Least squares means ± standard error for SCFA and lactate concentrations for CON and GOS in rumen, jejunum and colon 
1 TRT: dietary treatment effect (CON vs GOS) 
 2NA: undetectable level 
 
 
 
 
 
 
Table 4.10. Least squares means ± standard error for epithelial resistance (Ω//cm2) and change in 
Isc (Δ mv) in response to glucose, glutamine and arginine addition 
1 TRT: dietary treatment effect (CON vs GOS) 
2 R: resistance measured in ohlms (Ω) 
3 Δ mv = change in circuit current in millivolts upon addition of respective nutrient. Surrogate measure of 
nutrient transport. 
 
 
 
 
 
 CON GOS P-value 
 Rumen Jejunum Colon Rumen Jejunum Colon TRT
1
 TRT x  
GI site 
TRT x  
week 
 mmol/mL    
Total SCFA 34.86 ± 3.67 2.39 ± 0.74 47.0 ± 3.27  
A 34.86 ± 3.67 3.57 ± 0.74 26.64 ± 3.27   B 0.04 0.0005 0.90 
Acetate 25.10 ± 3.50  2.20 ± 0.70 35.0 ± 2.40  
A 29.8 ± 3.50 3.2 ± 0.70 21.6 ± 2.4   B 0.40 0.003 0.90 
Propionate 3.75 ± 0.34 0.23 ± 0.10 8.2 ± 0.74  
A 4.23 ± 0.34 0.37 ± 0.10 3.6 ± 0.74   B 0.01 0.0005 0.30 
Butyrate 0.30 ± 0.43 NA
2 4.50 ± 0.40  A 0.54 ± 0.38 NA2 1.5 ± 0.47   B 0.0014 0.0009 0.60 
Isobutyrate 0.09 ± 0.20  NA
2 0.30 ± 0.17 0.09 ± 0.20 NA2 0.8 ± 0.24 0.30 0.50 0.42 
Valerate 0.02 ± 0.3 NA
2 0.30 ± 0.22 0.02 ± 0.3 NA2 0.4 ± 0.23 0.60 0.90 0.30 
Isovalerate 0.20 ± 0.16 0.17  ± 0.46 0.22 ± 0.15 0.2 ± 0.14 0.07 ± 0.30 0.25 ± 0.18 0.50 0.40 0.90 
Lactate 0.13 ± 0.07 0.19 ± 0.79 2.30 ± 0.31  
A 0.21 ± 0.07 1.78 ± 0.79 0.81  ±  0.31 B 0.10 0.0004 0.90 
 Treatment P-value 
Epithelium function CON GOS TRT
1
 TRT x GI site TRT x week 
R, Ω//cm2   2 141.1 ± 7.06 143 ± 6.79 0.80 0.96 0.72 
Glucose, Δ mv  3 1.39 ± 0.35 2.1 ± 0.35 0.20 0.40 0.40 
Glutamine, Δ mv 2.5 ± 0.37 2.79 ± 0.37 0.60 0.60 0.14 
Arginine, Δ mv 1.83 ± 0.42 2.21 ± 0.44 0.54 0.40 0.80 
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Table 4.11. Least squares means ± standard error for histomorphology measures for CON and GOS at 2 and 4 weeks of age 
1 TRT: dietary treatment effect (CON vs GOS)  
 
 
 
 
 
 
 
Table 4.12. Least squares means ± standard error for average milk, grain, and total dry matter intakes 
1 TRT: dietary treatment effect (CON vs GOS) 
 
 
 
 CON GOS P-value 
 2 4 2 4 TRT
1
 TRT x GI site TRT x week 
 Rumen, duodenum, jejunum and ileum    
Villae/Papillae length, μm 407.2 ± 16.3 384.23 ± 14.7 362.7 ± 16.1 B 429.2 ± 14.3   A     0.90 0.20 0.01 
     
 Rumen, duodenum, jejunum, ileum and colon    
Villae/Papillae/crypt width, μm 119.5 ± 2.9 124.4 ± 2.6 118.3 ± 2.9  126.4 ± 2.6  0.90 0.80 0.40 
     
 Duodenum, jejunum, ileum and colon    
Crypt depth, μm 407.2 ± 14.6 B 394.9 ± 12.5 B 419.7 ± 14.5 A 439.0 ± 12.4 A 0.04 0.60 0.24 
  TREATMENT  P-value 
  CON GOS  TRT
1
 week TRT x week 
Milk DMI ,kg/d        
0-2 wk  0.68 ± 0.01 0.66 ± 0.01  0.0005 <0.0001 0.005 
0-4 wk  0.82 ± 0.01 0.79 ± 0.01  0.016 <0.0001 0.089 
0-8 wk  0.91 ± 0.01  0.87 ± 0.01  0.0001 <0.0001 0.077 
Grain DMI ,kg/d         
4-8 wk  1.15 ± 0.44 1.15 ± 0.44    0.34 <0.0001 0.43 
Total DMI, kg/d        
4-8 wk  2.11 ± 0.39  2.09 ± 0.39  0.67 <0.0001 0.36 
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Table 4.13. Least squares means ± standard error for energy and protein intakes 
1 TRT: dietary treatment effect (CON vs GOS) 
2 ME: Metabolizable energy. 
3 CP: Crude protein. 
 
 
 
 
Table 4.14. Least squares means ± standard error for average water intake   
1 TRT: dietary treatment effect (CON vs GOS) 
  TREATMENT  P-value 
Nutrient  CON GOS  TRT
1
 week TRT x week 
ME
2
, Mcal/d        
0-2 wk  2.92 ± 0.06 2.86 ± 0.06  0.0006 <0.0001 0.0026 
0-4 wk  3.53 ±0.38 3.42 ±0.38  0.005 <0.0001 0.23 
0-8 wk  8.13 ± 1.22 7.94 ± 1.22  0.16 <0.0001 0.32 
CP
3
 , kg/d         
0-2 wk  0.19 ± 0.004 0.19 ±0.004  0.24 <0.0001 0.03 
0-4 wk  0.24 ± 0.002 0.24 ± 0.002  0.30 <0.0001 0.18 
0-8 wk  0.52 ± 0.08 0.51 ± 0.08  0.54 <0.0001 0.43 
  TREATMENT  P-value 
  CON GOS  TRT
1
 week TRT x week 
Average daily water intake  ,kg/d        
0-2 wk  7.47 ±0.23 7.57 ±0.23  0.56 <0.0001 0.89 
0-4 wk  8.32 ± 0.28 8.37 ± 0.28  0.62 <0.0001 0.56 
0-8 wk  9.61 ± 0.16 9.66 ± 0.16  0.70 <0.0001 0.67 
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Table 4.15. Least squares means ± standard error for body measurements growth 
1 TRT: dietary treatment effect (CON vs GOS)  
2 BW: Body weight, HG: Heart girth, BL: Body length, WH: Wither height, HH: Hip height and  
HW: Hip width. 
 
 
 
Table 4.16.  Effect of milk replacer rich in galacto-oligosaccarides (GOS) on the odds of presenting fecal 
scores of 4 and number of days with scores over 2 in calves. 
1Exponentiation the of log (odds ratio) and the log (number of days with fecal scores over 2) 
 
 Treatment  P-value 
Variable
2
 CON GOS  TRT
1
 week TRT x 
week 
BW, kg       
2 wk 45.40 ±0.66 44.76 ±0.66  0.0264 <0.0001 0.18 
4 wk 50.03 ±0.33 49.00 ±0.33  0.014 <0.0001 0.10 
8 wk 61.16 ±2.24 59.02 ±2.24  0.0304 <0.0001 0.34 
HG, in        
2 wk 32.06 ±0.17 31.85 ±0.17  0.0107 <0.0001 0.0144 
4 wk 33.10 ±0.30 32.77 ±0.30  0.0005 <0.0001 0.0014 
8 wk 35.27 ± 0.22 34.80 ± 0.22  <0.0001 <0.0001 0.042 
BL, in        
2 wk 24.79 ± 0.05 24.70 ± 0.05  0.13 <0.0001 0.16 
4 wk 25.33 ± 0.15 25.04 ± 0.15   0.0002 <0.0001 0.0264 
8 wk 26.74 ± 0.17 26.18 ± 0.17   <0.0001 <0.0001 0.0147 
WH, in         
2 wk 24.79 ± 0.08 24.70 ± 0.08  0.14 <0.0001 0.18 
4 wk 25.32 ± 0.11 25.05 ± 0.11   0.0475 <0.0001 0.0056 
8 wk 26.71 ±0.16 26.24 ±0.16   0.0058 <0.0001 <0.0001 
HH, in         
2 wk 83.59 ± 0.17 83.45 ± 0.17  0.14 <0.0001 0.025 
4 wk 84.76 ±0.38 84.40 ±0.38  0.09 <0.0001 0.045 
8 wk 87.80 ±0.39 87.07 ±0.39  0.0216 <0.0001 0.08 
HW, in        
2 wk 6.83 ± 0.03 6.81 ± 0.03  0.20 <0.0001 0.17 
4 wk 6.99 ± 0.02 6.95 ± 0.02  0.09 <0.0001 0.015 
8 wk 7.48 ± 0.04 7.40 ± 0.04  0.0165 <0.0001 0.23 
 Logistic estimate of odds to present fecal scores of 4 
 Log odds ratio S.E Odds ratio
1
 P-value 
GOS vs CON 0.86   0.153 2.36 <0.001 
     
 Poisson estimate for number of days with fecal sores over 2 
 Log (days over 2) SE Number of days over 2
1
 P-value 
2 weeks 
CON 2.49       0.021 12.0       0.0002 
GOS 2.60  0.021 13.5        
4 weeks 
     
CON 2.93       0.031 18.7       < 0.001 
GOS 3.17       0.030 23.9        
8 weeks 
     
CON 3.3       0.044 26.6  < 0.001 
GOS 3.6      0.040 36.9  
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Figure 4.1. NMDS of digesta samples from CON and GOS treatments, in rumen and colon, and at 2 and 4 weeks of age 
B 
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COLON 
RUMEN 
A 
Figure 4.2.NMDS of samples from: a) colon and rumen for CON and GOS; b) Only samples from colon for CON and  
GOS at 2 and 4 weeks 
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Figure 4.3. Distribution of relative abundance of taxa driving dissimilarity between CON and GOS groups at 2 and 4 
weeks of age. CON.2 = CON at 2 weeks; GOS.2 = GOS at 2 weeks; CON.4 = CON at 4 weeks; GOS.4 = GOS at 4 
weeks. Faecalibacterium relative abundance square root presented for ease of visualization. 
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Figure 4.4. Probability of occurence of diarrhea for CON (circles line) and GOS (crosses line) treatments. 
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CHAPTER V 
 
EVALUATION OF VARIOUS ADDITIVES AS STIMULATORS OF GLP-2 
SECRETION AND GUT DEVELOPMENT 
 
ABSTRACT 
Glucagon like peptide 2 (GLP-2) is a trophic factor secreted by endocrine L cells in the 
distal intestine and is responsible for adaptational changes such as mucosal growth and enhanced 
intestinal permeability under stressful circumstances, and has been proposed to have therapeutic 
potential to help young calves in circumstances such as weaning and diarrheal disease. Previous 
research indicates that GLP-2 secretion can be stimulated by substances like glucose, sweeteners 
and umami flavor. The objective of this experiment was compare a non-supplemented milk 
replacer diet against 1) glucose (220 mg/kg of BW/day), 2) stevioside (10 mg/kg of BW/day), 3) 
non-metabolizable glucose ( 6 mg/ kg of BW/day) and 4)  glutamic acid source (GS) (i.e.,umami 
flavor) (20 mg/kg of BW/day) supplemented diets in regards to GLP-2 secretion, GI organ size, 
cellular proliferation, GLP-2 signaling pathway mRNA expression, and intestinal epithelium 
morphometric dimensions; as  indicators of intestinal development in newborn Holstein calves.  
No difference among treatments in GLP-2 secretion or any of the intestinal development 
measurements was observed. Two possible reasons for this could be that at moderate to high 
milk feeding levels, like those used here, GLP-2 secretion may not be as responsive; and also 
possible failure to identify the optimal dose to achieve stimulation. 
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INTRODUCTION 
Neonatal calves are faced with different types of stressors. Promoting an early balance 
among the animal, its environment and etiological agents is necessary to minimize the 
probability of illness episodes (Davis and Drackley, 1998). Diarrhea is a common condition in 
the newborn calf and is most incident in the first few weeks of life (NAHMS, 2010). 
Development of nutritional strategies for the improvement of gut health and development during 
this life stage is desirable.  
Glucagon like peptide 2 (GLP-2) is a trophic factor secreted by endocrine L cells in the 
distal ileum and proximal colon and is responsible for adaptational changes such as mucosal 
growth and enhanced intestinal barrier function under stressful circumstances, and has been 
proposed to have therapeutic potential to help young calves in circumstances such as weaning 
and diarrheal disease (Burrin et al., 2003). Enteral food intake is the primary stimulus for GLP-2 
secretion in neonatal animals (Burrin et al., 2000; Taylor-Edwards et al., 2010). In ruminants, 
ileal proglucagon and GLP2 receptor (GLP-2R) mRNA abundance and GLP-2 plasma 
concentrations were up-regulated in response to increased energy intake in steers, suggesting that 
GLP-2 does play a role in the trophic response of the ruminant gastrointestinal  tract to increased 
energy intake (Taylor-Edwards et al., 2010).  
But beyond food or energy as a whole entity, specific nutrients like glucose and certain 
peptides have shown potential to stimulate GLP-2 secretion in monogastric animals via chemical 
sensing in the gut. Direct application of glucose to the luminal surface of the ileum stimulates 
GLP secretion from L cells in rats and humans (Brubaker and Anini, 2003), possibly by 
signaling through the sweet taste receptor T1R2/R3 located in the luminal membrane (Burrin et 
al., 2003). Similarly, it was recently shown that perfusion of free glutamate, a common element 
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of the umami flavor, into the duodenum increased portal venous concentrations of GLP-2 in rats, 
possibly via the bitter taste receptor T1R1/R3 (Wang et al., 2011). Glucose and glutamate-
containing peptides are thus potential GLP-2 secretagogue candidates to evaluate in the young 
calf.     
Some artificial sweeteners like sucralose, saccharin, and acesulfame K have been proven 
to taste sweet in humans, mice, and pigs. In fact, sweeteners can  induce in vivo increased 
expression of T1R2/R3 and its signal transducing membrane protein, Gα-gustducin, probably by 
a similar mechanism as that of simple sugars (Margolskee et al., 2007; Moran et al., 2010). If 
glucose can indeed elicit GLP-2 secretion through the sweet taste receptor, then it is possible that 
sweeteners bear a similar potential to promote GLP-2 secretion (Shirazi-Beechey et al., 2011), 
which renders them research candidates of interest as well.  
GLP-2 secretion also takes place upon endocrine and neural stimulation of the L cells in 
the ileum and proximal colon via glucose dependent insulinotropic peptide (GIP) released from 
enteroendocrine K-cells in the duodenum, and neural reflexes involving gastrin-releasing peptide 
(GRP) released from vagus nerve terminals innervating the stomach, prior to arrival and actual 
direct contact between dietary nutrients and the L cells in the distal intestine (Roberge and 
Brubaker, 1993; Roberge et al., 1996; Burrin et al., 2003). After GLP-2 release, the 
intestinotropic actions of GLP-2 on the colon are mediated through the actions of keratinocyte 
growth factor (KGF) and insulin-like growth factor (IGF)-2, whereas small intestinal growth has 
been linked to IGF-1, IGF-2, and ErbB ligands, as well as the IGF-1 receptor and ErbB 
(Rowland and Brubaker, 2011). The cellular source of these mediators remains unclear, but it 
likely includes the intestinal subepithelial myofibroblasts (Rowland and Brubaker, 2011). 
Conversely, the anti-inflammatory and blood flow effects of GLP-2 are dependent on vasoactive 
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intestinal polypeptide released from submucosal enteric neurons and nitric oxide, respectively 
(Rowland and Brubaker, 2011).  
A critical aspect of GLP-2 bioactivity after secretion is its rapid degradation by dipeptidyl 
peptidase IV (DPP4), whose rapid action provides GLP-2 with a relatively short half-life of ~7 
minutes in blood circulation (Burrin et al., 2003).  
   Given its trophic and protective effects on the intestine, GLP-2 activity in calves 
may lead to improve intestinal health or development in the period between birth and weaning 
(Burrin et al., 2003). 
 The hypothesis of this experiment was that, compared to a non-supplemented milk 
replacer diet, glucose, stevioside, non-metabolizable glucose and umami flavor supplemented 
diets will enhance GLP-2 secretion, GI organ size, cellular proliferation, GLP-2 signaling 
pathway mRNA expression, and intestinal epithelium morphometric dimensions; thereby 
improving overall intestinal development of newborn Holstein calves.  
MATERIALS AND METHODS 
Animals and Treatment Allotment 
Seventy five newborn Holstein male calves were purchased from an outside vendor. 
Upon arrival to UIUC facilities, calves were weighed and their plasma protein level measured. 
Complete blocks of calves were made based upon BW and within each block the following five 
treatments were randomly assigned to each calf: 1) Control: commercial milk replacer, 2) control 
+ glucose (220 mg/kg of BW/day), 3) control + sweetener (stevioside, 10 mg/kg of BW/day), 4) 
control + 3-O-M glucose (i.e., non metabolizable glucose) ( 6 mg/ kg of BW/day) and 5) control 
+ a glutamate source (GS) (i.e. umami flavor) (20 mg/kg of BW/day).  
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Dosing of glucose was based on previous studies and made large enough to ensure 
induction of physiological response. Studies on expression of the sodium-glucose co-transporter 
1 (SGLT-1) in adult sheep infused with 1.5 liters per day of 30 mM D-glucose solutions  
successfully achieved a 40 to 80 fold increase in the rate of glucose transport (Shirazi-Beechey et 
al., 1991). One and a half liters of a 30 mM glucose solution equals about 8 to 9 g of glucose 
daily. We decided to dose ~ 10 g/d.  
3-O-M-glucose has been used at doses that range from 200 to 300 mg/d in humans to 
cause sustained measurable levels in plasma (Shirazi-Beechey et al., 1991). In-house research at 
LUCTA (Barcelona, spain) has also used about 300 mg/day in pigs which equals about 6 mg/kg 
of BW in 50-kg pigs, to reach measureable levels in plasma. Such concentration has been 
sufficient to up-regulate SLGT-1 (personal communication with Dr. I. Ipharraguerre).  
Sweetener and GS dosage was set following levels previously used in pig research at 
LUCTA as well (personal communication with Dr. I Ipharraguerre).  
After arrival, calves were fed commercial milk replacer twice daily at a rate of 1.25 % of 
BW daily divided into 2 feedings for the first 2 days. On day 3, the amount of milk replacer was 
increased to 1.75% of BW and then held constant through the end of the experiment. On day 7, 
treatments were introduced and continued until the end of experiment at day 22 of age.  
Milk replacers contained 28% crude protein and 16% fat on a DM basis. Milk replacer 
composition and feeding rate was set to meet or exceed NRC daily nutrient allowance 
recommendations (NRC, 2001).   
Plasma GLP-2 
On day 12, animals were fitted with catheters in the jugular vein for venous blood 
sampling. On day 13, jugular vein samples were taken at -30, 0, 5, 15, 30, 60, 120, and 240 min 
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relative to feeding for measurement of GLP-2 plasma concentrations. Blood samples were 
collected into tubes containing EDTA plus a pyrrolic acid based DPP4 inhibitor. All blood 
samples were centrifuged immediately after collection, the plasma was extracted and frozen at -
20 °C until analyses. Plasma GLP-2 concentrations were determined in the laboratory of Jens 
Juul Holst at the University of Copenhagen, Denmark.  
Animal Slaughter and Sample Collection  
On each of days 21 and 22 of age, all calves were euthanized for experimental 
measurements. Samples from fore stomach, small intestine and hind gut were collected 
immediately for various analyses as described below. Digesta was thoroughly removed and 
intestinal organs size was recorded.   
Histomorphology 
Sections of rumen, duodenum, jejunum, ileum, and proximal, middle, and distal colon 
were collected and fixed in 10% formalin for 24 h and then embedded in paraffin blocks and 
stained with hematoxylin and eosin. Paraffin sections 5-μm thick were cut and mounted onto 
glass slides and these were then scanned through a Nanozoomer scanning microscope 
(Hamamatsu, Japan) at 20 X to obtain digital microscopic scans on which papillae and villae 
height and width, and crypt width and depth were measured afterwards. These analyses were 
performed at the Institute for Genomic Biology at the University of Illinois. 
Cellular Proliferation 
Abundance of labeled cell nuclei with the protein marker Ki67 by immunohistochemistry 
was used as a measure of cellular proliferation. Paraffin-embedded tissue sections from jejunum, 
ileum, and colon were incubated for 1 h at 60
o
C, deparaffinized, and rehydrated.  Sections were 
treated in EDTA antigen retrieval for 25 min. Endogenous peroxide was blocked with methanol-
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3% hydrogen peroxide (15 min).  Sections were incubated in 2% normal mouse/2% normal goat 
in PBS/Tween for 20 min at room temperature. Serum was taped off and the primary antibody 
(Vector, VP-k451) was added at 1:1000 for 1 hr. Subsequently, sections were incubated in goat 
anti-rabbit secondary antibody (Jackson Immuno) for 30 min and Vector Elite ABC kit for 45 
min.  AEC was used for the choice of chromogen. Slides were counterstained with haematoxylin.  
The abundance of Ki-67 was assessed by scanning the slides on a Nanozoomer microscope 
(Hamamatsu, Japan) at 40 X to obtain digital microscopic scans. The digital image processing 
software AXIOVISION (ZEISS, Germany) was used to compute the Ki-67 stained area based on 
a pre-defined pixel intensity on the microscopic scans. This method is useful to avoid error from 
miscounting overlapping stained cells.  
mRNA Expression   
To assess treatment effects on mRNA expression of the GLP-2 signaling pathway in the 
distal gut, ileum and colon scrapings were collected into RNALater reagent (Qiagen, Hilden, 
Germany).  
For extraction, tissue was homogenized in ice-cold Trizol in a bead beater (Invitrogen 
Corp., Carlsbad, CA, USA). Afterward, extraction with acid-phenol chloroform was performed 
(Ambion, Austin, TX, USA). RNA purification and genomic DNA removal was carried out 
through a miRNAeasy mini spin column (Qiagen, Hilden, Germany) and incubation with DNase. 
The RNA purity was evaluated using an Agilent 2100 Bioanalyzer (Agilent Technologies, Palo 
Alto, CA).   
Upon extraction, complementary DNA was synthesized and subjected to Real Time 
Quantitative Polymerase Chain Reaction (RT-qPCR) in an ABI Prism 7900 HT SDS instrument 
(Applied Biosystems, CA, USA) following methodology previously reported by Khan (2013). 
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Briefly, for cDNA synthesis 100 ng RNA, 1 μg dT18 (Operon Biotechnologies, Huntsville, AL, 
USA), 1 μL 10 mmol/L dNTP mix (Invitrogen Corp., CA, USA), 1 μL random primer p(dN)6 
(Roche®, Roche Diagnostics GmbH, Mannheim, Germany), and 10 μL DNase/RNase free water 
were mixed and incubated at 65 °C for 5 min and cooled down on ice for 3 min. Then, 6 μL of a  
mixture of of 4.5 μL 5X First-Strand Buffer, 1 μL 0.1 M dithiothreitol, 0.25 μL (50 U) of 
SuperScriptTM III RT (Invitrogen Corp.CA, USA), and 0.25 μL of RNase Inhibitor (10 U; 
Promega, Madison, WI, USA) was added. The reaction was performed in an Eppendorf 
Mastercycler® Gradient. Complementary DNA was then diluted 1:4 (v:v) with DNase/RNase 
free water. Afterwards, quantitative PCR  was performed using 4 μL diluted cDNA (dilution 1:4) 
combined with 6 μL of a mixture composed of 5 μL 1 × SYBR Green master mix (Applied 
Biosystems, CA, USA), 0.4 μL each of 10 μM forward and reverse primers, and 0.2 μL 
DNase/RNase free water in a MicroAmp™ Optical 384-Well Reaction Plate (Applied 
Biosystems, CA, USA).  
Triplicate runs of each gene were made for each sample. Relative quantitation of RT-
qPCR product was performed using relative standard curve method with 6  points plus a non-
template control, and expression normalized to the reference gene mRNA expression.  The linear 
range of target quantification was established to determine the appropriate amount of cDNA 
template to be used in the PCR reaction.  
Data were calculated with the 7900 HT Sequence Detection Systems Software (version 
2.2.1, Applied Biosystems, CA, USA). Final abundance values for each gene were normalized 
using the geometric mean of 3 internal control genes: Glyceraldehyde 3-phosphate 
dehydrogenase (GAPDH), beta-2-microglobulin (B2M) and hypoxanthine 
phosphoribosyltransferase 1 (HPRT1) (Vandesompele et al., 2002). 
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Genes selected to represent the GLP-2 pathway were proglucagon (GCG) and GLP-2 
receptor (GLP2R) (Connor et al., 2010; Rowland and Brubaker, 2011). Genes thought and 
selected to represent the GLP-2 paracrine mediator network included keratinocyte growth factor 
(FGF7), endothelial nitric oxide synthase (NOS3), insulin like growth factor 1 and 2 (IGF1, 
IGF2), IGF1 receptor (IGF1R), vasoactive intestinal peptide (VIP), epidermal growth factor 
receptor (EGFR), heparin binding EGF like growth factor (HBEGF), early growth response 1 
(EGR1), c FOS proto-oncogene (FOS) and neuregulin 1 (NRG1) (Rowland and Brubaker, 2011). 
Genes previously suggested to be involved in the GLP-2 cellular signaling cascade (Rowland 
and Brubaker, 2011) and tested here were murine thymona viral oncogene (AKT1), 
phosphatidylinositol 3 biphosphate kinase (PIK3CA) (Rowland and Brubaker, 2011). In addition, 
a few previously reported functional marker genes were evaluated (Connor et al., 2010). For 
peptide transport, apoptosis and proliferation, the genes corresponding to the solute carrier 
family (SLC15A1), caspase 6 (CASP6), and proliferating cell nuclear antigen (PCNA) and cyclin 
D1 (CCND1), respectively, were assessed. Internal control genes included ATP synthase 
(ATP5B), B2 microglobulin (B2M) and hypoxanthine phosphoribosyltransferase (HPRT1) 
(Connor et al., 2010). 
Primers were designed using the NCBI (National Center Biotechnology) primer design 
online facility. Reference intestinal cDNA was used to test primers running them in a 4% agarose 
gel. If a band of expected size was present in the gel, PCR amplification product was submitted 
for sequencing to the core DNA sequencing facility at Roy J. Carver Biotechnology Center at the 
University of Illinois to verify the primer ability to amplify the desired gene sequences (tables 
6.1, 6.2). Alignment was performed using Chromas software (CHROMAS, South Brisbane, 
Australia).   
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Gene PCR amplification efficiency (table 6.3) was calculated from the standard curve as: 
              
( 
 
     ) 
Afterwards, mRNA abundance was computed as: 
               
 
               
, 
Where 
                                                        . 
Feed Intake and Health Check Scores 
Milk replacer intake was measured and recorded daily. Average daily milk and water 
intake, and cumulative milk refusal were calculated for analysis.  Fecal scores were recorded 
daily. Milk replacer samples were taken twice weekly for nutrient composition analysis. 
Statistical Analysis 
For measurements of nutrient intake, the analysis of variance model included treatment, 
week as a repeated measure, and their interaction (T*W) as fixed effects. Initial bodyweight and 
plasma protein concentration were tested as covariates. Different error structures were evaluated 
and the one that minimized the adjusted and unadjusted Akaike Information Criteria (AAIC and 
AIC), the Bayesian Information Criteria (BIC) and -2 Ratio Log-likelihood, with the least 
number of parameters was chosen. The model was: 
                                            
Where Eij and eijk are the error between calves within the same treatment and the error 
between repeated measures for the same calf, respectively.  
Similarly, for GLP-2 concentrations over time, the model included treatment, hour as a 
repeated measure and their interaction (T*H) as fixed effects. Initial bodyweight and plasma 
 134 
 
protein were tested as covariates. Error structure was evaluated as mentioned above. The model 
was: 
                                                   
Where Eij and eijk are the error between calves within the same treatment and the error 
between repeated measures for the same calf, respectively.  
GLP-2 secretion area under the curve was also assessed and compared among treatments. 
A similar statistical linear model was used for gastrointestinal organ size, 
histomorphometry and cellular proliferation measures since repeated measures were performed 
on various anatomical regions of the same calf. 
For mRNA abundance, because 21 genes were measured, a permutational multivariate 
analysis of variance (PERMANOVA) (Anderson, 2001) was conducted on a Euclidean distance 
matrix built from the standardized variables (mean=0, SD = 1) to test the hypothesis of an overall 
effect of treatments on any of the dependent variables. In addition, nonmetric multidimensional 
scaling (NMDS) plotting was used to visually identify treatment differences taking all genes into 
account simultaneously (Borcard et al., 2011).  
Residuals were checked for homogeneity of variance and normality assumptions all 
throughout by residual plots, extended Levene test and Shapiro-Wilk test. Heterogenous 
variances were handled by implementing error structures that allow heterogenous variances 
(Littell et al., 2006). If the normality assumption was not met, transformation of the dependent 
variable proceeded and normality and constancy of errors was verified again. Dunnett’s one 
sided lower bound adjustment would be used to test treatment mean differences. Experiment 
wise error rate was maintained at 5%. When significance is declared for any Pos-Hoc 
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comparison, a Tukey adjustment was used to compare treatment means maintaining the 
experiment-wise error rate at 5%.  
For fecal scores, a generalized linear model with a cumulative logistic multinomial link 
function and a random intercept was fitted to the data (Fitzmaurice et al., 2011). The linear 
predictor was: 
           , 
where X is a matrix containing the fixed effects of treatment, day and their interaction, 
and Z is a matrix containing a random effect for the intercept which accounts for the clustering 
of the observations from the same calf. 
Repeated measure analyses were performed using SAS (SAS Institute Inc. Cary, NC., ), 
whereas multivariate gene expression data analysis was carried out through specific packages 
(Oksanen et al., 2012) in R open source software. 
RESULTS  
GLP-2 Secretion  
There was no effect of treatment or its interaction with time post feeding on the average 
plasma GLP-2 concentration with respect to the control diet. Also, no treatment effect on area 
under the GLP-2 secretion curve was observed (Table 5.4). Figure 5.1.a visually illustrates the 
large overlap among confidence intervals for all treatment means.   
GI Organ Size  
There was no effect of treatment on organ weight expressed in kilograms or on a BW 
percentage basis, or organ length. The interaction between treatment and GI organ was also non-
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significant. Table 5.5 and Figure 5.1.b show the similar treatment means and their confidence 
intervals.   
Intestinal Epithelium Morphometric Dimensions 
There was no effect of treatment or its interaction with GI organ on the length or width of 
the rumen papillae, the length or width of the villae in the duodenum, jejunum or ileum or the 
crypt depth or width in duodenum, jejunum, ileum or colon (Table 5.5, Figure 5.2 ).   
Cellular Proliferation 
There was no effect of treatment or its interaction with GI organ on the average 
abundance of ki-67 stained nuclei with respect to the control diet (Table 5.5). Figure 5.1.c 
displays the similarity between confidence intervals for treatment means.  
GLP-2 Signaling Pathway mRNA Expression 
 PERMANOVA (Table 5.6) indicated that overall expression of the GLP-2 signaling 
pathways in ileum and colon was not affected by treatments. Figure 5.3 displays a NMDS plot 
that simultaneously considers information from all genes evaluated on all experimental units and 
it is clear that all treatment groups cluster together, thus corroborating PERMANOVA findings 
of no difference among treatments. In contrast, an analysis of similarities identified a very strong 
difference in the pathway gene expression between ileum and colon (Figure 5.3b).  
Water and Milk Replacer Intake and Refusals 
Average weekly milk liquid and dry matter intake and total refusal was not affected by 
treatments or their interaction with time. Mean water intake was also unaffected by treatment or 
its interaction with time. Table 5.7 and Figure 5.4 display treatment means and their confidence 
intervals.  
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Fecal Scores 
No effect of treatment or the interaction with time had a significant effect on the odds of 
calves presenting diarrheal episodes with respect to the control treatment.   
DISCUSSION  
The fact that no treatment elicited any response in at least GLP-2 secretion indicates that 
either these compounds (i.e., glucose, non-metabolizable glucose, sweetener, GS) do not actually 
have any effect or that we failed to properly identify the supplementation level required to induce 
such response.  
In the case of glucose and non-metabolizable glucose, there is evidence that infusing 
mature sheep with ~8 g/d can increase the monosaccharide transport from 40 to 80 fold as a 
result of an increase in the number of SGLT1 transporters (Shirazi-Beechey et al., 1991).  Mature 
sheep of the racial background reported in the cited study can be expected to present a similar 
BW to that of a calf (~50 kg); therefore the dosage per unit of BW would have been similar to 
the one used in our study. Because GLP-2 modulates expression of SGLT1 (Cheeseman, 1997; 
Ramsanahie et al., 2003; Cottrell et al., 2006; Sangild et al., 2006), we made the key assumption 
that if the above dosage could elicit such large changes in transporter expression and activity, it 
probably should have been through stimulation of the GPL-2 pathway (Shirazi-Beechey et al., 
2011).  
Regarding sweeteners, unlimited access to 2 mM sucralose, 10 mM acesulfame K and 20 
mM saccharin solutions as the water source increased SGLT1 mRNA and protein expression, 
and glucose absorption in mice (Margolskee et al., 2007). Unfortunately, the authors provided no 
information to allow calculation of the absolute amount of sweetener consumed by the animals. 
In this experiment we supplied stevioside at 10 mg/kg of BW/day for a total of about 500 mg/day 
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(average calf BW = 50 kg), which, for an intake volume of 2.9 L, results in a 0.54 mM solution. 
Although, on a molarity basis it seems a low stevioside supplementation level, it is hard to 
ascertain whether this is actually low comparatively because different sweeteners can elicit 
response at different levels as evidenced above (Margolskee et al., 2007). On a 
milligram/milliliter basis, Margolskee et al.(2007), supplied sucralose, acesulfame K and 
saccharin at ~ 265, 67 and 122 mg/mL/kg of BW, respectively; whereas, we supplied stevioside 
at 0.003 mg/kg of BW. On a mass basis our stevioside supplementation level would appear low 
as well, but again, it is impossible to compare on an absolute amount basis. Consequently, this 
impedes a more precise statement of how far we might have been from an optimal 
supplementation level for inducing a response in GLP-2 secretion.   
Nevertheless, sweetener and umami flavor dosage levels were set following levels 
previously determined to trigger response in pigs at LUCTA (personal communication with Dr. 
I. Ipharraguerre). Recently, it has been shown that the sweet-taste sensitivity varies widely 
among species and even strains within species. For example, unlike humans, rats do not perceive 
aspartame, cyclamate, neotame, monellin, thaumatin or alitame as sweet (Pepino and Bourne, 
2011). Also, although both mice and rats show some preference for stevia extracts over water, 
they differ in their responses to sucralose (Pepino and Bourne, 2011). Moreover, even though 
some animal studies have found that sweeteners activate gut sweet taste-pathways that control 
incretin release and up-regulate glucose transporters, human studies have found that the sole 
interaction of sweeteners with sweet-taste gut receptors is insufficient to elicit incretin responses 
(Pepino and Bourne, 2011). These observations should be considered in the future when 
designing studies that examine the effects of sweeteners on incretin responses. 
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But even if sensitivity to stevioside or GS were similar in pigs and calves, it is possible 
that dosage does not scale linearly from the former to the latter. That is, the number of 
milligrams per day per kilogram of BW may not be constant across species. Indeed, even though 
dosage scaling based on BW is commonly used for practical reasons, interspecies differences in 
the dose–response relationship can be large (Sharma and McNeill, 2009). Thus, this may have 
been another limitation in this study and perhaps running species specific dose-response curves 
may be more fruitful.  
Lastly, enteral food intake level is known to control GLP-2 secretion powerfully, indeed 
it perhaps is the single variable with the greatest secretory effect (Burrin et al., 2000). These 
calves were fed a fairly high feeding rate (1.75% of BW as DM). It is possible that incretin 
secretion responses to secretagogues like stevioside or umami are dependent upon enteral 
nutrient intake level. If so, this interaction shall be evaluated and the response surface of enteral 
intake level by secretagogue supplementation level be defined.       
   CONCLUSION 
The objective of this experiment was to test the hypothesis that glucose, non-
metabolizable glucose, stevioside and the umami flavor could enhance GLP-2 secretion and 
thereby increase gut growth or health of newborn Holstein calves. No effect of any treatment on 
intestinal growth and development was observed. Such lack of response was due to failure to 
identify supplementation levels that could stimulate incretin release, even though previously 
published work and LUCTA’s in-house research with models such as lambs and pigs, 
respectively, had detected responses at these concentrations. Species specific sensitivity to sweet 
flavor and GS may render direct dose extrapolation between species inappropriate and; therefore, 
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species specific dose response surfaces may provide a better approach to optimize the incretin 
release response.       
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 TABLES AND FIGURES 
 
Table 5.1. RT-qPCR performance for all genes measured in ileum and colon 
Gene Ct median
1
 Median ΔCt Slope2 r2   3 Efficiency 
AKT1 21.3291 1.341842 -2.91824 0.970876 2.201267 
ATP5B 19.96596 0.123137 -3.26196 0.9907 2.025651 
CASP6 21.43135 1.347451 -3.29044 0.990168 2.013311 
CCND1 24.93846 4.82878 -3.5273 0.991 1.920892 
EGFR 24.8108 4.709171 -3.27129 0.994946 2.021573 
EGR1 24.14954 4.137083 -3.29501 0.991319 2.011357 
FGF7 27.63172 7.378138 -2.87 0.995 2.230653 
FOS 24.42071 4.390363 -3.31165 0.98124 2.004306 
GCG 23.76609 3.520812 -3.28305 0.981486 2.016486 
GLP2R 25.31576 5.181228 -2.92008 0.993242 2.20017 
HBEGF 27.75724 7.798241 -2.96694 0.980093 2.172937 
IGF1 26.16876 6.125472 -3.01111 0.9937 2.148342 
IGF1R 24.88765 4.692747 -3.29146 0.987224 2.012875 
IGF-2 23.90864 3.731504 -3.10092 0.996313 2.101284 
NOS3 25.71666 5.452764 -3.07289 0.986515 2.115567 
NRG1 26.24303 6.147391 -3.20279 0.989386 2.052238 
PCNA 22.74805 2.539459 -3.35044 0.98995 1.988238 
PIK3CA 24.49259 4.416382 -3.42971 0.981818 1.956904 
SLC15A1 22.81702 2.987484 -3.07992 0.980693 2.11195 
VIP 29.58792 9.459522 -2.95473 0.985911 2.179919 
1 Median from all ileum and colon samples from 45 calves 
2 Slope of the standard curve 
3 Determination coefficient from standard curve 
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Table 5.2. Gene ID, accession number, and corresponding forward and reverse verified primers 
GENE NCBI ACCESSION # FORWARD REVERSE 
AKT1 NM_173986.2 GGATTACCTGCACTCGGAAAAG TCCGAAGTCGGTGATCTTGAT 
ATP5B BC116099.1 AGCATTTGGGTGAGAGCACA GTCTCAGGGCCAACAGGAAT 
B2M NM173893.3 TCCAGCGTCCTCCAAAGATT CCCATACACATAGCAGTTCAGGTAA 
CASP6 NM_001035419.2  CACAGGACAGACACGCCAGAT AAGTCGGCTCCAGCAGGAA 
CCND1 BC112798.1 GATGCCAACCTCCTCAACGA GGCAGGATCTCCTTCTGCAC 
EGFR AY486452.1 AACTGTGAGGTGGTCCTTGG CATATCCGGCAACCTCCTGG 
EGR1 BC118328 TGTGATGATGCTGTGACGATTC ACTCTGACACATGCTCCGAT 
FGF7 XM_005211861.1 AAGTTGCACAGGGCAGACAA GTTGCTGAGATGCTGTTTGCT 
FOS BT029837 GCAAAACGCATGGAGTGTGT AAAAGAGACGCAGACCCAGG 
GAPDH NM_001034034 TTGTCTCCTGCGACTTCAACA TCGTACCAGGAAATGAGCTTGAC 
GCG NM_173916.3 CCCTTCAGAACACAGAGGAGAAA GAGTGGCGCTTATCTTCATTGA 
GLP2R XM_589370.4| TTCTGGTGCAGTCTGTAATGGG CCCTTCCTGAGTTCTCTTCGC 
HBEGF NM_001144090.1 GCCATCTAGATTGGGCCTCC ACCCAGATCCCACTGGACAT 
HPRT1 NM_001034035.2 GCTGGCTCGAGATGTGATGA TCCAACAGGTCGGCAAAGAA 
IGF1 NM_001077828.1 CCAATTCATTTCCAGACTTTGCA CACCTGCTTCAAGAAATCACAAAA 
IGF1R NM_001244612.1 CGACATCCACAGCTGTAACCAT AGGAATGTCATCTGCTCCTTCTG 
IGF2 NM_174087.3 CCTCCAGTTTGTCTGTGGGG GGGTGGCACAGTAAGTCTCC 
NOS3 NM_181037.3 CGGAACAGCACAAGAGTTACAAGA TGTGTTGCTGGACTCCTTTCTC 
NRG1 XM_005226076.1 CGGTCAGTCCCTTCGTGGAA GGTTGCAGTGGAACGAGTTGA 
PCNA BC103068 GAACCTCACCAGCATGTCCA ACGTGTCCGCGTTATCTTCA 
PIK3CA NM_174574 ATTGGCCTCCAATCAAGCCT CACCGAACAGCAAAACCTCG 
SLC15A1 BC140526 ACTCCGTCTCCCAGACACAA CCACCCAACAGAGTGTCCTG 
VIP AF503910.1 CTTCTTGTGTTCCTGACGCTGTT AGAGCCGAAGGTGCTCCAA 
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Table 5.3. Sequence of amplicons obtained from primers and verified against NCBI primer BLAST. 
AKT1 CTCAGCTGAGACTCATGCTGGACAGGACGGGCACATCAAGATCACCGACTTCGGA 
ATP5B TGGTTAGAGGTCAGAAAGTCCTGGATTCTGGTGCACCAATCAGAATTCCTGTTGGCCCTG 
B2M GCAATGAACACCACAGAAGATGGAAGCAATTACTGAACTGCTATGTGTATGGGA 
CASP6 TTATACACTTCCGTGCTGGAGCCGACTT 
CCND1 GGAGGAACGTACGCGCCCTCGGGTATCCTACTTCAAGTGTGTGCAGAAGGAGATCCTGC 
EGFR ACCTTTCTTTTCTCAGACCATCCAGGAGGTTGCCGGATATG 
EGR1 TCTTGGTATTATCGGAGCATGTGTCAGAGT 
FGF7 GTATCAGCGTGTTATCACAGACAAAGTCAAGTAGCAAACAGCATCTCAGCAAC 
FOS CATCGTAGAGCGTTAGTTAGTAGCATGTGGAGCAGGCCTGGGTCTGCGTCTCTT 
GAPDH CACTCTTCTCTCGAGTCTGGGGGCGTGCATTGCCTCACGACCACTTTGTCAAGCTCATTTCCTGGTACGAAAT 
GCG CTCGGCGATCCAGATCAGATCAATGAAGATAAGCGCCACTC 
GLP2R TGTGTGCTGCCTCATCACTCTGGATGTCTCTGTCCCTGCCTTCCTACTTACCTTGGTGGCGCGAAGAGAACTCAGGAAGGGC 
HBEGF AACAGAATATGTCCAGTGGGATCTGGGT 
HPRT1 CCTCGTGTTGCTCAGGGGGGCTATAAGTTCTTTGCCGACCTGTTGGA 
IGF1 AATCAGCAGTCTTCACCCAATTATTTAAGTGCTGCTTTTGTGATTTCTTGAAGCAGGTG 
IGF1R ACTTTGTCTTTGCAAGAACCATGCCTGCAGAAGGAGCAGATGACATTCCT 
IGF2 
CGACATCAGCCGCATACCGACGCAGCCTGTGCATCGATGGAGAGTGTTGCTTCCGAAGCTGCGACCTGGCCCTGCTGG 
AGACTTACTGTGCCACCC 
NOS3 CAGCGTCTCTGCTCAGACCCGCTGTGTCCTCCTGGCGGCGGAGAGAAGGAGTCCAGCAACACA 
NRG1 TCCTTGTGTACGGCACACGGCGTCGGGAGAGTATGACCACCACGCCCAGCAATTTCAACTCGTTCCACTGCAACC 
PCNA AGACAATCATTACCTTAAGAGCTGAGATAACGCGGACACGT 
PIK3CA CATTACCCAGATCCTATGGTTCGAGGTTTTTGCTGTTCGGTG 
SLC15A1 CAGGTCTGTCCTGGGGGCAGGACACTCTGTTGGGTGGA 
VIP GCTCTTTTTGGAGCACTTC 
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Table 5.4. Treatment means for plasma GLP-2 concentrations and AUC 
 Treatment
1
  P-value 
 CON Gluc 3-o-M-G Sweet GS S.E. Trt
2
 Trt x min.
3
 
[GLP-2], pmol/ml  38.3 47.4 35.6 38.5 39.7 7.1 0.8 0.47 
AUC, nmol
4
 8.6 11.9 8.1 8.7 9.6 2.3 0.76 NA 
1CON: control; Gluc: glucose; 3-o-M-G: 3-O-Methyl glucose; Sweet: sweetener, GS: glutamate source.  
2Trt: treatment effect 
3Trt x min.: treatment by minute interaction effect 
4AUC: Area under the GLP-2 secretion curve 
 
 
 
Table 5.5.Treatment means for organ size, histomorphology and proliferation 
 Treatment
1
  P-value 
 CON Gluc 3-o-M-G Sweet GS S.E. Trt
2
 Trt x 
 GI organ
3
 
 GIT organ size    
Weight, kg 0.32 0.34 0.32 0.31 0.32 0.01 0.55 0.94 
Weight, % of BW 0.7 0.75 0.71 0.71 0.72 0.025 0.64 0.91 
Length, cm 336 351 339 335 335 7.9 0.60 0.86 
         
 Histomorphology    
Villae length, μm 515.4 510.0 499.0 491.1 507.0 17.6 0.88 0.69 
Villae width, μm 176.0 179.6 171.8 183.0 176.3 6.4 0.76 0.8 
Crypt depth, μm 361.0 376.3 376.8 383.3 367.2 9.0 0.48 0.79 
Crypt width, μm 61.7 64.3 60.0 61.2 63.7 1.4 0.15 0.59 
         
 Proliferation    
ki-67 abundance, % 6.9 6.2 6.0 6.3 6.2 0.3 0.38 0.16 
1CON: control; Gluc: glucose; 3-o-M-G: 3-O-Methyl glucose; Sweet: sweetener, GS: glutamate source.  
2Trt: treatment effect 
3Trt x GI organ: treatment by GI organ interaction effect 
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Table 5.6.PERMANOVA test for treatment effects on the GLP-2 pathway gene expression 
Source DF
1
 SS
2
 MS
3
 F
4
 R
2
 P-value 
Treatment  4 0.1 0.025 0.81 0.08 0.68 
Residuals 38 1.2 0.031    
Total 42 1.3     
1 Degress of freedom 
2 Sum of squared distances 
3 Mean squares 
4 F statistic 
 
 
Table 5.7.Treatment means for milk intake and water intake 
 Treatment   P-value 
 CON
1
 Gluc 3-o-M-G Sweet GS  S.E. trt
2
 trt x week
3
 
Milk intake, kg/d 2.98 2.92 2.98 2.93 2.96  0.05 0.85 0.99 
Milk DMI, kg/d 0.34 0.33 0.34 0.34 0.34  0.005 0.85 0.99 
Milk refusal, kg
4
 1.35 1.80 0.69 1.39 1.19  0.34 0.21 NA 
Water intake, kg/d 1.07 0.95 1.40 1.12 1.34  0.15 0.07 0.72 
1CON: control; Gluc: glucose; 3-o-M-G: 3-O-Methyl glucose; Sweet: sweetener, GS: glutamate source.  
2Trt: treatment effect 
3Trt x week: treatment by week interaction effect 
4 Cumulative liquid milk refusal over the entire trial (square root transformation to meet normality assumptions) 
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a  b 
 c 
3OMG  Control        Gluc         Sweet          GS 3OMG   Control        Gluc         Sweet          GS 
3OMG    Control        Gluc           Sweet          GS 
 
 
Figure 5.1. Confidence intervals for treatment means of a) plasma GLP-2, b) organ size and c) proliferation. 3OMG: 3-o-Methyl 
glucose, Gluc: glucose, Sweet: Stevioside, GS: Glutamate source. 
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Figure 5.2. Confidence limits for treatment means of histomorphometry measures. 3OMG: 3-o-Methyl glucose, Gluc: 
glucose, Sweet: Stevioside, GS: Glutamate source. 
Control   3OMG         Gluc            Sweet           GS Control    3OMG            Gluc           Sweet        GS 
Control   3OMG           Gluc           Sweet           GS Control   3OMG          Gluc          Sweet            GS 
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Figure 5.4. Confidence limits for treatment means of a) milk and b) water intake 
Control    3OMG           Gluc           Sweet           GS Control     3OMG          Gluc            Sweet           GS 
a b 
Figure 5.3. NMDS plot of observations and treatments. a) Treatment groups, b) Ileum and colon groups 
 (ANOSIM, R=0.8, p<0.001) 
 
R = 0.8, p < 0.001 
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